TW201219450A - Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same - Google Patents
Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same Download PDFInfo
- Publication number
- TW201219450A TW201219450A TW100123676A TW100123676A TW201219450A TW 201219450 A TW201219450 A TW 201219450A TW 100123676 A TW100123676 A TW 100123676A TW 100123676 A TW100123676 A TW 100123676A TW 201219450 A TW201219450 A TW 201219450A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- compound
- acid
- crystal alignment
- reaction
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 209
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 84
- -1 diamine compound Chemical class 0.000 claims abstract description 198
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 52
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 47
- 150000004985 diamines Chemical class 0.000 claims abstract description 37
- 229920000642 polymer Polymers 0.000 claims abstract description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 20
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 16
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 53
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims description 45
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims description 30
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims description 20
- 125000002837 carbocyclic group Chemical group 0.000 claims description 17
- 108010039918 Polylysine Proteins 0.000 claims description 12
- 229920000656 polylysine Polymers 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 4
- 239000004642 Polyimide Substances 0.000 abstract description 2
- 229920001721 polyimide Polymers 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 143
- 239000002904 solvent Substances 0.000 description 78
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 76
- 238000000034 method Methods 0.000 description 75
- 239000002585 base Substances 0.000 description 70
- 150000001875 compounds Chemical class 0.000 description 67
- 239000010408 film Substances 0.000 description 67
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 58
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 56
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 53
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 48
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 45
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 44
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 43
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 40
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 39
- 239000000758 substrate Substances 0.000 description 38
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 36
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 36
- 239000003054 catalyst Substances 0.000 description 35
- 239000003446 ligand Substances 0.000 description 33
- 239000000243 solution Substances 0.000 description 30
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 29
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 28
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 229910052763 palladium Inorganic materials 0.000 description 26
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 25
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 25
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 24
- 150000002148 esters Chemical class 0.000 description 24
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 23
- 150000001412 amines Chemical class 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 22
- 238000004519 manufacturing process Methods 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 20
- 229940126214 compound 3 Drugs 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 239000012044 organic layer Substances 0.000 description 19
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 18
- 210000002858 crystal cell Anatomy 0.000 description 18
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 18
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 18
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 17
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 16
- 125000006239 protecting group Chemical group 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 229940113088 dimethylacetamide Drugs 0.000 description 15
- 229910052731 fluorine Inorganic materials 0.000 description 15
- 239000003960 organic solvent Substances 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 14
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 238000004440 column chromatography Methods 0.000 description 14
- 229940126208 compound 22 Drugs 0.000 description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
- 230000035484 reaction time Effects 0.000 description 14
- 125000001424 substituent group Chemical group 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- 238000009835 boiling Methods 0.000 description 13
- 238000004821 distillation Methods 0.000 description 13
- 239000003495 polar organic solvent Substances 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 12
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 12
- 239000000460 chlorine Substances 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- 150000004696 coordination complex Chemical class 0.000 description 12
- 239000012024 dehydrating agents Substances 0.000 description 12
- 239000002274 desiccant Substances 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 150000002825 nitriles Chemical class 0.000 description 12
- 239000003208 petroleum Substances 0.000 description 12
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 12
- 238000001953 recrystallisation Methods 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 12
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 11
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical group CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 11
- 229910052794 bromium Inorganic materials 0.000 description 11
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 11
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 11
- 229940117389 dichlorobenzene Drugs 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- 229910000104 sodium hydride Inorganic materials 0.000 description 11
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 11
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 11
- 239000008096 xylene Substances 0.000 description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 10
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 229940125782 compound 2 Drugs 0.000 description 10
- 229940125810 compound 20 Drugs 0.000 description 10
- 229940125898 compound 5 Drugs 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 10
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 10
- 229910052736 halogen Inorganic materials 0.000 description 10
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 10
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 10
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 10
- 235000011181 potassium carbonates Nutrition 0.000 description 10
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 239000012312 sodium hydride Substances 0.000 description 10
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 10
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 9
- 238000010511 deprotection reaction Methods 0.000 description 9
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 9
- 150000002367 halogens Chemical class 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 229920000768 polyamine Polymers 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 8
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 8
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 8
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 8
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 229940125904 compound 1 Drugs 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 150000002170 ethers Chemical class 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 229940017219 methyl propionate Drugs 0.000 description 8
- 229960003975 potassium Drugs 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 8
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 8
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 8
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 7
- 101150041968 CDC13 gene Proteins 0.000 description 7
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 7
- 229920000954 Polyglycolide Polymers 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 7
- 229940125961 compound 24 Drugs 0.000 description 7
- 229940125851 compound 27 Drugs 0.000 description 7
- 229940125877 compound 31 Drugs 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 229910001873 dinitrogen Inorganic materials 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 150000004820 halides Chemical class 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000004633 polyglycolic acid Substances 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 230000002194 synthesizing effect Effects 0.000 description 7
- 239000001211 (E)-4-phenylbut-3-en-2-one Substances 0.000 description 6
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 6
- 229930008407 benzylideneacetone Natural products 0.000 description 6
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 6
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 229940127204 compound 29 Drugs 0.000 description 6
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 150000002466 imines Chemical class 0.000 description 6
- 229910052744 lithium Inorganic materials 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- UJNZOIKQAUQOCN-UHFFFAOYSA-N methyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C)C1=CC=CC=C1 UJNZOIKQAUQOCN-UHFFFAOYSA-N 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 6
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 108010094020 polyglycine Proteins 0.000 description 6
- 229920000232 polyglycine polymer Polymers 0.000 description 6
- 229910000105 potassium hydride Inorganic materials 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 235000017550 sodium carbonate Nutrition 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- BWHOZHOGCMHOBV-BQYQJAHWSA-N trans-benzylideneacetone Chemical compound CC(=O)\C=C\C1=CC=CC=C1 BWHOZHOGCMHOBV-BQYQJAHWSA-N 0.000 description 6
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 5
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 5
- 239000013065 commercial product Substances 0.000 description 5
- 229940125797 compound 12 Drugs 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 229910052707 ruthenium Inorganic materials 0.000 description 5
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 238000001308 synthesis method Methods 0.000 description 5
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 5
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 5
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- CTMHWPIWNRWQEG-UHFFFAOYSA-N 1-methylcyclohexene Chemical compound CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 description 4
- LSKONYYRONEBKA-UHFFFAOYSA-N 2-Dodecanone Chemical compound CCCCCCCCCCC(C)=O LSKONYYRONEBKA-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 150000001241 acetals Chemical class 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 229940125833 compound 23 Drugs 0.000 description 4
- 150000001879 copper Chemical class 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 229960003843 cyproterone Drugs 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000007529 inorganic bases Chemical class 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 4
- 229910052808 lithium carbonate Inorganic materials 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
- 235000011056 potassium acetate Nutrition 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 description 4
- 235000011009 potassium phosphates Nutrition 0.000 description 4
- 238000006798 ring closing metathesis reaction Methods 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 4
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 4
- 150000003751 zinc Chemical class 0.000 description 4
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 3
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 3
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 3
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 3
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 3
- PPPFYBPQAPISCT-UHFFFAOYSA-N 2-hydroxypropyl acetate Chemical compound CC(O)COC(C)=O PPPFYBPQAPISCT-UHFFFAOYSA-N 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 3
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 3
- FRDAATYAJDYRNW-UHFFFAOYSA-N 3-methyl-3-pentanol Chemical compound CCC(C)(O)CC FRDAATYAJDYRNW-UHFFFAOYSA-N 0.000 description 3
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 3
- 241000208140 Acer Species 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- JDRQHKQFKPUYHP-UHFFFAOYSA-N C(CCCCCCCCC)N.CC(C)(C)C.NN Chemical compound C(CCCCCCCCC)N.CC(C)(C)C.NN JDRQHKQFKPUYHP-UHFFFAOYSA-N 0.000 description 3
- QYUNTSZVJSFXNN-UHFFFAOYSA-N C(CCCCCCCCC)N.[Li] Chemical compound C(CCCCCCCCC)N.[Li] QYUNTSZVJSFXNN-UHFFFAOYSA-N 0.000 description 3
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000002723 alicyclic group Chemical group 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 150000001342 alkaline earth metals Chemical class 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 229910052797 bismuth Inorganic materials 0.000 description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- 229940125846 compound 25 Drugs 0.000 description 3
- 150000004699 copper complex Chemical class 0.000 description 3
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin Natural products [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 3
- 235000007336 cyanidin Nutrition 0.000 description 3
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 3
- 229960000978 cyproterone acetate Drugs 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- 229940043279 diisopropylamine Drugs 0.000 description 3
- HASCQPSFPAKVEK-UHFFFAOYSA-N dimethyl(phenyl)phosphine Chemical compound CP(C)C1=CC=CC=C1 HASCQPSFPAKVEK-UHFFFAOYSA-N 0.000 description 3
- IGTXUDQEBIVUOK-UHFFFAOYSA-N dinitro(phenyl)methanol Chemical compound [O-][N+](=O)C([N+]([O-])=O)(O)C1=CC=CC=C1 IGTXUDQEBIVUOK-UHFFFAOYSA-N 0.000 description 3
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 150000004698 iron complex Chemical class 0.000 description 3
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 3
- 229910000103 lithium hydride Inorganic materials 0.000 description 3
- 229940057867 methyl lactate Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000006268 reductive amination reaction Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 3
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 3
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 3
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- HUCQPHINKBNKRU-UHFFFAOYSA-N (4-methylphenyl)phosphane Chemical compound CC1=CC=C(P)C=C1 HUCQPHINKBNKRU-UHFFFAOYSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 2
- SBHHKGFHJWTZJN-UHFFFAOYSA-N 1,3-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C)(C(O)=O)C1C(O)=O SBHHKGFHJWTZJN-UHFFFAOYSA-N 0.000 description 2
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 2
- PNBCGVPSRHMZDO-UHFFFAOYSA-N 1-(1-propoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCCOCC(C)OCC(C)OC(C)=O PNBCGVPSRHMZDO-UHFFFAOYSA-N 0.000 description 2
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 2
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- RQUBQBFVDOLUKC-UHFFFAOYSA-N 1-ethoxy-2-methylpropane Chemical compound CCOCC(C)C RQUBQBFVDOLUKC-UHFFFAOYSA-N 0.000 description 2
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 2
- ONDSSKDTLGWNOJ-UHFFFAOYSA-N 1-methoxyhexan-2-ol Chemical compound CCCCC(O)COC ONDSSKDTLGWNOJ-UHFFFAOYSA-N 0.000 description 2
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 2
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 2
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 2
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 2
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 2
- WFRBDWRZVBPBDO-UHFFFAOYSA-N 2-methyl-2-pentanol Chemical compound CCCC(C)(C)O WFRBDWRZVBPBDO-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 2
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- GDSLUYKCPYECNN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(4-fluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC=C(C=C2)F)C=CC=1 GDSLUYKCPYECNN-UHFFFAOYSA-N 0.000 description 2
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 2
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 2
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 description 2
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 2
- QNVNLUSHGRBCLO-UHFFFAOYSA-N 5-hydroxybenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC(O)=CC(C(O)=O)=C1 QNVNLUSHGRBCLO-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 238000007341 Heck reaction Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000976924 Inca Species 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 125000005595 acetylacetonate group Chemical group 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000004703 alkoxides Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000010953 base metal Substances 0.000 description 2
- WXNOJTUTEXAZLD-UHFFFAOYSA-L benzonitrile;dichloropalladium Chemical compound Cl[Pd]Cl.N#CC1=CC=CC=C1.N#CC1=CC=CC=C1 WXNOJTUTEXAZLD-UHFFFAOYSA-L 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 238000001354 calcination Methods 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical group [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 2
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 2
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 2
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 2
- 229940117360 ethyl pyruvate Drugs 0.000 description 2
- WUOIAOOSKMHJOV-UHFFFAOYSA-N ethyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(CC)C1=CC=CC=C1 WUOIAOOSKMHJOV-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- LZGUHMNOBNWABZ-UHFFFAOYSA-N n-nitro-n-phenylnitramide Chemical compound [O-][N+](=O)N([N+]([O-])=O)C1=CC=CC=C1 LZGUHMNOBNWABZ-UHFFFAOYSA-N 0.000 description 2
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- UFOIOXZLTXNHQH-UHFFFAOYSA-N oxolane-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1OC(C(O)=O)C(C(O)=O)C1C(O)=O UFOIOXZLTXNHQH-UHFFFAOYSA-N 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 2
- 235000019798 tripotassium phosphate Nutrition 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AXBNMPTWUWEFAH-UHFFFAOYSA-N (1-chloro-3-methylbutan-2-yl)benzene Chemical compound CC(C)C(CCl)C1=CC=CC=C1 AXBNMPTWUWEFAH-UHFFFAOYSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- ZWVMLYRJXORSEP-LURJTMIESA-N (2s)-hexane-1,2,6-triol Chemical compound OCCCC[C@H](O)CO ZWVMLYRJXORSEP-LURJTMIESA-N 0.000 description 1
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 1
- OLQWMCSSZKNOLQ-ZXZARUISSA-N (3s)-3-[(3r)-2,5-dioxooxolan-3-yl]oxolane-2,5-dione Chemical compound O=C1OC(=O)C[C@H]1[C@@H]1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-ZXZARUISSA-N 0.000 description 1
- AKOGNYJNGMLDOA-UHFFFAOYSA-N (4-acetyloxyphenyl) acetate Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C=C1 AKOGNYJNGMLDOA-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- JDGFELYPUWNNGR-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene-1,3,4,6-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C2C(C(=O)O)CC(C(O)=O)C21 JDGFELYPUWNNGR-UHFFFAOYSA-N 0.000 description 1
- USSLAFCGNMDMNX-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid Chemical compound C1=CC=C2C(C(O)=O)C(C(=O)O)CCC2=C1 USSLAFCGNMDMNX-UHFFFAOYSA-N 0.000 description 1
- CCKODBHYAPROLJ-UHFFFAOYSA-N 1,2,5-thiadiazole-3,4-dicarboxylic acid Chemical compound OC(=O)C1=NSN=C1C(O)=O CCKODBHYAPROLJ-UHFFFAOYSA-N 0.000 description 1
- MQQRFOXFIPBFOV-UHFFFAOYSA-N 1,2-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C(O)=O)C1(C)C(O)=O MQQRFOXFIPBFOV-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- HFHARFNUBJTTGI-UHFFFAOYSA-N 1,3-thiazole-4,5-dicarboxylic acid Chemical compound OC(=O)C=1N=CSC=1C(O)=O HFHARFNUBJTTGI-UHFFFAOYSA-N 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- UTYAEKVPLFDTTI-UHFFFAOYSA-N 1,4-dioxoanthracene-2,3-dicarboxylic acid Chemical compound C1=CC=C2C=C(C(C(C(=O)O)=C(C(O)=O)C3=O)=O)C3=CC2=C1 UTYAEKVPLFDTTI-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 description 1
- OGFAWKRXZLGJSK-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)ethanone Chemical compound OC1=CC(O)=CC=C1C(=O)CC1=CC=C([N+]([O-])=O)C=C1 OGFAWKRXZLGJSK-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VOSLIUIVGWBSOK-UHFFFAOYSA-N 1-n-phenylbenzene-1,2,4-triamine Chemical compound NC1=CC(N)=CC=C1NC1=CC=CC=C1 VOSLIUIVGWBSOK-UHFFFAOYSA-N 0.000 description 1
- GBURUDXSBYGPBL-UHFFFAOYSA-N 2,2,3-trimethylhexanedioic acid Chemical compound OC(=O)C(C)(C)C(C)CCC(O)=O GBURUDXSBYGPBL-UHFFFAOYSA-N 0.000 description 1
- WKRCUUPMCASSBN-UHFFFAOYSA-N 2,2-diethylbutanedioic acid Chemical compound CCC(CC)(C(O)=O)CC(O)=O WKRCUUPMCASSBN-UHFFFAOYSA-N 0.000 description 1
- BTUDGPVTCYNYLK-UHFFFAOYSA-N 2,2-dimethylglutaric acid Chemical compound OC(=O)C(C)(C)CCC(O)=O BTUDGPVTCYNYLK-UHFFFAOYSA-N 0.000 description 1
- DDHUNHGZUHZNKB-UHFFFAOYSA-N 2,2-dimethylpropane-1,3-diamine Chemical compound NCC(C)(C)CN DDHUNHGZUHZNKB-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- IFFLKGMDBKQMAH-UHFFFAOYSA-N 2,4-diaminopyridine Chemical compound NC1=CC=NC(N)=C1 IFFLKGMDBKQMAH-UHFFFAOYSA-N 0.000 description 1
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- KCNISYPADDTFDO-UHFFFAOYSA-N 2,4-dinitrophenylacetic acid Chemical compound OC(=O)CC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O KCNISYPADDTFDO-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- QAYVHDDEMLNVMO-UHFFFAOYSA-N 2,5-dichlorobenzene-1,4-diamine Chemical compound NC1=CC(Cl)=C(N)C=C1Cl QAYVHDDEMLNVMO-UHFFFAOYSA-N 0.000 description 1
- BWAPJIHJXDYDPW-UHFFFAOYSA-N 2,5-dimethyl-p-phenylenediamine Chemical group CC1=CC(N)=C(C)C=C1N BWAPJIHJXDYDPW-UHFFFAOYSA-N 0.000 description 1
- XGKKWUNSNDTGDS-UHFFFAOYSA-N 2,5-dimethylheptane-1,7-diamine Chemical compound NCC(C)CCC(C)CCN XGKKWUNSNDTGDS-UHFFFAOYSA-N 0.000 description 1
- YXOKJIRTNWHPFS-UHFFFAOYSA-N 2,5-dimethylhexane-1,6-diamine Chemical compound NCC(C)CCC(C)CN YXOKJIRTNWHPFS-UHFFFAOYSA-N 0.000 description 1
- FKUJGZJNDUGCFU-UHFFFAOYSA-N 2,5-dimethylterephthalic acid Chemical compound CC1=CC(C(O)=O)=C(C)C=C1C(O)=O FKUJGZJNDUGCFU-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- AONMTYOVKUOHQP-UHFFFAOYSA-N 2-(2,4-dinitrophenyl)ethanol Chemical compound OCCC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O AONMTYOVKUOHQP-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- UTENGZNBNPABQE-UHFFFAOYSA-N 2-[3-(carboxymethyl)-1-adamantyl]acetic acid Chemical compound C1C(C2)CC3CC1(CC(=O)O)CC2(CC(O)=O)C3 UTENGZNBNPABQE-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- AQHFCRYZABKUEV-UHFFFAOYSA-N 2-chloro-5-methoxybenzoic acid Chemical compound COC1=CC=C(Cl)C(C(O)=O)=C1 AQHFCRYZABKUEV-UHFFFAOYSA-N 0.000 description 1
- LRLQQERNMXHASR-UHFFFAOYSA-N 2-diphenylphosphanylpropan-2-yl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)C(C)(C)P(C=1C=CC=CC=1)C1=CC=CC=C1 LRLQQERNMXHASR-UHFFFAOYSA-N 0.000 description 1
- KDEAZJJSARLKAO-UHFFFAOYSA-N 2-ethyl-2-phenylpropanedioic acid Chemical compound CCC(C(O)=O)(C(O)=O)C1=CC=CC=C1 KDEAZJJSARLKAO-UHFFFAOYSA-N 0.000 description 1
- RLHGFJMGWQXPBW-UHFFFAOYSA-N 2-hydroxy-3-(1h-imidazol-5-ylmethyl)benzamide Chemical compound NC(=O)C1=CC=CC(CC=2NC=NC=2)=C1O RLHGFJMGWQXPBW-UHFFFAOYSA-N 0.000 description 1
- HGUYBLVGLMAUFF-UHFFFAOYSA-N 2-methoxybenzene-1,4-diamine Chemical compound COC1=CC(N)=CC=C1N HGUYBLVGLMAUFF-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- TVHXQIGBVCWCIS-UHFFFAOYSA-N 2-phenyl-1,3-thiazole-4,5-dicarboxylic acid Chemical compound S1C(C(O)=O)=C(C(=O)O)N=C1C1=CC=CC=C1 TVHXQIGBVCWCIS-UHFFFAOYSA-N 0.000 description 1
- VSZJLXSVGVDPMJ-UHFFFAOYSA-N 2-phenylterephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C=2C=CC=CC=2)=C1 VSZJLXSVGVDPMJ-UHFFFAOYSA-N 0.000 description 1
- KPKOSOUTWDOOIW-UHFFFAOYSA-N 3,5-bis(4-aminophenoxy)benzoic acid Chemical compound C1=CC(N)=CC=C1OC1=CC(OC=2C=CC(N)=CC=2)=CC(C(O)=O)=C1 KPKOSOUTWDOOIW-UHFFFAOYSA-N 0.000 description 1
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 1
- LJQFYBCLMVVNAQ-UHFFFAOYSA-N 3-(2-aminoethyl)aniline Chemical compound NCCC1=CC=CC(N)=C1 LJQFYBCLMVVNAQ-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 1
- HBLPYXIZPMDWIO-UHFFFAOYSA-N 3-(methylaminomethyl)aniline Chemical compound CNCC1=CC=CC(N)=C1 HBLPYXIZPMDWIO-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- UVUCUHVQYAPMEU-UHFFFAOYSA-N 3-[2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound NC1=CC=CC(C(C=2C=C(N)C=CC=2)(C(F)(F)F)C(F)(F)F)=C1 UVUCUHVQYAPMEU-UHFFFAOYSA-N 0.000 description 1
- POTQBGGWSWSMCX-UHFFFAOYSA-N 3-[2-(3-aminopropoxy)ethoxy]propan-1-amine Chemical compound NCCCOCCOCCCN POTQBGGWSWSMCX-UHFFFAOYSA-N 0.000 description 1
- DKKYOQYISDAQER-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)phenoxy]aniline Chemical compound NC1=CC=CC(OC=2C=C(OC=3C=C(N)C=CC=3)C=CC=2)=C1 DKKYOQYISDAQER-UHFFFAOYSA-N 0.000 description 1
- DFOCUWFSRVQSNI-UHFFFAOYSA-N 3-[4-(2-carboxyethyl)phenyl]propanoic acid Chemical compound OC(=O)CCC1=CC=C(CCC(O)=O)C=C1 DFOCUWFSRVQSNI-UHFFFAOYSA-N 0.000 description 1
- HAEQAUJYNHQVHV-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylbenzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 HAEQAUJYNHQVHV-UHFFFAOYSA-N 0.000 description 1
- NQIXOLQSTCNTKL-UHFFFAOYSA-N 3-[5-(methylamino)pentyl]aniline Chemical compound CNCCCCCC1=CC=CC(N)=C1 NQIXOLQSTCNTKL-UHFFFAOYSA-N 0.000 description 1
- JLNLYTLHNXFPCP-UHFFFAOYSA-N 3-acetyloxycyclopentane-1,2,4-tricarboxylic acid Chemical compound CC(=O)OC1C(C(O)=O)CC(C(O)=O)C1C(O)=O JLNLYTLHNXFPCP-UHFFFAOYSA-N 0.000 description 1
- HKSVUXQBIFEVHE-UHFFFAOYSA-N 3-ethoxy-1h-indole Chemical compound C1=CC=C2C(OCC)=CNC2=C1 HKSVUXQBIFEVHE-UHFFFAOYSA-N 0.000 description 1
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 1
- XKIRHOWVQWCYBT-UHFFFAOYSA-N 3-ethylpentan-3-ol Chemical compound CCC(O)(CC)CC XKIRHOWVQWCYBT-UHFFFAOYSA-N 0.000 description 1
- CKDZUORTXOCQNI-UHFFFAOYSA-N 3-methoxy-1h-indole Chemical compound C1=CC=C2C(OC)=CNC2=C1 CKDZUORTXOCQNI-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- FASUFOTUSHAIHG-UHFFFAOYSA-N 3-methoxyprop-1-ene Chemical compound COCC=C FASUFOTUSHAIHG-UHFFFAOYSA-N 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- HSSYVKMJJLDTKZ-UHFFFAOYSA-N 3-phenylphthalic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1C(O)=O HSSYVKMJJLDTKZ-UHFFFAOYSA-N 0.000 description 1
- LJMPOXUWPWEILS-UHFFFAOYSA-N 3a,4,4a,7a,8,8a-hexahydrofuro[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1C2C(=O)OC(=O)C2CC2C(=O)OC(=O)C21 LJMPOXUWPWEILS-UHFFFAOYSA-N 0.000 description 1
- WECDUOXQLAIPQW-UHFFFAOYSA-N 4,4'-Methylene bis(2-methylaniline) Chemical compound C1=C(N)C(C)=CC(CC=2C=C(C)C(N)=CC=2)=C1 WECDUOXQLAIPQW-UHFFFAOYSA-N 0.000 description 1
- ICNFHJVPAJKPHW-UHFFFAOYSA-N 4,4'-Thiodianiline Chemical compound C1=CC(N)=CC=C1SC1=CC=C(N)C=C1 ICNFHJVPAJKPHW-UHFFFAOYSA-N 0.000 description 1
- ZWIBGDOHXGXHEV-UHFFFAOYSA-N 4,4-dimethylheptane-1,7-diamine Chemical compound NCCCC(C)(C)CCCN ZWIBGDOHXGXHEV-UHFFFAOYSA-N 0.000 description 1
- OPQVOOASZKDKBH-UHFFFAOYSA-N 4,8-dioxoadamantane-1,3-dicarboxylic acid Chemical compound C1C(C2=O)CC3CC2(C(O)=O)CC1(C(=O)O)C3=O OPQVOOASZKDKBH-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- AIVVXPSKEVWKMY-UHFFFAOYSA-N 4-(3,4-dicarboxyphenoxy)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 AIVVXPSKEVWKMY-UHFFFAOYSA-N 0.000 description 1
- LFBALUPVVFCEPA-UHFFFAOYSA-N 4-(3,4-dicarboxyphenyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C(C(O)=O)=C1 LFBALUPVVFCEPA-UHFFFAOYSA-N 0.000 description 1
- OMNVECQLILUEFL-UHFFFAOYSA-N 4-(3-aminopropyl)aniline Chemical compound NCCCC1=CC=C(N)C=C1 OMNVECQLILUEFL-UHFFFAOYSA-N 0.000 description 1
- XDYLWBWPEDSSLU-UHFFFAOYSA-N 4-(3-carboxyphenyl)benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C(C(O)=O)=CC=2)C(O)=O)=C1 XDYLWBWPEDSSLU-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical compound CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- LFEWXDOYPCWFHR-UHFFFAOYSA-N 4-(4-carboxybenzoyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C=C1 LFEWXDOYPCWFHR-UHFFFAOYSA-N 0.000 description 1
- WVDRSXGPQWNUBN-UHFFFAOYSA-N 4-(4-carboxyphenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C=C1 WVDRSXGPQWNUBN-UHFFFAOYSA-N 0.000 description 1
- SQJQLYOMPSJVQS-UHFFFAOYSA-N 4-(4-carboxyphenyl)sulfonylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1S(=O)(=O)C1=CC=C(C(O)=O)C=C1 SQJQLYOMPSJVQS-UHFFFAOYSA-N 0.000 description 1
- QIBWMPZRHCPSCY-UHFFFAOYSA-N 4-(4-heptoxyphenoxy)aniline Chemical compound NC1=CC=C(OC2=CC=C(OCCCCCCC)C=C2)C=C1 QIBWMPZRHCPSCY-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- GNPSQUCXOBDIDY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane Chemical compound C(CCCCCCC)C(C(OC)(OC)OC)CCC GNPSQUCXOBDIDY-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- ZWUBBMDHSZDNTA-UHFFFAOYSA-N 4-Chloro-meta-phenylenediamine Chemical compound NC1=CC=C(Cl)C(N)=C1 ZWUBBMDHSZDNTA-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- GAMSSMZJKUMFEY-UHFFFAOYSA-N 4-[(4-carboxyphenyl)disulfanyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1SSC1=CC=C(C(O)=O)C=C1 GAMSSMZJKUMFEY-UHFFFAOYSA-N 0.000 description 1
- ZSQIQUAKDNTQOI-UHFFFAOYSA-N 4-[1-(4-aminophenyl)cyclohexyl]aniline Chemical compound C1=CC(N)=CC=C1C1(C=2C=CC(N)=CC=2)CCCCC1 ZSQIQUAKDNTQOI-UHFFFAOYSA-N 0.000 description 1
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 1
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 1
- HCUNREWMFYCWAQ-UHFFFAOYSA-N 4-[2-(4-carboxyphenyl)ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCC1=CC=C(C(O)=O)C=C1 HCUNREWMFYCWAQ-UHFFFAOYSA-N 0.000 description 1
- NNIPOYNUFNLQMO-UHFFFAOYSA-N 4-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=C(N)C=C1 NNIPOYNUFNLQMO-UHFFFAOYSA-N 0.000 description 1
- HESXPOICBNWMPI-UHFFFAOYSA-N 4-[2-[4-[2-(4-aminophenyl)propan-2-yl]phenyl]propan-2-yl]aniline Chemical compound C=1C=C(C(C)(C)C=2C=CC(N)=CC=2)C=CC=1C(C)(C)C1=CC=C(N)C=C1 HESXPOICBNWMPI-UHFFFAOYSA-N 0.000 description 1
- HPUJEBAZZTZOFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)-2,2-dimethylpropoxy]aniline Chemical compound C=1C=C(N)C=CC=1OCC(C)(C)COC1=CC=C(N)C=C1 HPUJEBAZZTZOFL-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- KWFFEQXPFFDJER-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)propoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCOC1=CC=C(N)C=C1 KWFFEQXPFFDJER-UHFFFAOYSA-N 0.000 description 1
- BMIUMBLWVWZIHD-UHFFFAOYSA-N 4-[3-(4-aminophenyl)propyl]aniline Chemical compound C1=CC(N)=CC=C1CCCC1=CC=C(N)C=C1 BMIUMBLWVWZIHD-UHFFFAOYSA-N 0.000 description 1
- LAFZPVANKKJENB-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)butoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCOC1=CC=C(N)C=C1 LAFZPVANKKJENB-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- HHLMWQDRYZAENA-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-yl]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C(F)(F)F)C(F)(F)F)C=C1 HHLMWQDRYZAENA-UHFFFAOYSA-N 0.000 description 1
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 1
- SLHXQWDUYXSTPA-UHFFFAOYSA-N 4-[5-(4-aminophenoxy)pentoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCOC1=CC=C(N)C=C1 SLHXQWDUYXSTPA-UHFFFAOYSA-N 0.000 description 1
- SOKDIHGREPWQCY-UHFFFAOYSA-N 4-[5-(4-aminophenyl)pentyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCC1=CC=C(N)C=C1 SOKDIHGREPWQCY-UHFFFAOYSA-N 0.000 description 1
- GRFCDFDVGOXFPY-UHFFFAOYSA-N 4-[6-(4-aminophenoxy)hexoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCOC1=CC=C(N)C=C1 GRFCDFDVGOXFPY-UHFFFAOYSA-N 0.000 description 1
- XLKGPJIGDHZIMW-UHFFFAOYSA-N 4-[6-(4-aminophenyl)hexyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCCC1=CC=C(N)C=C1 XLKGPJIGDHZIMW-UHFFFAOYSA-N 0.000 description 1
- JBXBSFFXAMVASC-UHFFFAOYSA-N 4-[7-(4-aminophenoxy)heptoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCOC1=CC=C(N)C=C1 JBXBSFFXAMVASC-UHFFFAOYSA-N 0.000 description 1
- YJPXABVNBBJWSP-UHFFFAOYSA-N 4-[8-(4-aminophenyl)octyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCCCCC1=CC=C(N)C=C1 YJPXABVNBBJWSP-UHFFFAOYSA-N 0.000 description 1
- NCHKHHWDVWTPDX-UHFFFAOYSA-N 4-[9-(4-aminophenyl)decyl]aniline Chemical compound NC1=CC=C(C=C1)CCCCCCCCC(C)C1=CC=C(C=C1)N NCHKHHWDVWTPDX-UHFFFAOYSA-N 0.000 description 1
- HTBBXIVJOSIHBY-UHFFFAOYSA-N 4-anthracen-1-ylaniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC2=CC3=CC=CC=C3C=C12 HTBBXIVJOSIHBY-UHFFFAOYSA-N 0.000 description 1
- HAEJSGLKJYIYTB-ZZXKWVIFSA-N 4-carboxycinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(C(O)=O)C=C1 HAEJSGLKJYIYTB-ZZXKWVIFSA-N 0.000 description 1
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 description 1
- VSHBABSXFHFTJN-UHFFFAOYSA-N 4-methoxymorpholine Chemical compound CON1CCOCC1 VSHBABSXFHFTJN-UHFFFAOYSA-N 0.000 description 1
- ORKQJTBYQZITLA-UHFFFAOYSA-N 4-octylaniline Chemical compound CCCCCCCCC1=CC=C(N)C=C1 ORKQJTBYQZITLA-UHFFFAOYSA-N 0.000 description 1
- GVXJJTXNJGGQIV-UHFFFAOYSA-N 5-(2-aminoethyl)naphthalen-2-amine Chemical compound NC1=CC=C2C(CCN)=CC=CC2=C1 GVXJJTXNJGGQIV-UHFFFAOYSA-N 0.000 description 1
- QQGYZOYWNCKGEK-UHFFFAOYSA-N 5-[(1,3-dioxo-2-benzofuran-5-yl)oxy]-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(OC=2C=C3C(=O)OC(C3=CC=2)=O)=C1 QQGYZOYWNCKGEK-UHFFFAOYSA-N 0.000 description 1
- KBZFDRWPMZESDI-UHFFFAOYSA-N 5-aminobenzene-1,3-dicarboxylic acid Chemical compound NC1=CC(C(O)=O)=CC(C(O)=O)=C1 KBZFDRWPMZESDI-UHFFFAOYSA-N 0.000 description 1
- PMZBHPUNQNKBOA-UHFFFAOYSA-N 5-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=CC(C(O)=O)=CC(C(O)=O)=C1 PMZBHPUNQNKBOA-UHFFFAOYSA-N 0.000 description 1
- BJLUCDZIWWSFIB-UHFFFAOYSA-N 5-tert-butylbenzene-1,3-dicarboxylic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(O)=O)=C1 BJLUCDZIWWSFIB-UHFFFAOYSA-N 0.000 description 1
- OOEGQLPPMITCBZ-UHFFFAOYSA-N 6-propan-2-yl-1,3,5-triazine-2,4-diamine Chemical compound CC(C)C1=NC(N)=NC(N)=N1 OOEGQLPPMITCBZ-UHFFFAOYSA-N 0.000 description 1
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ADLIOUBSDCTSDF-UHFFFAOYSA-N C(=O)(N1COC=C1)N1COC=C1 Chemical compound C(=O)(N1COC=C1)N1COC=C1 ADLIOUBSDCTSDF-UHFFFAOYSA-N 0.000 description 1
- OTXFGEHSBKFEAB-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC OTXFGEHSBKFEAB-UHFFFAOYSA-N 0.000 description 1
- SWUMRQQSIBCUPC-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SWUMRQQSIBCUPC-UHFFFAOYSA-N 0.000 description 1
- PXUZMWOTICHNDV-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC PXUZMWOTICHNDV-UHFFFAOYSA-N 0.000 description 1
- SNPIERCLNKIBEM-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SNPIERCLNKIBEM-UHFFFAOYSA-N 0.000 description 1
- XRNDMACZMJPCRX-UHFFFAOYSA-N C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC XRNDMACZMJPCRX-UHFFFAOYSA-N 0.000 description 1
- ODBHLFJWOFPWLM-UHFFFAOYSA-N C1(=CC=CC=2C3=CC=CC=C3CC12)C(C1=C(C=CC=C1)P)(C1=CC=CC=2C3=CC=CC=C3CC12)C1=CC=CC=2C3=CC=CC=C3CC12 Chemical compound C1(=CC=CC=2C3=CC=CC=C3CC12)C(C1=C(C=CC=C1)P)(C1=CC=CC=2C3=CC=CC=C3CC12)C1=CC=CC=2C3=CC=CC=C3CC12 ODBHLFJWOFPWLM-UHFFFAOYSA-N 0.000 description 1
- YDEAAJZYBOCXIO-UHFFFAOYSA-N C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC YDEAAJZYBOCXIO-UHFFFAOYSA-N 0.000 description 1
- VWRQZMSSWYCZTG-UHFFFAOYSA-N CC1(C(N(N(C=CC1)C)C)(C)C)C.[Li] Chemical compound CC1(C(N(N(C=CC1)C)C)(C)C)C.[Li] VWRQZMSSWYCZTG-UHFFFAOYSA-N 0.000 description 1
- QVAHZZVDLUHIMD-UHFFFAOYSA-N CCCC.[I] Chemical compound CCCC.[I] QVAHZZVDLUHIMD-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N Dipicolinic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 1
- 229910021575 Iron(II) bromide Inorganic materials 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- 229910021576 Iron(III) bromide Inorganic materials 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- HDJGANPLOWXKTM-UHFFFAOYSA-N NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC HDJGANPLOWXKTM-UHFFFAOYSA-N 0.000 description 1
- HNJYHRSYMUUVEX-UHFFFAOYSA-N NC(CC(C(OC)(OC)OC)CCCCCCCC)C Chemical compound NC(CC(C(OC)(OC)OC)CCCCCCCC)C HNJYHRSYMUUVEX-UHFFFAOYSA-N 0.000 description 1
- AJOYCSBPBSZRHI-UHFFFAOYSA-N NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C Chemical compound NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C AJOYCSBPBSZRHI-UHFFFAOYSA-N 0.000 description 1
- FBONFKVOCURIDQ-UHFFFAOYSA-N NC1=CC=C(C=C1)C(CC(=O)OC)(CC(=O)OC)C1=CC=C(C=C1)N Chemical compound NC1=CC=C(C=C1)C(CC(=O)OC)(CC(=O)OC)C1=CC=C(C=C1)N FBONFKVOCURIDQ-UHFFFAOYSA-N 0.000 description 1
- IYSWXSOVWPQKSR-UHFFFAOYSA-N NC1=CC=C(C=C1)C(CCCCCCCCC)C1=CC=C(C=C1)N.C1=CC=CC=2C3=CC=CC=C3CC12 Chemical compound NC1=CC=C(C=C1)C(CCCCCCCCC)C1=CC=C(C=C1)N.C1=CC=CC=2C3=CC=CC=C3CC12 IYSWXSOVWPQKSR-UHFFFAOYSA-N 0.000 description 1
- SCECHYBTQMOHQK-UHFFFAOYSA-N NC=1C=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC(=CC=C2)N)C=CC1 SCECHYBTQMOHQK-UHFFFAOYSA-N 0.000 description 1
- KTGXWDZUZLWXOF-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)C)CCCCCCCC KTGXWDZUZLWXOF-UHFFFAOYSA-N 0.000 description 1
- PEXBBTCNDBSFHT-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)OC)CCCCCCCC PEXBBTCNDBSFHT-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- GVOYMPVTJXSURP-UHFFFAOYSA-N [Br].OC(=O)C(O)=O Chemical compound [Br].OC(=O)C(O)=O GVOYMPVTJXSURP-UHFFFAOYSA-N 0.000 description 1
- DDFGTVSLZJLQEV-UHFFFAOYSA-N [C](C1CCCCC1)C1CCCCC1 Chemical compound [C](C1CCCCC1)C1CCCCC1 DDFGTVSLZJLQEV-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PWUBONDMIMDOQY-UHFFFAOYSA-N acetonitrile;hydrochloride Chemical compound Cl.CC#N PWUBONDMIMDOQY-UHFFFAOYSA-N 0.000 description 1
- PAVQGHWQOQZQEH-UHFFFAOYSA-N adamantane-1,3-dicarboxylic acid Chemical compound C1C(C2)CC3CC1(C(=O)O)CC2(C(O)=O)C3 PAVQGHWQOQZQEH-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- NYWRQWIADFDBST-UHFFFAOYSA-N aniline;ethanamine Chemical compound CCN.NC1=CC=CC=C1 NYWRQWIADFDBST-UHFFFAOYSA-N 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical group NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- DNKYMRIVXIQCFO-UHFFFAOYSA-N benzene pentane Chemical compound CCCCC.CCCCC.C1=CC=CC=C1 DNKYMRIVXIQCFO-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- DOYWWWWTUGGBQS-UHFFFAOYSA-N bicyclo[2.2.2]octane-2,3-dicarboxylic acid Chemical compound C1CC2CCC1C(C(=O)O)C2C(O)=O DOYWWWWTUGGBQS-UHFFFAOYSA-N 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- ZLKZWBLIQRAZKR-UHFFFAOYSA-N butan-2-yloxyhydrazine Chemical compound CCC(C)ONN ZLKZWBLIQRAZKR-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000006364 carbonyl oxy methylene group Chemical group [H]C([H])([*:2])OC([*:1])=O 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- MUYSADWCWFFZKR-UHFFFAOYSA-N cinchomeronic acid Chemical compound OC(=O)C1=CC=NC=C1C(O)=O MUYSADWCWFFZKR-UHFFFAOYSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- CCQPAEQGAVNNIA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-N 0.000 description 1
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 1
- WYHYNUWZLKTEEY-UHFFFAOYSA-N cyclobutane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C1 WYHYNUWZLKTEEY-UHFFFAOYSA-N 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- GEQHKFFSPGPGLN-UHFFFAOYSA-N cyclohexane-1,3-diamine Chemical compound NC1CCCC(N)C1 GEQHKFFSPGPGLN-UHFFFAOYSA-N 0.000 description 1
- XBZSBBLNHFMTEB-UHFFFAOYSA-N cyclohexane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCCC(C(O)=O)C1 XBZSBBLNHFMTEB-UHFFFAOYSA-N 0.000 description 1
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 1
- YZFOGXKZTWZVFN-UHFFFAOYSA-N cyclopentane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1 YZFOGXKZTWZVFN-UHFFFAOYSA-N 0.000 description 1
- WOSVXXBNNCUXMT-UHFFFAOYSA-N cyclopentane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1C(O)=O WOSVXXBNNCUXMT-UHFFFAOYSA-N 0.000 description 1
- LNGJOYPCXLOTKL-UHFFFAOYSA-N cyclopentane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)C1 LNGJOYPCXLOTKL-UHFFFAOYSA-N 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- IPKCFGQXHZKYLH-UHFFFAOYSA-N cyclopropene Chemical compound C1=C[CH+]1 IPKCFGQXHZKYLH-UHFFFAOYSA-N 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- DHDZMONMPFKUJO-UHFFFAOYSA-N decane-1,9-diamine Chemical compound CC(N)CCCCCCCCN DHDZMONMPFKUJO-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- YCDUMXSNRLISHV-UHFFFAOYSA-N dibenzofuran-2,7-diamine Chemical compound C1=C(N)C=C2C3=CC=C(N)C=C3OC2=C1 YCDUMXSNRLISHV-UHFFFAOYSA-N 0.000 description 1
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 1
- DRUKNYVQGHETPO-UHFFFAOYSA-N dimethyl azelate Chemical compound COC(=O)CCCCCCCC(=O)OC DRUKNYVQGHETPO-UHFFFAOYSA-N 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- JGUQDUKBUKFFRO-CIIODKQPSA-N dimethylglyoxime Chemical compound O/N=C(/C)\C(\C)=N\O JGUQDUKBUKFFRO-CIIODKQPSA-N 0.000 description 1
- OREAFAJWWJHCOT-UHFFFAOYSA-N dimethylmalonic acid Chemical compound OC(=O)C(C)(C)C(O)=O OREAFAJWWJHCOT-UHFFFAOYSA-N 0.000 description 1
- MPFLRYZEEAQMLQ-UHFFFAOYSA-N dinicotinic acid Chemical compound OC(=O)C1=CN=CC(C(O)=O)=C1 MPFLRYZEEAQMLQ-UHFFFAOYSA-N 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical group CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- SYLAFCZSYRXBJF-UHFFFAOYSA-N furan-3,4-dicarboxylic acid Chemical compound OC(=O)C1=COC=C1C(O)=O SYLAFCZSYRXBJF-UHFFFAOYSA-N 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- AWKZQVYCCQCKBH-UHFFFAOYSA-N hydrazine 1-methylpyrrolidin-2-one Chemical compound CN1C(CCC1)=O.NN AWKZQVYCCQCKBH-UHFFFAOYSA-N 0.000 description 1
- ZXIRTZXVKYMLKJ-UHFFFAOYSA-N hydrazine;phthalic acid Chemical compound NN.OC(=O)C1=CC=CC=C1C(O)=O ZXIRTZXVKYMLKJ-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- GYCHYNMREWYSKH-UHFFFAOYSA-L iron(ii) bromide Chemical compound [Fe+2].[Br-].[Br-] GYCHYNMREWYSKH-UHFFFAOYSA-L 0.000 description 1
- FZGIHSNZYGFUGM-UHFFFAOYSA-L iron(ii) fluoride Chemical compound [F-].[F-].[Fe+2] FZGIHSNZYGFUGM-UHFFFAOYSA-L 0.000 description 1
- SHXXPRJOPFJRHA-UHFFFAOYSA-K iron(iii) fluoride Chemical compound F[Fe](F)F SHXXPRJOPFJRHA-UHFFFAOYSA-K 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- MJIVRKPEXXHNJT-UHFFFAOYSA-N lutidinic acid Chemical compound OC(=O)C1=CC=NC(C(O)=O)=C1 MJIVRKPEXXHNJT-UHFFFAOYSA-N 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- UJQMLHKSZKBMMO-UHFFFAOYSA-N n,n-diethylethanamine;pyridine Chemical compound C1=CC=NC=C1.CCN(CC)CC UJQMLHKSZKBMMO-UHFFFAOYSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 1
- ABMFBCRYHDZLRD-UHFFFAOYSA-N naphthalene-1,4-dicarboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1 ABMFBCRYHDZLRD-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- VAWFFNJAPKXVPH-UHFFFAOYSA-N naphthalene-1,6-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC2=CC(C(=O)O)=CC=C21 VAWFFNJAPKXVPH-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- WPUMVKJOWWJPRK-UHFFFAOYSA-N naphthalene-2,7-dicarboxylic acid Chemical compound C1=CC(C(O)=O)=CC2=CC(C(=O)O)=CC=C21 WPUMVKJOWWJPRK-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- CJYCVQJRVSAFKB-UHFFFAOYSA-N octadecane-1,18-diamine Chemical compound NCCCCCCCCCCCCCCCCCCN CJYCVQJRVSAFKB-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000006146 oximation reaction Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002927 oxygen compounds Chemical class 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- OGBPILLJZSJJRC-UHFFFAOYSA-N phenoxyphosphonoyloxybenzene Chemical group C=1C=CC=CC=1OP(=O)OC1=CC=CC=C1 OGBPILLJZSJJRC-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004597 plastic additive Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 108010026466 polyproline Proteins 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- QRFYVTBXHOOBEP-UHFFFAOYSA-N prop-2-enoic acid;hydrobromide Chemical compound Br.OC(=O)C=C QRFYVTBXHOOBEP-UHFFFAOYSA-N 0.000 description 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 229940032159 propylene carbonate Drugs 0.000 description 1
- 229940116423 propylene glycol diacetate Drugs 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 125000002577 pseudohalo group Chemical group 0.000 description 1
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 1
- WCYJXDMUQGVQQS-UHFFFAOYSA-N pyridine;ruthenium Chemical compound [Ru].C1=CC=NC=C1 WCYJXDMUQGVQQS-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- JQZAKMJZYGPUFD-UHFFFAOYSA-N spiro[3.3]heptane-2,6-dicarboxylic acid Chemical compound C1C(C(=O)O)CC21CC(C(O)=O)C2 JQZAKMJZYGPUFD-UHFFFAOYSA-N 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- SBUXRMKDJWEXRL-ZWKOTPCHSA-N trans-body Chemical compound O=C([C@@H]1N(C2=O)[C@H](C3=C(C4=CC=CC=C4N3)C1)CC)N2C1=CC=C(F)C=C1 SBUXRMKDJWEXRL-ZWKOTPCHSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- FEONEKOZSGPOFN-UHFFFAOYSA-K tribromoiron Chemical group Br[Fe](Br)Br FEONEKOZSGPOFN-UHFFFAOYSA-K 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- HEPBQSXQJMTVFI-UHFFFAOYSA-N zinc;butane Chemical compound [Zn+2].CCC[CH2-].CCC[CH2-] HEPBQSXQJMTVFI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/32—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and esterified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nonlinear Science (AREA)
- Mathematical Physics (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
201219450 六、發明說明: 【發明所屬之技術領域】 本發明係有關在作爲使用於液晶配向膜之聚合物之原 料爲有用的新穎二胺化合物、使用其所得到的聚醯胺酸及 聚醯亞胺,以及液晶配向處理劑。進而有關於具有由前述 液晶配向處理劑所得到的液晶配向膜之液晶顯示元件。更 詳細爲關於,藉由少量照射量之偏光或非偏光之放射線, 可形成垂直配向用之液晶配向膜之液晶配向處理劑、該液 晶配向膜與其形成方法、具備有如此液晶配向膜之液晶顯 示元件及光特性構件。 【先前技術】 液晶配向膜,爲作爲顯示裝置被廣泛地使用的液晶顯 示元件之構成構件,擔任所謂的使液晶配向於一定之方向 之角色。現在,工業上被利用之主要的液晶配向膜,係由 來自聚醯亞胺前驅物之聚醯胺酸(亦稱爲聚醯胺酸)、聚 醯胺酸酯、或聚醯亞胺之溶液所成的液晶配向處理劑所形 成。一般而言,在將液晶配向處理劑塗佈於基板上進行加 熱·锻燒後,會實施用來使液晶相對於基板面爲平行或傾 斜配向之配向處理。此配向處理方面,已知有藉由綿、尼 龍、嫘縈等之布將有機膜表面磨擦,即被稱呼爲磨擦之表 面處理方法、將氧化矽斜方蒸鍍於基板表面之方法、使用 Langmuir· Brochette法(LB法)在基板表面上形成具有長 鏈烷基之單分子膜之方法等。此等之中,特別就基板尺寸 -5- 201219450 t*. 、液晶之配向均一性、處理時間、成本等之觀點而言,藉 由磨擦處理來賦予液晶配向能爲一般的。 但,在藉由磨擦處理來賦予液晶配向能之方面,因磨 擦而會有液晶配向膜之缺陷之產生、起因爲液晶配向膜之 缺陷之顯示缺陷之產生、塵埃產生、因靜電之發生而TFT (Thin Film Transistor )元件回路破壞等之問題。 又,垂直配向方式之液晶顯示元件,已知有將用來控 制液晶之倒下方向之突起形成於TFT基板或彩色濾光片基 板之 MVA ( Multi Vertical Alignment )方式、將隙縫( slit)形成於基板之ITO ( Indium Tin Oxide)電極上,藉 由電場來控制液晶之倒下方向之PVA ( Patterned Vertical Alignment )方式、使用ITO電極上爲已形成有隙縫(slit )之基板,及已添加有光聚合性化合物之液晶來製作液晶 面板,予以外加電場,在液晶倒下之狀態照射紫外線( UV)等,來固定化液晶之配向之PSA( Polymer Sustained A1 i g n m e n t )方式等。 此等以往的垂直配向方式之問題點方面,有因爲使用 複雜的基板之面板之高成本化、因突起或隙縫等面板之透 過率之降低等》 另一方面,作爲賦予液晶晶胞中液晶配向膜之液晶配 向能之其他手段,已知有對於已形成於基板表面之聚乙烯 基桂皮酸酯、聚醯亞胺等之感光性薄膜,藉由照射偏光或 非偏光之放射線,而賦予液晶配向能之光配向法(參考專 利文獻1〜8 )。201219450 VI. Description of the Invention: [Technical Field of the Invention] The present invention relates to a novel diamine compound which is useful as a raw material of a polymer used for a liquid crystal alignment film, and a polyamic acid and a polyamidene obtained therefrom. An amine, and a liquid crystal alignment treatment agent. Further, there is a liquid crystal display element having a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent. More specifically, a liquid crystal alignment treatment agent for a liquid crystal alignment film for vertical alignment, a liquid crystal alignment film and a method for forming the same, and a liquid crystal display having such a liquid crystal alignment film can be formed by a small amount of polarized or non-polarized radiation. Component and optical characteristic member. [Prior Art] The liquid crystal alignment film is a constituent member of a liquid crystal display element which is widely used as a display device, and functions as a so-called alignment of liquid crystal in a certain direction. Nowadays, the main liquid crystal alignment film used in the industry is a solution of polylysine (also known as polyglycolic acid), polyamidomate or polyimine from polyimine precursors. The resulting liquid crystal alignment treatment agent is formed. In general, after the liquid crystal alignment treatment agent is applied onto a substrate and heated and calcined, an alignment treatment for making the liquid crystal parallel or obliquely aligned with respect to the substrate surface is performed. In the aspect of the alignment treatment, it is known that the surface of the organic film is rubbed by a cloth such as cotton, nylon or enamel, that is, a surface treatment method called rubbing, a method of vapor-depositing cerium oxide on the surface of a substrate, and using Langmuir - Brochette method (LB method) A method of forming a monomolecular film having a long-chain alkyl group on the surface of a substrate. Among these, particularly in terms of the substrate size -5 - 201219450 t*., the alignment uniformity of the liquid crystal, the processing time, the cost, and the like, it is common to impart liquid crystal alignment by the rubbing treatment. However, in the aspect of imparting the alignment property to the liquid crystal by the rubbing treatment, there is a defect of the liquid crystal alignment film due to the friction, a display defect due to the defect of the liquid crystal alignment film, generation of dust, and occurrence of static electricity due to the occurrence of static electricity. (Thin Film Transistor) Problems such as component loop destruction. Further, in the liquid crystal display device of the vertical alignment type, an MVA (Multi Vertical Alignment) method in which a projection for controlling the falling direction of the liquid crystal is formed on a TFT substrate or a color filter substrate is known, and a slit is formed in the slit. On the ITO (Indium Tin Oxide) electrode of the substrate, a PVA (Patterned Vertical Alignment) method for controlling the liquid crystal falling direction by an electric field, a substrate having a slit formed on the ITO electrode, and a light added thereto A PSA (Polymer Sustained A1 ignment) method in which a liquid crystal panel is formed by a liquid crystal of a polymerizable compound, an electric field is applied thereto, and ultraviolet rays (UV) or the like is applied to the liquid crystal in a state where the liquid crystal is dropped. The problem of the conventional vertical alignment method is that the cost of the panel using a complicated substrate is high, and the transmittance of a panel such as a protrusion or a slit is lowered. On the other hand, the liquid crystal alignment in the liquid crystal cell is imparted. Other means for the liquid crystal alignment energy of the film, it is known that a photosensitive film such as polyvinyl cinnamate or polyimine which has been formed on the surface of the substrate is irradiated with polarized or non-polarized radiation to impart alignment to the liquid crystal. The optical alignment method (refer to Patent Documents 1 to 8).
-6- S 201219450 此光配向法,已知在垂直配向型之液晶顯示元件中, 在作爲控制液晶分子之傾斜方向之方法亦爲有用的》即, 已知藉由使用以光配向法所賦予配向管制力之垂直配向膜 ,可將外加電壓時之液晶分子之傾斜方向予以均一地控制 (參考專利文獻9〜1 1 )。 藉由使用如此般以光配向法所賦予配向管制力之垂直 配向膜,使液晶分子由基板法線方向朝向基板面內之一方 向以僅僅傾斜者成爲可能的。 如此般地,藉由光配向法所製造的液晶配向膜,適宜 作爲液晶顯示元件用。然而,將已知含有桂皮酸酯或聚醯 亞胺等之液晶配向處理劑使用於光配向法時,有所謂相對 於得到的液晶配向能,所需要的放射線照射量多之問題。 因照射量多所造成之問題點,會增加液晶顯示元件製作之 工站時間(tact time )之增加、作爲因長時間之照射液晶 配向膜產生缺陷,進而伴隨著,產生液晶面板之信賴性之 降低。 又,在垂直配向方式之液晶顯示元件中,若未反應的 光反應性基存在於液晶配向膜中時,因液晶面板之長時間 曝露於背光(BL)光源下,未反應的光反應性基會產生反 應,有液晶之預傾角變化等之問題。 〔先前技術文獻〕 〔專利文獻〕 〔專利文獻1〕日本特開平6-287453號公報 〔專利文獻2〕日本特開平10_25 1 646號公報 201219450 〔專利文獻3〕日本特開平n_2815號公報 〔專利文獻4〕日本特開平n_152475號公報 〔專利文獻5〕日本特開2〇〇〇_144136號公報 〔專利文獻6〕日本特開2〇〇〇_31951〇號公報 〔專利文獻7〕日本特開2000-281724號公報 〔專利文獻8〕日本特開平9_2973 1 3號公報 〔專利文獻9〕日本特開2〇〇3_3〇7736號公報 〔專利文獻10〕日本專利第4088 1 56號公報 〔專利文獻11〕日本特開20 04-163646號公報 【發明內容】 〔發明所欲解決的課題〕 本發明之目的係以提供一在形成藉由少量照射量之偏 光或非偏光之放射線可展現出預傾角,且即使是在因長時 間之背光光源之曝露中,亦能維持安定預傾角之垂直配向 用液晶配向膜時所使用的液晶配向處理劑、所形成的液晶 配向膜,以及具備該液晶配向膜之液晶顯示元件。 〔解決課題之手段〕 本發明人爲達成上述目的而進行深入硏究之結果,發 現一具有特定新穎構造之二胺化合物,發現含有使用該二 胺化合物所得到的聚合物之液晶配向處理劑達成了上述之 目的。本發明係基於該見解者,具有以下之要旨。 (1 )—種液晶配向處理劑,其係含有由聚醯胺酸、-6- S 201219450 This photo-alignment method is known to be useful as a method of controlling the tilt direction of liquid crystal molecules in a liquid crystal display device of a vertical alignment type, that is, it is known to be imparted by a photo-alignment method. The vertical alignment film of the alignment control force can uniformly control the tilt direction of the liquid crystal molecules at the time of applying a voltage (refer to Patent Documents 9 to 1 1). By using the vertical alignment film imparted with the alignment control force by the photoalignment method as described above, it is possible to tilt the liquid crystal molecules from the substrate normal direction toward one of the substrate faces with only the tilt. In this manner, the liquid crystal alignment film produced by the photo-alignment method is suitably used as a liquid crystal display element. However, when a liquid crystal alignment agent containing a cinnamic acid ester or a polyimine is known to be used in a photo-alignment method, there is a problem that a required amount of radiation irradiation is required with respect to the obtained liquid crystal alignment energy. The problem caused by the large amount of irradiation increases the increase in the tact time of the liquid crystal display element production, and causes defects in the liquid crystal alignment film due to the long-time exposure, which in turn leads to the reliability of the liquid crystal panel. reduce. Further, in the liquid crystal display device of the vertical alignment type, when the unreacted photoreactive group is present in the liquid crystal alignment film, the liquid crystal panel is exposed to the backlight (BL) light source for a long time, and the unreacted photoreactive group is exposed. There will be a reaction, and there is a problem such as a change in the pretilt angle of the liquid crystal. [PATENT DOCUMENT] [Patent Document 1] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei 6-287453 (Patent Document 2) Japanese Laid-Open Patent Publication No. Hei No. Hei. Japanese Unexamined Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. [Problem to be Solved by the Invention] The object of the present invention is to provide a pretilt angle which can exhibit a polarized or non-polarized radiation by a small amount of irradiation. Further, even in the case of exposure to a backlight source for a long period of time, the liquid crystal alignment agent and the liquid to be used for maintaining the liquid crystal alignment film for the vertical alignment of the pretilt angle can be maintained. A crystal alignment film and a liquid crystal display element including the liquid crystal alignment film. [Means for Solving the Problem] As a result of intensive research to achieve the above object, the present inventors have found that a diamine compound having a specific novel structure is found to have reached a liquid crystal alignment treatment agent containing a polymer obtained by using the diamine compound. The above purpose. The present invention is based on this insight and has the following gist. (1) a liquid crystal alignment treatment agent containing polyamic acid,
-8- S 201219450 及將該聚醯胺酸醯亞胺化所得到的聚釀亞胺所成之群所 出之至少一種的聚合物;其中,該聚醯胺酸爲藉由含有下 述式〔1〕之二胺化合物之二胺成分與四竣酸二肝成分之 反應所得到; 【化1】 〇-8-S 201219450 and a polymer of at least one of the group of polyamidiamine obtained by imidating the polyphosphonium amide; wherein the polyglycolic acid comprises the following formula The reaction of the diamine component of the diamine compound of [1] with the di-hepatic component of tetradecanoic acid; [Chemical 1] 〇
(式中,X1 示爲單鍵、-ch2〇-、-〇-、_CC)C)_、_0CC)_ 、-NHCO-、或- CONH-,X2示爲碳數1〜3之伸院基,χ3示 爲- 0-、-ΝΗ-、或-NCR1) -,X4 示爲單鍵、-〇-、-S-、或_ NH-。X5示爲單鍵或由下述式[X5-l]〜[X5-5]之群所選出之 碳環,X6示爲碳數1〜18之直鏈或分支狀之烷基’ χ7示爲 氫原子、-R2、-OR3、-NHR4、-N ( R5 ) 2、或-SR6。在此 ,R1〜R6分別獨立示爲碳數1〜5之烷基。η示爲1或2之整 數), 【化2】 [X5-2](wherein X1 is shown as a single bond, -ch2〇-, -〇-, _CC)C)_,_0CC)_, -NHCO-, or -CONH-, and X2 is shown as a carbon number of 1 to 3 , χ3 is shown as -0-, -ΝΗ-, or -NCR1) -, X4 is shown as a single bond, -〇-, -S-, or _ NH-. X5 is shown as a single bond or a carbocyclic ring selected from the group of the following formulas [X5-1] to [X5-5], and X6 is shown as a linear or branched alkyl group having a carbon number of 1 to 18'. A hydrogen atom, -R2, -OR3, -NHR4, -N(R5)2, or -SR6. Here, R1 to R6 are each independently shown as an alkyl group having 1 to 5 carbon atoms. η is shown as an integer of 1 or 2), [Chemical 2] [X5-2]
[X5-3][X5-3]
[XS-5] (惟,在上述碳環構造中,任意之氫原子可被ch3取 代)。 (2 )如上述(1 )之液晶配向處理劑,其中,前述二 -9- 201219450 胺成分中式〔i〕之二胺化合物之含有量爲30〜100莫耳% 〇 (3) 如上述(1)或(2)之液晶配向處理劑,其中 ,前述式〔1〕之X3爲- 〇·’χ7爲氫原子。 (4) 如上述(1)〜(3)中任一項之液晶配向處理 劑,其中,前述式〔1〕之X5爲單鍵。 (5) 如上述(1)〜(4)中任一項之液晶配向處理 劑,其中,前述式〔1〕之X1爲單鍵,X4爲-0-。 (6 )如上述(1 )〜(5 )中任一項之液晶配向處理 劑,其中,前述式〔1〕之η爲1。 (7 )如上述(1 )〜(6 )中任一項之液晶配向處理 劑,其中,前述式〔1〕之X2爲- CH2-,X6爲碳數8〜12之 烷基。 (8) —種液晶配向膜,其係由上述(1)〜(7)中 任一項之液晶配向處理劑所得到。 (9) —種液晶配向膜,其係由上述(1)〜(7)中 任一項之液晶配向處理劑所得到,係藉由偏光或非偏光之 放射線之照射而賦予液晶配向能。 (10) —種液晶顯示元件,其係具備有上述(8)或 (9 )之液晶配向膜。 (11) —種下述式[1]所示之二胺化合物,[XS-5] (However, in the above carbocyclic structure, any hydrogen atom may be replaced by ch3). (2) The liquid crystal alignment treatment agent according to the above (1), wherein the content of the diamine compound of the formula [i] in the above-mentioned two-9-201219450 amine component is 30 to 100 mol% 〇(3) as described above (1) Or a liquid crystal alignment treatment agent of (2), wherein X3 of the above formula [1] is -〇·'χ7 is a hydrogen atom. (4) The liquid crystal alignment treatment agent according to any one of the above (1), wherein X5 of the above formula [1] is a single bond. (5) The liquid crystal alignment treatment agent according to any one of the above (1), wherein X1 of the above formula [1] is a single bond, and X4 is -0-. (6) The liquid crystal alignment treatment agent according to any one of the above (1), wherein the η of the above formula [1] is 1. (7) The liquid crystal alignment treatment agent according to any one of the above (1), wherein X2 of the above formula [1] is -CH2-, and X6 is an alkyl group having 8 to 12 carbon atoms. (8) A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of the above (1) to (7). (9) A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of the above (1) to (7), which is provided with a liquid crystal alignment energy by irradiation of polarized light or non-polarized radiation. (10) A liquid crystal display device comprising the liquid crystal alignment film of (8) or (9) above. (11) a diamine compound represented by the following formula [1],
-10- S 201219450 【化3】 Η2Νγ^-Χ1-Χ2-Χ3 Η2Ν^-10- S 201219450 【化3】 Η2Νγ^-Χ1-Χ2-Χ3 Η2Ν^
χ4.χ5.χβ [1] (式中,χΐ示爲單鍵 ' -CH20-、_0.、-COO-、-OCO-、-NHCO-、或- CONH-,X2示爲碳數1〜3之伸烷基’ X3示 爲.0·、-NH-、或_N(R丨)_,X4示爲單鍵、-〇_、-S-、或_ NH-。X5示爲單鍵或由下述式[X5-l]〜[X5-5]之群所選出之 碳環,X6示爲碳數1〜18之直鏈或分支狀之烷基’ χ7示爲 氫原子、-R2、-OR3、-NHR4、-N ( R5 ) 2、或-SR6。在此 ,R1〜R6分別獨立示爲碳數1〜5之烷基。η示爲1或2之整 數), 【化4】 [X5-!] [Χ5-2]Χ4.χ5.χβ [1] (wherein χΐ is shown as a single bond '-CH20-, _0., -COO-, -OCO-, -NHCO-, or -CONH-, X2 is shown as carbon number 1~3 The alkyl group 'X3 is shown as .0·, -NH-, or _N(R丨)_, and X4 is shown as a single bond, -〇_, -S-, or _NH-. X5 is shown as a single bond or A carbocyclic ring selected from the group of the following formulas [X5-1] to [X5-5], and X6 is a linear or branched alkyl group having a carbon number of 1 to 18, which is represented by a hydrogen atom, -R2. -OR3, -NHR4, -N(R5)2, or -SR6. Here, R1 to R6 are each independently shown as an alkyl group having 1 to 5 carbon atoms. η is an integer of 1 or 2), [Chemical 4] [X5-!] [Χ5-2]
~CKD~ [X5-S] (惟,在上述碳環構造中,任意之氫原子可被ch3取 代)。 (12)如上述(11)之二胺化合物,其中,前述式〔 1〕之X3爲-0-,X7爲氫原子。 (1 3 )如上述(1 1 )或(丨2 )之二胺化合物,其中, 前述式〔1〕之X5爲單鍵。 (1 4 )如上述(1 1 )〜(i 3 )中任—項之二胺化合物 ’其中’前述式〔1〕之X1爲單鍵,X4爲-0-。 -11 - 201219450 (15) 如上述(11)〜(14)中任一項之二胺化合物 ,其中,前述式〔1〕之η爲1» (16) 如上述(11)〜(15)中任一項之二胺化合物 ,其中,前述式〔1〕之X2爲-CH2-,X6爲碳數8〜12之烷 基。 (17) —種聚醯亞胺,其係使含有如上述(1)〜( 16)中任一項之二胺化合物之二胺成分與四羧酸二酐成分 反應而得到的聚醯胺酸、或將該聚醯胺酸醯亞胺化而得到 〔發明之效果〕~CKD~ [X5-S] (However, in the above carbon ring structure, any hydrogen atom can be replaced by ch3). (12) A diamine compound according to the above (11), wherein X3 of the above formula [1] is -0-, and X7 is a hydrogen atom. (1 3 ) The diamine compound of the above (1 1 ) or (丨2), wherein X5 of the above formula [1] is a single bond. (1 4) The diamine compound of any one of the above (1 1 ) to (i 3 ) wherein X1 of the above formula [1] is a single bond, and X4 is -0-. The diamine compound according to any one of the above (11) to (14), wherein η of the above formula [1] is 1» (16) as in the above (11) to (15) Any one of the diamine compounds, wherein X2 of the above formula [1] is -CH2-, and X6 is an alkyl group having 8 to 12 carbon atoms. (17) A polyimine which is obtained by reacting a diamine component of the diamine compound according to any one of the above (1) to (16) with a tetracarboxylic dianhydride component. Or imidizing the polyphosphonium hydrazide to obtain the effect of the invention
I 藉由本發明之液晶配向處理劑,相較於以往的光配向 法,使用少量放射線之照射量,可得到用來展現出預傾角 之液晶配向膜。又,具有本發明之液晶配向膜之液晶顯示 元件’即使是在因長時間之背光光源之曝露中,亦能安定 地展現出預傾角,在作爲信賴性高的液晶顯示元件爲有用 的。 〔實施發明的最佳型態〕 <式〔1〕所示二胺化合物> 本發明之二胺化合物(以下,亦會稱爲特定二胺化合 物),如下述式〔1〕所示,In the liquid crystal alignment agent of the present invention, a liquid crystal alignment film for exhibiting a pretilt angle can be obtained by using a small amount of radiation irradiation compared to the conventional photoalignment method. Further, the liquid crystal display element ’ having the liquid crystal alignment film of the present invention can stably exhibit a pretilt angle even when exposed to a backlight source for a long period of time, and is useful as a liquid crystal display element having high reliability. [Best Mode of Carrying Out the Invention] <Diamine Compound of the Formula [1]> The diamine compound of the present invention (hereinafter also referred to as a specific diamine compound) is represented by the following formula [1].
SS
[1] 201219450 【化5】[1] 201219450 【化5】
式中,X1示爲單鍵、_CH2o-、-ο-、-coo-、-oco-、-NHCO·、或-CONH-。 X2示爲碳數1〜3之伸烷基。 X3 示爲 _〇_、-NH·、或-NCR1)-。 X4示爲單鍵、-0-、-S-、或-NH-。 X5示爲單鍵或由下述式[X5-l]〜[X5-5]之群所選出之 碳環。 X6示爲碳數1〜18之直鏈或分支狀之烷基。 X7 示爲氫原子、-R2、-〇R3、-NHR4、-N(R5) 2、或_ SR6。在此,R1〜R6分別獨立示爲碳數1〜5之烷基。 η示爲1或2之整數。 【化6】In the formula, X1 is represented by a single bond, _CH2o-, -ο-, -coo-, -oco-, -NHCO·, or -CONH-. X2 is shown as an alkylene group having a carbon number of 1 to 3. X3 is shown as _〇_, -NH·, or -NCR1)-. X4 is shown as a single bond, -0-, -S-, or -NH-. X5 is shown as a single bond or a carbocyclic ring selected from the group of the following formulas [X5-1] to [X5-5]. X6 is shown as a linear or branched alkyl group having 1 to 18 carbon atoms. X7 is shown as a hydrogen atom, -R2, -〇R3, -NHR4, -N(R5) 2, or _SR6. Here, R1 to R6 are each independently shown as an alkyl group having 1 to 5 carbon atoms. η is shown as an integer of 1 or 2. 【化6】
的] pts-2]Pts-2]
[Χ5-5] 在上述式[X5-l]〜[Χ5-5]之碳環構造中’任意之氮原 子可被ch3取代。 在式〔1〕中的二個胺基(-NH2)之鍵結位置未限定 。具體舉例如相對於側鏈之鍵結基(X1 ) ’爲苯環上之 2,3之位置、2,4之位置、2,5之位置、2,6之位置、3,4之位 -13- 201219450 置、或3,5之位置。此等之中,又以合成聚醯胺酸之際之 反應性、及合成二胺化合物之際之容易性之觀點而言,二 個胺基之鍵結位置以2,4之位置、2,5之位置、或3,5之位置 爲特佳。 本發明之二胺化合物,在利用作爲垂直配向用液晶配 向膜時,係以藉由紫外線之照射而賦予預傾角爲目的,式 〔1〕中所含有的下述式〔2〕所示部分爲決定預傾角之展 現之部分。藉由將此構造予以最佳化,可得到較佳預傾角 之大小。 【化7】[Χ5-5] In the carbocyclic structure of the above formula [X5-1] to [Χ5-5], any nitrogen atom may be substituted by ch3. The bonding position of the two amine groups (-NH2) in the formula [1] is not limited. Specifically, for example, the bonding group (X1) with respect to the side chain is the position of 2, 3 on the benzene ring, the position of 2, 4, the position of 2, 5, the position of 2, 6, and the position of 3, 4 - 13- 201219450 Set, or 3, 5 position. Among these, the bonding position of the two amine groups is 2, 4, 2, from the viewpoint of the reactivity at the time of synthesizing polyamic acid and the easiness of synthesizing the diamine compound. The position of 5, or the position of 3, 5 is particularly good. When the diamine compound of the present invention is used as a liquid crystal alignment film for vertical alignment, the pretilt angle is imparted by irradiation of ultraviolet rays, and the portion represented by the following formula [2] contained in the formula [1] is Determine the part of the pretilt. By optimizing this configuration, a better pretilt angle can be obtained. 【化7】
式〔2〕中,X1 爲單鍵、-CH20-、-0-、-COO·、-OCO-、-NHCO-、或-CONH-之鍵結基,X2爲碳數1〜3之伸 烷基。 X2之伸烷基鏈之長度,對於以少量照射量來展現出預 傾角爲重要的,若此伸烷基鏈過長時,直到展現出预傾角 爲止的照射量會變多。此爲,因爲在形成垂直配向用液晶 配向膜之聚合物中所含有的胺之側鏈(來自於上述式〔2 〕之鍵結於X3之羰基之部位)之根部之部位產生光反應, 因光反應之異向性而影響到全體側鏈,因而側鏈之給予液 晶之配向管制力變大之故。此結果,即使是少量照射量, -14-In the formula [2], X1 is a single bond, a bond group of -CH20-, -0-, -COO., -OCO-, -NHCO-, or -CONH-, and X2 is a alkylene having a carbon number of 1 to 3. base. The length of the alkyl chain of X2 is important for exhibiting a pretilt angle with a small amount of irradiation, and if the alkyl chain is too long, the amount of irradiation until the pretilt angle is exhibited increases. This is because a photoreaction occurs at a portion of the base of the amine (from the portion of the above formula [2] bonded to the carbonyl group of X3) contained in the polymer forming the liquid crystal alignment film for vertical alignment. The anisotropy of the photoreaction affects the entire side chain, and thus the alignment control force imparted to the liquid crystal by the side chain becomes large. This result, even for a small amount of exposure, -14-
S 201219450 亦能使展現出液晶之預傾角成爲可能的。 式〔2〕中,X3 示爲-〇-、-NH-、或-NCR1) -,X4 示 爲單鍵、-0-、-S-、或-NH-。 R1示爲碳數1〜5之烷基。 X3、及X4爲光反應性部分之鍵結基,就光反應性基之 光吸收波長長度或合成之容易性而言,X3、及X4特佳爲-〇 - 〇 式〔2〕中,X5爲單鍵或由下述式[xM]〜[X5-5]之群 所選出之碳環,X6爲碳數1〜18之直鏈或分支狀之烷基。 X5及X6,在用來使液晶垂直地配向爲重要的,X5爲單 鍵時,就垂直配向能方面而言,X6較佳爲長鏈烷基。此情 形時之X6之碳數,較佳爲6〜18、更佳爲8〜12。 又,X5若爲由下述式[X5-l]〜[X5-5]之群所選出之碳 環時,爲了提昇垂直配向能,X4較佳爲稍微短之烷基。此 情形時之X4之碳數,較佳爲1〜1 2、更佳爲3〜8。S 201219450 also makes it possible to exhibit the pretilt angle of the liquid crystal. In the formula [2], X3 is represented by -〇-, -NH-, or -NCR1)-, and X4 is represented by a single bond, -0-, -S-, or -NH-. R1 is shown as an alkyl group having 1 to 5 carbon atoms. X3 and X4 are the bonding groups of the photoreactive portion, and in terms of the wavelength of the light absorption wavelength of the photoreactive group or the ease of synthesis, X3 and X4 are particularly preferably -〇-〇[2], X5 It is a single bond or a carbocyclic ring selected from the group of the following formulas [xM] to [X5-5], and X6 is a linear or branched alkyl group having 1 to 18 carbon atoms. X5 and X6 are important for aligning liquid crystals vertically, and when X5 is a single bond, X6 is preferably a long-chain alkyl group in terms of vertical alignment energy. The carbon number of X6 in this case is preferably 6 to 18, more preferably 8 to 12. Further, when X5 is a carbon ring selected from the group of the following formulas [X5-1] to [X5-5], X4 is preferably a slightly shorter alkyl group in order to enhance the vertical alignment energy. In this case, the carbon number of X4 is preferably from 1 to 1, more preferably from 3 to 8.
-〇〇- [XS-5] 式〔2〕中,X7示爲氫原子、-R2、-OR3、-NHR4、-N (R5 ) 2、或- SR6。在此,R2〜R6分別獨立示爲碳數1〜5 之烷基。η示爲1或2之整數。 X7及η,爲用來決定光反應性基之感光波長爲重要的 -15- 201219450 v • ...... ,若於χ7使用電子供予性之取代基時,光反應性基之吸收 波長會有長波長化。.又,若η爲2時,會得到同樣之效果。 X7及η,可使免反應性基之感光波長成爲較佳之波長。 就作爲垂直配向'用液晶配向膜使用時之感光波長及光 反應性'之感度之觀點而會,式〔1〕之X1〜X7之較佳具體 組合如下所示。 【化9】-〇〇- [XS-5] In the formula [2], X7 is represented by a hydrogen atom, -R2, -OR3, -NHR4, -N(R5)2, or -SR6. Here, R2 to R6 are each independently shown as an alkyl group having 1 to 5 carbon atoms. η is shown as an integer of 1 or 2. X7 and η are important for determining the photoreactive wavelength of the photoreactive group -15-201219450 v • ..., if the electron-donating substituent is used in χ7, the absorption of photoreactive groups The wavelength will be longer wavelength. Also, if η is 2, the same effect will be obtained. X7 and η can make the photosensitive wavelength of the non-reactive group a preferred wavelength. From the viewpoint of the sensitivity of the vertical alignment 'photosensitive wavelength and photoreactivity when used in the liquid crystal alignment film', the preferred specific combinations of X1 to X7 of the formula [1] are as follows. 【化9】
【化10.】[化10.]
-16- S 201219450-16- S 201219450
【化12】【化12】
-17- 201219450 【化13】-17- 201219450 【化13】
【化14】【化14】
【化15】【化15】
-18--18-
S 201219450 【化’16】S 201219450 【化'16】
【化17】【化17】
【化18】【化18】
-19- 201219450 【化19】-19- 201219450 【化19】
-20- s 201219450 【化21】-20- s 201219450 【化21】
201219450 【化23】201219450 【化23】
【化24】【化24】
S 201219450 【化25】S 201219450 【化25】
【化26】【化26】
在上述示例之二胺化合物所記載的CnH2n + 1部分中,η 示爲1〜18之整數。 <特定二胺化合物之合成方法> 製法1 藉由將由二硝基體1所得到的丙烯酸酯體2,與具有脫 離性官能基之Υ之苯衍生物3之反應,而製造在側鏈具有桂 -23- 201219450 皮酸部位之二硝基體4。所得到的二硝基體4,藉由選擇對 於側鏈之雙鍵部分不會影響之還原方法,予以實施’而變 換成爲目的之二胺5爲可能的。In the CnH2n + 1 moiety described in the above-exemplified diamine compound, η is represented by an integer of from 1 to 18. <Synthesis method of specific diamine compound> Process 1 is produced by reacting acrylate body 2 obtained from dinitrogen 1 with benzene derivative 3 having a cleavable functional group in the side chain桂-23- 201219450 Dinitrogen 4 of the citric acid site. The obtained dinitrogen 4 can be carried out by selecting a reduction method which does not affect the double bond portion of the side chain, and it is possible to convert it to the intended diamine 5.
化合物1之製法 〈X1爲單鍵時(m爲1〜3之整數,X3示爲- 〇·、-NH-、或-NR1-) > 幾個原料可作爲市售品而予以購得。當市售品方面之 取得爲困難時’對於化合物6所示般之羧酸使用硼烷還原 劑進行還原反應時’可合成X3爲對應於-〇-之原料。又, 只要使硼院還原劑作用於化合物6之羧酸部分爲氰基之化 合物’即’化合物7時,可合成X3爲_NH_之二胺化合物之 原料。 【化28】Method for Producing Compound 1 <X1 is a single bond (m is an integer of 1 to 3, and X3 is represented by -〇·, -NH-, or -NR1-) > Several raw materials are commercially available. When it is difficult to obtain a commercially available product, when a borane reducing agent is used as a carboxylic acid as shown in the compound 6, a reduction reaction is carried out, and X3 is synthesized as a raw material corresponding to -〇. Further, when a boron-reducing agent is allowed to act on the compound of the compound 6 in which the carboxylic acid moiety is a cyano group, that is, the compound 7, the raw material of the diamine compound in which X3 is _NH_ can be synthesized. 【化28】
-24--twenty four-
S 201219450 將X3爲-〇-之化合物la’之羥基變換成爲鹵素或磺酸酯 等之脫離基後,即使是將使與疊氮化物反應所得到對應的 疊氮基衍生物予以還原,可得到X3爲-NH-之化合物la”。 又,於變換成脫離基後,使與琥珀酸醯亞胺或鄰苯二甲醯 亞胺反應後,使用肼將生成的N-烷基醯亞胺予以分解,即 ,以藉由加柏利合成之胺之合成,亦能得到X3爲-NH-之化 合物1 a”。 對於X3爲-NH-之化合物la”,使烷基鹵化物或烷基磺 酸酯在鹼之共存下反應,可得到X3爲-NR1 ( R1示爲碳數1 〜5之烷基)之化合物la”。又,使醛化合物作用以成爲對 應的亞胺化合物,將該亞胺部分以硼烷系之還原劑等進行 還原,即,藉由利用還原性胺基化反應,可得到X3爲-NR1 (R1示爲碳數1〜5之烷基)之化合物la”’。前者之烷基化 之情形時,雖然可得到導入有複數個烷基之副產物,但以 後者之方法時無副產物’對於烷基之導入爲有效的。 〈X1爲·〇-時(m爲1〜3之整數’ X3示爲-0-、-NH-、或-NR1-) > 將作爲市售品可取得的二硝基酚8,藉由具有保護基P 之化合物9予以烷基化,而得到具有側鏈之二硝基體1 〇 ° 將二硝基體丨〇中所含有的保護基P藉由脫保護’可製造二 硝基中間物1 b。 -25- 201219450 【化29】S 201219450 After converting the hydroxyl group of the compound la' wherein X3 is -〇- into a leaving group such as a halogen or a sulfonate, even if the azide derivative obtained by reacting with the azide is reduced, X3 is -NH-compound la". Further, after conversion to a leaving group, after reacting with succinimide or phthalimide, the resulting N-alkyl sulfimine is treated with hydrazine. Decomposition, that is, a compound 1 a" in which X3 is -NH- can also be obtained by synthesis of an amine synthesized by Gabriel. For the compound la" wherein X3 is -NH-, an alkyl halide or an alkyl sulfonate is reacted in the presence of a base to obtain a compound wherein X3 is -NR1 (R1 is represented by an alkyl group having 1 to 5 carbon atoms). La". Further, the aldehyde compound acts to form a corresponding imine compound, and the imine moiety is reduced with a borane-based reducing agent or the like, that is, by using a reductive amination reaction, X3 is obtained as -NR1 (R1) The compound la"' is shown as an alkyl group having a carbon number of 1 to 5). In the case of alkylation of the former, although a by-product in which a plurality of alkyl groups are introduced can be obtained, the latter method has no by-products. The introduction of an alkyl group is effective. <X1 is ·〇- (m is an integer of 1 to 3 'X3 is shown as -0-, -NH-, or -NR1-) > Available as a commercial product Dinitrophenol 8 is alkylated by a compound 9 having a protecting group P to obtain a dinitro group having a side chain 1 〇° The deprotecting group P contained in the dinitro group is deprotected' It can produce dinitro intermediate 1 b. -25- 201219450 【化29】
8 9 1〇 在化合物9中,Y示爲F、Cl、Br、I等之鹵素原子、或 甲烷磺醯氧基、苯磺醯氧基、甲苯磺醯氧基、三氟甲烷磺 醯基等之磺酸酯類。 保護基之P舉例如甲醯基、乙醯基、丙醯基、苯甲醯 基等之酯系的保護基、甲氧基甲基、乙氧基乙基、四氫哌 喃基、四氫呋喃基等之縮醛系的保護基、三甲基矽基、三 乙基矽基、三(異丙基)矽基、三苯基矽基、tert-丁基二 甲基矽基、tert-丁基二苯基矽基、異苯丙基二苯基矽基等 之矽基系的保護基、甲氧基羰基、乙氧基羰基、苯甲氧基 羰基、苯氧基羰基、tert-丁氧基羰基等之碳酸酯系的保護 基。就控制副反應之觀點而言,較佳爲縮醛系或矽基系的 保護基。 在由化合物8與化合物9得到二硝基體10之反應之際, 爲使與鹼共存,作爲使用的鹼,可使用碳酸鉀、碳酸氫鈉 、氫化鈉、氫化鉀等之無機鹼、三乙基胺、二(異丙基) 乙基胺等之胺類等。在進行本反應之際,爲了使反應圓滑 地進行,較佳爲添加碘化鈉、碘化鉀、或四-η-丁基銨碘化 物。 化合物10之脫保護之反應時,選擇適合於所使用的保 護基之脫保護條件來予以實施》使用酯系或碳酸酯系的保8 9 1〇 In the compound 9, Y is a halogen atom such as F, Cl, Br, I or the like, or a methanesulfonyloxy group, a benzenesulfonyloxy group, a toluenesulfonyloxy group, a trifluoromethanesulfonyl group, or the like. Sulfonates. The protective group P includes an ester-based protecting group such as a mercapto group, an ethyl fluorenyl group, a propyl fluorenyl group or a benzamidine group, a methoxymethyl group, an ethoxyethyl group, a tetrahydropyranyl group or a tetrahydrofuranyl group. Acetal-based protecting group, trimethylsulfonyl, triethylsulfonyl, tris(isopropyl)decyl, triphenylsulfonyl, tert-butyldimethylhydrazino, tert-butyl A protecting group for an indenyl group such as a diphenylfluorenyl group or an isophenylpropyldiphenylfluorenyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a benzyloxycarbonyl group, a phenoxycarbonyl group, or a tert-butoxy group. A carbonate-based protecting group such as a carbonyl group. From the viewpoint of controlling side reactions, an acetal or sulfhydryl protecting group is preferred. In the reaction between the compound 8 and the compound 9 to obtain the dinitro group 10, in order to coexist with a base, an inorganic base such as potassium carbonate, sodium hydrogencarbonate, sodium hydride or potassium hydride or a triethyl group can be used as the base to be used. An amine, an amine such as di(isopropyl)ethylamine or the like. In the case of carrying out the reaction, in order to carry out the reaction smoothly, it is preferred to add sodium iodide, potassium iodide or tetra-n-butylammonium iodide. In the case of the deprotection reaction of the compound 10, it is carried out by selecting a deprotection condition suitable for the protective group to be used.
-26- S 201219450 護基時,酸性或鹼性任何一方之液性水解反應均爲有效的 。又,利用與低級醇之酯交換反應亦可進行脫保護。使用 縮醛系的保護基時,較佳爲將礦酸或蟻酸、醋酸、甲苯磺 酸等之有機酸以使用觸媒量之脫保護反應。使用矽基系的 保護基時,在與縮醛系的保護基之脫保護爲同樣之條件下 ,較佳爲利用四-η-丁基銨氟化物等之氟化物之脫保護^ 對於以上述所得到的X3爲-ΝΗ-之化合物,藉由實施還 原性的胺基化反應,可合成X3爲對應於-NR1 ( R1示爲碳數 1〜5之烷基)之化合物lb。 又,將上述化合物8與化合物9之OH基與Y基予以更換 之化合物,即,化合物8之羥基部分爲氟或氯、化合物9之 Y爲OH基之化合物,在鹼之存在下使反應,爲亦可能得到 化合物1 〇。 〈X1爲-COO-、或-CONH-時(m爲1〜3之整數,X3示爲-〇-、-NH-、或-NR1-) >-26- S 201219450 When the base is protected, the liquid hydrolysis reaction of either acidic or alkaline is effective. Further, deprotection can also be carried out by a transesterification reaction with a lower alcohol. When an acetal protecting group is used, it is preferred to use a mineral acid or an organic acid such as formic acid, acetic acid or toluenesulfonic acid to remove the protective reaction using a catalytic amount. When a protecting group based on a fluorenyl group is used, it is preferably a deprotection of a fluoride using a tetra-n-butylammonium fluoride or the like under the same conditions as the deprotection of the acetal protecting group. The obtained X3 is a compound of -ΝΗ-, and by performing a reductive amination reaction, X3 can be synthesized into a compound lb corresponding to -NR1 (the alkyl group represented by R1 as a carbon number of 1 to 5). Further, a compound in which the above-mentioned compound 8 and the OH group of the compound 9 are replaced with a Y group, that is, a compound in which the hydroxyl group of the compound 8 is fluorine or chlorine, and the compound 9 is an OH group, the reaction is carried out in the presence of a base. It is also possible to obtain compound 1 〇. <X1 is -COO-, or -CONH- (m is an integer of 1-3, X3 is shown as -〇-, -NH-, or -NR1-) >
藉由羧酸或該衍生物11與具有保護基P之化合物12之 反應,而得到具有側鏈之二硝基-酯體1 3 ( Q = 0 )、或、 二硝基-醯胺體13 ( Q爲-NH-) »藉由將二硝基-酯體13 (Q 爲-〇-)、或、二硝基-醯胺體13 ( Q爲-NH-)中所含有的 保護基進行脫保護,可製造具有酯鍵結基之二硝基中間物 -27- 201219450 【化30】By reacting a carboxylic acid or the derivative 11 with a compound 12 having a protecting group P, a dinitro-ester having a side chain 1 3 (Q = 0) or a dinitro-lutamine 13 is obtained. (Q is -NH-) » by protecting the dinitro-ester 13 (Q is -〇-), or dinitro-valeramine 13 (Q is -NH-) Deprotection, a dinitro intermediate having an ester bond group can be produced -27- 201219450
在化合物11中,Hal示爲OH基、或、鹵素原子,若考 量安定性時,較佳爲使用〇H基或氯基之化合物1 1。 化合物12中的保護基P,較佳的保護基亦與前述爲同 義。 化合物12中的Z示爲羥基 '胺基、鹵素、或磺醯基。 化合物13中的Q示爲、-0-、或-NH-。考量使用的化合 物1 1之Hal部分之構造,來選擇化合物12中Z所示的官能基 。例如,Hal爲OH基,作爲Z若爲選擇OH基或NH2基時, 使用二環己基碳二醯亞胺、1-乙基- 3-(3-二甲基胺基丙基 )碳二醯亞胺、羰基二咪唑等之縮合劑進行反應時,可得 到具有酯(Q爲-〇-)或醯胺結合(Q爲-NH-)之化合物13 。Hal爲OH基,作爲Z若選擇鹵素、或磺醯基時,利用碳 酸鉀、碳酸氫鈉、氫化鈉、氫化鉀等之無機鹼、三乙基胺 、二(異丙基)乙基胺等之胺類使反應時,可得到酯化合 物13 ( Q爲-0-)。爲了使反應圓滑地進行,添加碘化鈉、 碘化鉀、或四-η -丁基銨碘化物亦爲有效的。In the compound 11, Hal is an OH group or a halogen atom, and when stability is considered, a compound 11 having a hydrazine H group or a chloro group is preferably used. The protecting group P in the compound 12, preferably a protecting group, is also synonymous with the foregoing. Z in compound 12 is represented by a hydroxy 'amine group, a halogen, or a sulfonyl group. Q in the compound 13 is shown as -0-, or -NH-. The functional group represented by Z in the compound 12 is selected in consideration of the configuration of the Hal moiety of the compound 11 used. For example, Hal is an OH group, and if Z is an OH group or an NH 2 group, dicyclohexylcarbodiimide or 1-ethyl-3-(3-dimethylaminopropyl)carbon dioxime is used. When a condensing agent such as an imine or a carbonyldiimidazole is reacted, a compound 13 having an ester (Q is -〇-) or a guanamine combination (Q is -NH-) can be obtained. Hal is an OH group, and when a halogen or a sulfonyl group is selected as Z, an inorganic base such as potassium carbonate, sodium hydrogencarbonate, sodium hydride or potassium hydride, triethylamine or di(isopropyl)ethylamine is used. When the amine is reacted, the ester compound 13 (Q is -0-) can be obtained. In order to carry out the reaction smoothly, it is also effective to add sodium iodide, potassium iodide or tetra-n-butylammonium iodide.
Hal若爲以氯基所代表的鹵素原子時,化合物12中的Ζ 爲使用羥基或胺基者,可得到酯化合物13 ( Q爲-0-)或醯 胺化合物1 3 ( Q爲-NH-)。此反應爲添加三乙基胺、吡啶 等之胺類來作爲鹼。When Hal is a halogen atom represented by a chloro group, and hydrazine in the compound 12 is a hydroxyl group or an amine group, an ester compound 13 (Q is -0-) or a guanamine compound 13 (Q is -NH-) can be obtained. ). This reaction is carried out by adding an amine such as triethylamine or pyridine as a base.
-28- S 201219450 藉由將所得到的化合物13之保護基P進行脫保護,可 得到化合物1 c,作爲脫保護之條件,與上述化合物1 〇之脫 保護條件爲同樣的。 對於X3爲-NH-之化合物la”,使烷基鹵化物或~院基磺 酸酯在鹼之共存下反應,可得到X3爲NR1 ( R1示爲碳數1〜 5之烷基)之化合物1 c。又,使醛化合物作用以成爲對應 的亞胺化合物,將該亞胺部分以硼烷系之還原劑等進行還 原,即,藉由利用還原性胺基化反應,可得到X3爲NR1 ( R1示爲碳數1〜5之烷基)之化合物lc»前者之烷基化之情 形時,雖然可得到導入有複數個烷基之副產物,但以後者 之方法時無副產物,對於烷基之導入爲有效的。 〈X1爲-OCO-、或-NHCO-時(m爲1〜3之整數,X3示爲-0-、-NH-、或-NR-) > 藉由二硝基酚(Q爲-〇-)或二硝基苯胺(Q爲-NH-) 14與具有保護基P之羧酸衍生物15之反應’來進行酯化或 醯胺化,以成爲具有酯或醯胺側鏈之二硝基體1 6後’藉由 將二硝基體16中所含有的保護基進行脫保護’可製造具有 酯結合或醯胺結合之二硝基中間物1 d。-28-S 201219450 By subjecting the obtained protecting group P of the compound 13 to deprotection, the compound 1 c can be obtained, and the conditions for deprotection are the same as those for the above compound 1 oxime. For the compound la" wherein X3 is -NH-, an alkyl halide or a sulfonate is reacted in the presence of a base to obtain a compound wherein X3 is NR1 (R1 is represented by an alkyl group having 1 to 5 carbon atoms). Further, the aldehyde compound acts to form a corresponding imine compound, and the imine moiety is reduced with a borane-based reducing agent or the like, that is, by using a reductive amination reaction, X3 is obtained as NR1. In the case of alkylation of the former compound lc» (wherein R1 is represented by an alkyl group having 1 to 5 carbon atoms), although a by-product of introducing a plurality of alkyl groups can be obtained, the latter method has no by-products. The introduction of an alkyl group is effective. <X1 is -OCO-, or -NHCO- (m is an integer of 1-3, X3 is shown as -0-, -NH-, or -NR-) > The reaction of nitrophenol (Q is -〇-) or dinitroaniline (Q is -NH-) 14 with the carboxylic acid derivative 15 having a protecting group P to carry out esterification or oximation to become an ester Alternatively, a dinitro intermediate 1 d having an ester bond or a guanamine bond can be produced by deprotecting the dinitro group of the guanamine side chain by a 'protection group contained in the dinitro group 16'.
-29- 201219450 化合物14、二硝基體16、及二硝基中間物Id中的Q示 爲-0·或-NH-。 在羧酸衍生物15中,Hal示爲OH基、或、鹵素原子, 但考量安定性時,較佳爲使用OH基或氯基之化合物15 ^ 保護基P之較佳保護基亦與前述同義。-29- 201219450 Q in compound 14, dinitroso 16, and dinitro intermediate Id is shown as -0 or -NH-. In the carboxylic acid derivative 15, Hal is shown as an OH group or a halogen atom, but in consideration of stability, a compound having an OH group or a chlorine group is preferably used. 15 A preferred protecting group of the protecting group P is also synonymous with the foregoing. .
Hal爲OH基,即I,使羧酸15與二硝基酚14(Q爲-0-) 或二硝基苯胺14 ( Q爲-NH-)反應時,一般爲利用二環己 基碳二醯亞胺、1-乙基-3-(3·二甲基胺基丙基)碳二醯亞 胺、羰基二咪唑等之縮合劑。更,添加觸媒量之酸或N,N-二甲基胺基吡啶,對於反應之進行爲宜。亦宜爲使用Hal 爲氯基等所代表的酸性鹵化物衍生物來實施反應之方法, 此時,添加三乙基胺、吡啶等之胺類等之鹼來進行反應。 藉由將所得到化合物16之保護基之P進行脫保護,可 得到二硝基中間物1 d,作爲脫保護之條件,與上述化合物 10之脫保護條件爲同樣的》 化合物2之製法 化合物2,可藉由所對應的二硝基苄基醇等之原料1與 丙烯酸衍生物之間之酯化而予以製造。 作爲丙烯酸衍生物,較佳爲使用丙烯酸性氯化物、丙 烯酸溴化物等之酸性鹵化物類、丙烯酸酐等。 在酯化反應中,作爲鹼,可使用氫氧化鈉、氫氧化鉀 、氫氧化鋰、碳酸氫鈉、碳酸氫鉀、磷酸鉀、碳酸鈉、碳 酸鉀、碳酸鋰、碳酸铯、NaH、KaH等之無機鹼、三甲基 -30- 兹 201219450 胺、三乙基胺、三丙基胺、三異丙基胺、三丁基胺、二異 丙基乙基胺、吡啶、喹啉、柯林鹼等之胺類、tert-鈉丁氧 化物、tert-鉀丁氧化物等之有機鹼。 作爲溶媒,只要是在該當反應條件下爲惰性、安定、 不妨礙反應者即可,可適宜地予以選擇。例如,可使用胺 類、非質子性極性有機溶媒(二甲基甲醯胺、二甲基亞楓 、二甲基乙醯胺、N-甲基吡咯啶酮等)、醚類(二乙基醚 、二異丙基醚、tert·丁基甲基醚、環戊基甲基醚、四氫呋 喃、二噁烷等)、脂肪族烴類(戊烷、己烷、庚烷、石油 醚等)、芳香族烴類(苯、甲苯、二甲苯、均三甲苯、氯 苯、二氯苯、硝基苯、四氫萘等)、鹵素系烴類(氯仿、 二氯甲烷、四氯化碳、二氯乙烷等)、低級脂肪酸酯類( 醋酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯等)、腈類( 乙腈、丙腈、丁腈等)。此等溶媒,可於考量反應條件或 反應之容易產生性等而予以選擇,能以單獨1種或混合2種 以上使用。又,視情況,亦可使用脫水劑或乾燥劑來作爲 非水溶媒使用。 反應溫度較佳爲由-100 °C至所使用溶媒之沸點之範圍 ’更佳爲-50〜150 °C之範圍。 反應時間較佳爲0.1〜1,000小時。 如上述般所得到的化合物2,能以再結晶、蒸餾、矽 凝膠管柱層析法、活性碳等予以純化。 又’化合物2,亦能以丙烯酸甲酯、丙烯酸乙酯等之 丙烯酸酯與二硝基苄基醇之酯交換反應、或、丙烯酸與二 -31 - 201219450 硝基氯化苄基、二硝基溴化苄基等之二硝基苄基鹵化物之 反應來予以合成》 化合物3之製法 【化32】Hal is an OH group, i.e., when carboxylic acid 15 is reacted with dinitrophenol 14 (Q is -0-) or dinitroaniline 14 (Q is -NH-), generally using dicyclohexyl carbon dioxime A condensing agent such as an imine or 1-ethyl-3-(3.dimethylaminopropyl)carbodiimide or carbonyldiimidazole. Further, it is preferred to add a catalytic amount of acid or N,N-dimethylaminopyridine for the reaction. It is also preferred to carry out the reaction by using an acid halide derivative represented by a chlorine group or the like, and a reaction such as an amine such as triethylamine or pyridine is added thereto. By deprotecting the protecting group P of the obtained compound 16, a dinitro intermediate 1 d can be obtained, and the conditions for deprotection are the same as those of the above compound 10. The compound 2 of the compound 2 It can be produced by esterification between the corresponding raw material 1 such as dinitrobenzyl alcohol and an acrylic acid derivative. As the acrylic acid derivative, an acid halide such as an acryl chloride or an acrylate bromide or an acrylic anhydride is preferably used. In the esterification reaction, as the base, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium hydrogencarbonate, potassium hydrogencarbonate, potassium phosphate, sodium carbonate, potassium carbonate, lithium carbonate, cesium carbonate, NaH, KaH, or the like can be used. Inorganic base, trimethyl-30-z 201219450 amine, triethylamine, tripropylamine, triisopropylamine, tributylamine, diisopropylethylamine, pyridine, quinoline, Colin An organic base such as an amine such as a base, tert-sodium butoxide or tert-potassium butoxide. The solvent can be appropriately selected as long as it is inert under the reaction conditions, stable, and does not interfere with the reaction. For example, an amine, an aprotic polar organic solvent (dimethylformamide, dimethyl sulfoxide, dimethylacetamide, N-methylpyrrolidone, etc.), an ether (diethyl) can be used. Ether, diisopropyl ether, tert butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane, heptane, petroleum ether, etc.), aromatic Hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), halogenated hydrocarbons (chloroform, dichloromethane, carbon tetrachloride, dichloroethane) Alkane, etc., lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). These solvents can be selected in consideration of the reaction conditions, the ease of production, and the like, and can be used alone or in combination of two or more. Further, as the case may be, a dehydrating agent or a desiccant may be used as the nonaqueous solvent. The reaction temperature is preferably in the range of from -100 °C to the boiling point of the solvent used, more preferably in the range of -50 to 150 °C. The reaction time is preferably from 0.1 to 1,000 hours. The compound 2 obtained as described above can be purified by recrystallization, distillation, hydrazine gel column chromatography, activated carbon or the like. Further, 'Compound 2 can also be transesterified with an acrylate such as methyl acrylate or ethyl acrylate and dinitrobenzyl alcohol, or acrylic acid with bis-31 - 201219450 benzyl chloride, dinitro The reaction of dinitrobenzyl halide such as benzyl bromide is carried out to synthesize the compound 3 method [Chem. 32]
L-Xs-X6 γ·\|/·υ • X? Jn 17 3 在上述化合物17與化合物18中’ ϋ示爲F、Cl、Br、I 等之鹵素原子、·〇Η、-SH、或-NH2’ X5示爲單鍵或由前 述[X5-l]〜[X5-5]之群所選出之碳環,X6示爲碳數1〜18之 直鏈或分支狀之烷基。 X7示爲氫原子、-R2、-OR3、-NHR4、·Ν ( R5 ) 2、或-SR6。在此,R2〜R6分別獨-ϋ*不爲碳數1〜5之院基。 η示爲1或2之整數。 Υ及L分別獨立爲鹵素或擬鹵素基’例如,示爲F、C1 、Br、I、甲烷磺醯氧基、苯磺醯氧基、甲苯磺醯氧基、 三氟甲烷磺醯基等之烷基磺醯氧基、或芳香族磺醯氧基。 化合物3之製法,可藉由例如1 7所示之化合物與丨8所 示之化合物之反應而予以製造。又’幾個化合物17與化合 物1 8爲可作爲市售品而容易地取得° < X4 爲-0-、-S-、或-NH-時〉L-Xs-X6 γ·\|/·υ • X? Jn 17 3 In the above compounds 17 and 18, 'halogen atoms, such as F, Cl, Br, I, etc., -〇Η, -SH, or -NH2' X5 is shown as a single bond or a carbocyclic ring selected from the group of [X5-1] to [X5-5], and X6 is shown as a linear or branched alkyl group having a carbon number of 1 to 18. X7 is shown as a hydrogen atom, -R2, -OR3, -NHR4, ·(R5)2, or -SR6. Here, R2 to R6 are exclusive to each other and are not a hospital base having a carbon number of 1 to 5. η is shown as an integer of 1 or 2. Υ and L are each independently a halogen or a pseudohalogen. For example, it is represented by F, C1, Br, I, methanesulfonyloxy, benzenesulfonyloxy, toluenesulfonyloxy, trifluoromethanesulfonyl, and the like. Alkylsulfonyloxy, or aromatic sulfonyloxy. The method for producing the compound 3 can be produced by, for example, a reaction of a compound represented by 17 with a compound represented by oxime 8. Further, a few of the compounds 17 and the compound 18 are easily obtained as a commercial product. When X4 is -0-, -S-, or -NH->
-32- S 201219450 化合物1 7之取代基U爲-OH、-SH、或-NH2,化合物1 8 之X5爲單鍵、或由前述[X5-l]〜[X5-5]之群所選出之碳環 時,在鹼之存在下,使兩化合物反應,可得到化合物3。 作爲所使用的鹼,例如,有鋰、鈉、鉀等之鹼金屬之氫氧 化物或碳酸鹽、三乙基胺、二吖雙環辛烷、二吖雙環十一 烯、吡啶、4-二甲基胺基吡啶等之有機脂肪族、芳香族、 及雜環之有機鹼等。亦可使用此等鹼之混合物。特佳爲碳 酸鉀。 作爲溶媒,只要是在該當反應條件下爲安定,惰性而 不會妨礙反應者即可,可適宜地予以選擇。例如,可使用 酮系溶媒(丙酮、2-丁酮、甲基異丁基酮等)、非質子性 極性有機溶媒(二甲基甲醯胺、二甲基亞颯、二甲基乙醯 胺、N-甲基吡咯啶酮等)、醚類(二乙基醚、二異丙基醚 、ter t-丁基甲基醚、環戊基甲基醚、四氫呋喃、二噁烷等 )、脂肪族烴類(戊烷、己烷、庚烷、石油醚等)、芳香 族烴類(苯、甲苯、二甲苯、均三甲苯、氯苯、二氯苯、 硝基苯、四氫萘等)、齒素系烴類(氯仿、二氯甲烷、四 氯化碳、二氯乙烷等)、低級脂肪酸酯類(醋酸甲酯、醋 酸乙酯、醋酸丁酯、丙酸甲酯等)、腈類(乙腈、丙腈、 丁腈等)。此等之溶媒,可於考量反應之容易產生性等後 適宜地予以選擇,能以單獨1種或混合2種以上使用。又, 視情況’亦可使用脫水劑或乾燥劑來作爲非水溶媒使用。 反應溫度較佳爲-100°c〜所使用溶媒之沸點、更佳爲-5 0〜1 5 0 °C之範圍。 -33- 201219450 反應時間較佳爲o.l〜1,000小時。 如上述般所得到的化合物3,可以再結晶、蒸餾、矽 凝膠管柱層析法等予以純化。 化合物17之取代基U爲-OH、-SH、或-ΝΗ2,化合物1 8 之X5爲單鍵、或[Χ5-5]時,可在適當之鹼存在下,將金屬 錯合物與配位基作爲觸媒,利用偶合反應來合成化合物3 。作爲金屬錯合物,較佳爲使用銅錯合物、鈀錯合物、或 、鎳錯合物。特別又以將三級膦或三級亞磷酸作爲配位基 之零價錯合物之使用爲宜。又,在反應系中,亦可使用能 容易地變換成零價錯合物之適當的前驅物。更,在反應系 中,亦可將作爲配位基爲未含有三級膦或三級亞磷酸之錯 合物,與三級膦或三級亞磷酸混合,並使產生將三級膦或 三級亞磷酸作爲配位基之低原子價錯合物。-32- S 201219450 The substituent U of compound 1 7 is -OH, -SH, or -NH2, and X5 of compound 18 is a single bond or is selected from the group of [X5-l]~[X5-5] In the case of a carbocyclic ring, the compound 2 is obtained by reacting the two compounds in the presence of a base. As the base to be used, for example, a hydroxide or carbonate of an alkali metal such as lithium, sodium, potassium or the like, triethylamine, dicyclobicyclooctane, dinonicycloundecene, pyridine, 4-dimethyl An organic aliphatic, aromatic, or heterocyclic organic base such as a guanylpyridine. Mixtures of such bases can also be used. Particularly preferred is potassium carbonate. The solvent can be appropriately selected as long as it is stable under the reaction conditions and is inert and does not interfere with the reaction. For example, a ketone solvent (acetone, 2-butanone, methyl isobutyl ketone, etc.), an aprotic polar organic solvent (dimethylformamide, dimethyl hydrazine, dimethyl acetamide) can be used. , N-methylpyrrolidone, etc.), ethers (diethyl ether, diisopropyl ether, ter t-butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons Classes (pentane, hexane, heptane, petroleum ether, etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), teeth Prime hydrocarbons (chloroform, methylene chloride, carbon tetrachloride, dichloroethane, etc.), lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles ( Acetonitrile, propionitrile, butyronitrile, etc.). The solvent can be appropriately selected in consideration of the ease of production of the reaction, etc., and can be used alone or in combination of two or more. Further, a dehydrating agent or a desiccant may be used as a non-aqueous solvent, as the case may be. The reaction temperature is preferably -100 ° c to the boiling point of the solvent used, more preferably in the range of -5 0 to 150 ° C. -33- 201219450 The reaction time is preferably from 0.1 to 1,000 hours. The compound 3 obtained as described above can be purified by recrystallization, distillation, hydrazine gel column chromatography or the like. The substituent U of the compound 17 is -OH, -SH, or -ΝΗ2, and when the X5 of the compound 18 is a single bond or [Χ5-5], the metal complex and the coordination can be carried out in the presence of a suitable base. The base is used as a catalyst to synthesize the compound 3 by a coupling reaction. As the metal complex, a copper complex, a palladium complex, or a nickel complex is preferably used. In particular, it is preferred to use a zero-valent complex which uses a tertiary phosphine or a tertiary phosphite as a ligand. Further, in the reaction system, an appropriate precursor which can be easily converted into a zero-valent complex can also be used. Further, in the reaction system, a complex which does not contain a tertiary phosphine or a tertiary phosphite as a ligand may be mixed with a tertiary phosphine or a tertiary phosphite, and a tertiary phosphine or a trisole may be produced. The grade of phosphorous acid acts as a low valence complex of the ligand.
作爲配位基之三級膦或三級亞磷酸,例如,舉例如三 苯基膦、三-〇-甲苯基膦、二苯基甲基膦、苯基二甲基膦、 1,2·雙(二苯基膦基)乙烷、ι,3-雙(二苯基膦基)丙烷 、1,4-雙(二苯基膦基)丁烷、1,1’-雙(二苯基膦基)二 茂鐵、三甲基亞磷酸、三乙基亞磷酸、三苯基亞磷酸等, 亦能適當地使用含有混合此等配位基之2種以上之錯合物 。作爲觸媒’可使用未含有三級膦或三級亞磷酸之銅錯合 物或鈀錯合物。又’亦宜爲將含有三級膦或三級亞磷酸之 錯合物,與前述的配位基予以組合來使用。作爲在與上述 配位基之組合所使用的未含有三級膦或三級亞磷酸之錯合 物,銅觸媒方面爲 CuCl、CuBr、Cul、Cu20、CuCN、CuO -34- s 201219450 等,鈀觸媒方面爲雙(亞苄基丙酮)鈀、參(亞苄基丙酮 )二鈀、雙(乙腈)二氯鈀、雙(苯甲腈)二氯鈀、醋酸 鈀、氯化鈀、氯化鈀-乙腈錯合物、鈀-活性碳等。又,作 爲含有將三級膦或三級亞磷酸作爲配位基之錯合物,舉例 如二甲基雙(三苯基膦)鈀、二甲基雙(二苯基甲基膦) 鈀、(乙烯)雙(三苯基膦)鈀、肆(三苯基膦)鈀、雙 (三苯基膦)二氯鈀等,並不限定於此等。作爲觸媒之銅 錯合物、鈀錯合物、鎳錯合物等之使用量,以所謂的觸媒 量即可,一般以使反應之化合物之20莫耳%以下爲足夠, 通常爲10莫耳%以下。 作爲鹼,除了氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸 氫鈉、碳酸氫鉀、磷酸鉀、碳酸鈉、碳酸鉀、碳酸鋰、碳 酸鉋等之無機鹼、甲基胺、二甲基胺、三甲基胺、乙基胺 、二乙基胺、三乙基胺、丙基胺、二丙基胺、三丙基胺、 異丙基胺、二異丙基胺、三異丙基胺、丁基胺、二丁基胺 、三丁基胺、二異丙基乙基胺、吡啶、咪唑、喹啉、柯林 鹼等之胺類等意外,亦可使用醋酸鈉、醋酸鉀、醋酸鋰等 〇 作爲溶媒,只要是在該當反應條件下爲安定,惰性而 不會妨礙反應者即可,可適宜地予以選擇。例如,舉例如 水、醇類、胺類、非質子性極性有機溶媒(二甲基甲醯胺 、二甲基亞楓、二甲基乙醯胺、N-甲基吡咯啶酮等)、醚 類(二乙基醚、二異丙基醚、tert-丁基甲基醚、環戊基甲 基醚、四氫呋喃、二噁烷等)、脂肪族烴類(戊烷、己烷 -35- 201219450 、庚烷、石油醚等)、芳香族烴類(苯、甲苯、二甲苯、 均三甲苯、氯苯、二氯苯、硝基苯、四氫萘等)、鹵素系 烴類(氯仿、二氯甲烷、四氯化碳、二氯乙烷等)、低級 脂肪酸酯類(醋酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯 等)、腈類(乙腈、丙腈、丁腈等)。此等溶媒,可於考 量反應條件或反應之容易產生性等而予以選擇,能以單獨 1種或混合2種以上使用。又,視情況,亦可使用脫水劑或 乾燥劑來作爲非水溶媒使用。 反應溫度爲-100 °C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 反應時間較佳爲〇. 1〜1,000小時》 如上述般所得到的化合物3,能以再結晶、蒸餾、矽 凝膠管柱層析法、活性碳等予以純化。 < X4爲單鍵時〉 化合物17之取代基U爲F、Cl、Br、或I,化合物3之X4 爲單鍵時,可在適當之鹼存在下,利用將金屬錯合物與配 位基作爲觸媒之偶合反應來合成化合物3。作爲金屬錯合 物,較佳爲鐵錯合物、鈀錯合物、或、鎳錯合物。特別以 將三級膦或三級亞磷酸作爲配位基之零價錯合物爲佳。又 ,在反應系中,亦可使用能容易地變換成零價錯合物之適 當的前驅物。更,在反應系中,亦可將作爲配位基爲未含 有三級膦或三級亞磷酸之錯合物,與三級膦或三級亞磷酸 混合,並使產生將三級膦或三級亞磷酸作爲配位基之低原As the tertiary phosphine or tertiary phosphite of the ligand, for example, triphenylphosphine, tris-fluorenyltolylphosphine, diphenylmethylphosphine, phenyldimethylphosphine, 1,2·double (diphenylphosphino)ethane, iota, bis(diphenylphosphino)propane, 1,4-bis(diphenylphosphino)butane, 1,1'-bis(diphenylphosphine) As the ferrocene, trimethylphosphite, triethylphosphite, triphenylphosphoric acid or the like, two or more kinds of complexes containing such a ligand may be suitably used. As the catalyst, a copper complex or a palladium complex which does not contain a tertiary phosphine or a tertiary phosphite can be used. Further, it is also preferred to use a complex containing a tertiary phosphine or a tertiary phosphite in combination with the above-mentioned ligand. As a complex which does not contain a tertiary phosphine or a tertiary phosphite used in combination with the above ligand, the copper catalyst is CuCl, CuBr, Cul, Cu20, CuCN, CuO-34-s 201219450, etc. Palladium catalysts are bis(benzylideneacetone)palladium, bis(benzylideneacetone)dipalladium, bis(acetonitrile)dichloropalladium, bis(benzonitrile)dichloropalladium, palladium acetate, palladium chloride, chlorine Palladium-acetonitrile complex, palladium-activated carbon, and the like. Further, as a complex containing a tertiary phosphine or a tertiary phosphite as a ligand, for example, dimethylbis(triphenylphosphine)palladium or dimethylbis(diphenylmethylphosphine)palladium, (ethylene) bis(triphenylphosphine)palladium, ruthenium (triphenylphosphine)palladium, bis(triphenylphosphine)dichloropalladium or the like is not limited thereto. The amount of the copper complex, the palladium complex, the nickel complex or the like used as the catalyst may be a so-called amount of the catalyst, and it is usually sufficient to make the reaction compound 20 mol% or less, usually 10 Mole% or less. As the base, in addition to sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium hydrogencarbonate, potassium hydrogencarbonate, potassium phosphate, sodium carbonate, potassium carbonate, lithium carbonate, carbonic acid, etc., inorganic base, methylamine, dimethyl Amine, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, dipropylamine, tripropylamine, isopropylamine, diisopropylamine, triisopropyl An amine, a butylamine, a dibutylamine, a tributylamine, a diisopropylethylamine, a pyridine, an imidazole, a quinoline, a colin base, etc., may also be used, such as sodium acetate or potassium acetate. The hydrazine such as lithium acetate may be appropriately selected as long as it is stable under the reaction conditions and is inert and does not interfere with the reaction. For example, water, alcohols, amines, aprotic polar organic solvents (dimethylformamide, dimethyl sulfoxide, dimethylacetamide, N-methylpyrrolidone, etc.), ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane-35-201219450, heptane , petroleum ether, etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), halogen hydrocarbons (chloroform, dichloromethane, Carbon tetrachloride, dichloroethane, etc.), lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). These solvents can be selected in consideration of the reaction conditions, the ease of production, and the like, and can be used alone or in combination of two or more. Further, as the case may be, a dehydrating agent or a desiccant may be used as the nonaqueous solvent. The reaction temperature is -100 ° C to the boiling point of the solvent to be used, preferably in the range of -50 to 150 ° C. The reaction time is preferably 〇. 1 to 1,000 hours. The compound 3 obtained as described above can be purified by recrystallization, distillation, hydrazine gel column chromatography, activated carbon or the like. < When X4 is a single bond> The substituent U of the compound 17 is F, Cl, Br, or I, and when X4 of the compound 3 is a single bond, the metal complex and the coordination can be utilized in the presence of a suitable base. Compound 3 is synthesized as a coupling reaction of a catalyst. As the metal complex, an iron complex, a palladium complex, or a nickel complex is preferred. It is particularly preferred to use a tertiary phosphine or a tertiary phosphite as a zero-valent complex of a ligand. Further, in the reaction system, an appropriate precursor which can be easily converted into a zero-valent complex can also be used. Further, in the reaction system, a complex which does not contain a tertiary phosphine or a tertiary phosphite as a ligand may be mixed with a tertiary phosphine or a tertiary phosphite, and a tertiary phosphine or a trisole may be produced. Grade of phosphorous acid as a low base of ligand
-36- S 201219450 子價錯合物。 作爲配位基之三級膦或三級亞磷酸,例如,舉例如三 苯基膦、三-0-甲苯基膦、二苯基甲基膦、苯基二甲基膦、 1,2·雙(二苯基膦基)乙烷' ι,3-雙(二苯基膦基)丙烷 、1,4-雙(二苯基膦基)丁烷、ι,ι‘_雙(二苯基膦基)二 茂鐵、三甲基亞磷酸、三乙基亞磷酸、三苯基亞磷酸等, 亦能適當地使用含有混合此等配位基之2種以上之錯合物 。作爲觸媒’可使用未含有三級膦或三級亞磷酸之鐵錯合 物或鈀錯合物。又’亦宜爲將含有三級膦或三級亞磷酸之 錯合物’與前述的配位基予以組合來使用。作爲與上述配 位基組合所使用的未含有三級膦或三級亞磷酸之錯合物, 鐵觸媒方面爲 FeBr3、FeBr2,FeCl3、FeCl2、FeF3、FeF2、-36- S 201219450 Subvalent complex. A tertiary phosphine or a tertiary phosphite as a ligand, for example, triphenylphosphine, trioxo-tolylphosphine, diphenylmethylphosphine, phenyldimethylphosphine, 1,2·double (diphenylphosphino)ethane ' ι,3-bis(diphenylphosphino)propane, 1,4-bis(diphenylphosphino)butane, ι,ι'_bis(diphenylphosphine) As the ferrocene, trimethylphosphite, triethylphosphite, triphenylphosphoric acid or the like, two or more kinds of complexes containing such a ligand may be suitably used. As the catalyst, an iron complex or a palladium complex which does not contain a tertiary phosphine or a tertiary phosphite can be used. Further, it is also preferred to use a complex compound containing a tertiary phosphine or a tertiary phosphite, in combination with the above-mentioned ligand. As a complex which does not contain a tertiary phosphine or a tertiary phosphite used in combination with the above ligand, the iron catalyst is FeBr3, FeBr2, FeCl3, FeCl2, FeF3, FeF2.
Fe ( acetylacetonato ) 3、Fe ( acetylacetonato ) 2等,紀觸 媒方面爲雙(亞苄基丙酮)鈀、參(亞苄基丙酮)二鈀、 雙(乙腈)二氯鈀、雙(苯甲腈)二氯鈀、醋酸鈀、氯化 鈀、氯化鈀-乙腈錯合物、鈀-活性碳等》又,作爲含有將 三級膦或三級亞磷酸作爲配位基之錯合物,舉例如二甲基 雙(三苯基膦)鈀、二甲基雙(二苯基甲基膦)鈀、(乙 烯)雙(三苯基膦)鈀、肆(三苯基膦)鈀、雙(三苯基 膦)二氯鈀等,並不限定於此等。作爲觸媒之鐵錯合物、 鈀錯合物、鎳錯合物等之使用量,以所謂的觸媒量即可, 一般以使反應之化合物之20莫耳%以下爲足夠,通常爲10 莫耳%以下。 作爲鹼,除了氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸 -37- 201219450 氫鈉、碳酸氫鉀、磷酸鉀、碳酸鈉、碳酸鉀、碳酸鋰、碳 酸鉋等之無機鹼或Ν,Ν-二甲基乙烯二胺、甲基胺、二甲基 胺、三甲基胺、乙基胺、二乙基胺、三乙基胺、丙基胺、 二丙基胺、三丙基胺、異丙基胺、二異丙基胺、三異丙基 胺、丁基胺、二丁基胺、三丁基胺、二異丙基乙基胺、吡 啶、咪唑、喹啉、柯林鹼等之胺類以外,亦可使用醋酸鈉 、醋酸鉀、醋酸鋰等。 作爲溶媒,只要是在該當反應條件下爲安定,惰性而 不會妨礙反應者即可,可適宜地予以選擇。例如,可使用 水、醇類、胺類、非質子性極性有機溶媒(二甲基甲醯胺 、二甲基亞颯、二甲基乙醯胺、Ν -甲基吡咯啶酮等)、醚 類(二乙基醚、二異丙基醚、tert-丁基甲基醚、環戊基甲 基醚、四氫呋喃、二噁烷等)、脂肪族烴類(戊烷、己烷 、庚烷、石油醚等)、芳香族烴類(苯、甲苯、二甲苯、 均三甲苯、氯苯、二氯苯、硝基苯、四氫萘等)、鹵素系 烴類(氯仿、二氯甲烷、四氯化碳、二氯乙烷等)、低級 脂肪酸酯類(醋酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯 等)、腈類(乙腈、丙腈、丁腈等)。此等溶媒,可於考 量反應之容易產生性等而予以選擇,能以單獨1種或混合2 種以上使用。又,視情況,亦可使用脫水劑或乾燥劑來作 爲非水溶媒使用。 反應溫度-100 °C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 反應時間較佳爲0.1〜1,〇〇〇小時。 -38-Fe (acetylacetonato) 3, Fe (acetylacetonato) 2, etc., in terms of catalysts are bis(benzylideneacetone)palladium, ginseng (benzylideneacetone)dipalladium, bis(acetonitrile)dichloropalladium, bis(benzonitrile) ) palladium dichloride, palladium acetate, palladium chloride, palladium chloride-acetonitrile complex, palladium-activated carbon, etc. Further, as a complex containing a tertiary phosphine or a tertiary phosphite as a ligand, for example Such as dimethyl bis(triphenylphosphine)palladium, dimethylbis(diphenylmethylphosphine)palladium, (ethylene)bis(triphenylphosphine)palladium, ruthenium (triphenylphosphine)palladium, bis ( Triphenylphosphine, dichloropalladium or the like is not limited thereto. The amount of the iron complex, the palladium complex, the nickel complex or the like used as the catalyst may be a so-called amount of the catalyst, and it is usually sufficient to make the reaction compound 20 mol% or less, usually 10 Mole% or less. As the base, in addition to sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate -37-201219450, sodium hydrogencarbonate, potassium hydrogen phosphate, potassium phosphate, sodium carbonate, potassium carbonate, lithium carbonate, carbonic acid, etc. - dimethylethylene diamine, methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, dipropylamine, tripropylamine, Isopropylamine, diisopropylamine, triisopropylamine, butylamine, dibutylamine, tributylamine, diisopropylethylamine, pyridine, imidazole, quinoline, colin base, etc. In addition to the amines, sodium acetate, potassium acetate, lithium acetate or the like can also be used. The solvent can be appropriately selected as long as it is stable under the reaction conditions and is inert and does not interfere with the reaction. For example, water, alcohols, amines, aprotic polar organic solvents (dimethylformamide, dimethyl hydrazine, dimethylacetamide, hydrazine-methylpyrrolidone, etc.), ethers can be used. Classes (diethyl ether, diisopropyl ether, tert-butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane, heptane, petroleum ether) Etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), halogenated hydrocarbons (chloroform, dichloromethane, tetrachlorinated) Carbon, dichloroethane, etc., lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). These solvents can be selected in consideration of the ease of production and the like, and can be used alone or in combination of two or more. Further, depending on the case, a dehydrating agent or a desiccant may be used as the nonaqueous solvent. The reaction temperature is -100 ° C to the boiling point of the solvent to be used, preferably in the range of -50 to 150 ° C. The reaction time is preferably from 0.1 to 1, hrs. -38-
S 201219450 如上述般所得到的化合物3,亦能以再結晶、蒸餾、 矽凝膠管柱層析法、活性碳等予以純化。 化合物4之製法 化合物4’將化合物2與化合物3在金屬錯合物觸媒、 配位基、及鹼之共存下,可藉由Heck反應等之偶合反應來 予以合成。 作爲化合物3中的Y,只要是具有脫離能力之取代基即 可’例如’可使用F、Cl、Br' I等之鹵素原子、甲烷磺醯 氧基、苯磺醯氧基、甲苯磺醯氧基、三氟甲烷磺醯基等之 烷基磺醯氧基、芳香族磺醯氧基等,若考量反應性時,較 佳爲Br、I、或三氟甲烷磺醯基。 偶合反應’較佳爲將金屬錯合物與配位基作爲觸媒使 用。通常’作爲金屬錯合物,爲使用鈀錯合物、鎳錯合物 等。 作爲觸媒,雖然可使用各種構造者,較佳爲使用所謂 的低原子價之鈀錯合物或鎳錯合物,特別又以將三級膦或 三級亞磷酸作爲配位基之零價錯合物爲佳。又,在反應系 中’亦可使用能容易地變換成零價錯合物之適當的前驅物 。更’在反應系中’亦可將作爲配位基爲未含有三級膦或 三級亞磷酸之錯合物’與三級膦或三級亞磷酸混合,並使 產生將三級膦或三級亞磷酸作爲配位基之低原子價錯合物 〇 作爲配位基之三級膦或三級亞磷酸,例如,舉例如三 -39- 201219450 苯基膦、三甲苯棊膦、二苯基甲基膦、苯基二甲基膦、 I,2-雙(二苯基膦基)乙烷、1,3-雙(二苯基膦基)丙烷 、1,4-雙(二苯基•勝基)丁烷、1,1‘-雙(二苯基膦基)二 茂鐵、三甲基亞磷酸、三乙基亞磷酸、三苯基亞磷酸等, 亦能適當地使用含有混合此等配位基之2種以上之錯合物 。作爲觸媒,較佳之樣態亦爲將未含有三級膦或三級亞磷 酸之鈀錯合物及/或含有三級膦或三級亞磷酸之錯合物, 與前述配位基予以組合來使用。作爲組合於上述配位基所 使用的未含有三級膦或三級亞磷酸之錯合物,舉例如雙( 亞苄基丙酮)鈀、參(亞苄基丙酮)二鈀、雙(乙腈)二 氯鈀、雙(苯甲腈)二氯鈀、醋酸鈀、氯化鈀、鈀-活性 碳等。又,作爲含有將三級膦或三級亞磷酸作爲配位基之 錯合物,舉例如二甲基雙(三苯基膦)鈀、二甲基雙(二 苯基甲基膦)鈀、(乙烯)雙(三苯基膦)鈀、肆(三苯 基膦)鈀、雙(三苯基膦)二氯鈀等,但不限定於此等。 此等鈀錯合物之使用量,以所謂的觸媒量即可,一般以使 反應之化合物之20莫耳%以下爲足夠,通常爲10莫耳%以 下。 作爲驗’除了無機驗或甲基胺、二甲基胺、三甲基胺 、乙基胺、二乙基胺、三乙基胺、丙基胺、二丙基胺、三 丙基胺、異丙基胺、二異丙基胺、三異丙基胺、丁基胺、 二丁基胺、三丁基胺、二異丙基乙基胺、吡啶、咪唑、喹 啉、柯林鹼等之胺類以外,亦可使用醋酸鈉、醋酸鉀、醋 酸鋰等。 -40-S 201219450 The compound 3 obtained as described above can also be purified by recrystallization, distillation, hydrazine gel column chromatography, activated carbon or the like. Process for Producing Compound 4 Compound 4' can be synthesized by a coupling reaction of a Heck reaction or the like in the presence of a compound of a metal complex, a ligand, and a base. As Y in the compound 3, a substituent having a dissociable ability can be used, for example, a halogen atom such as F, Cl or Br' I, a methanesulfonyloxy group, a benzenesulfonyloxy group or a toluenesulfonyloxy group can be used. The alkylsulfonyloxy group, the aromatic sulfonyloxy group or the like of a group such as a trifluoromethanesulfonyl group or the like is preferably Br, I or a trifluoromethanesulfonyl group when the reactivity is considered. The coupling reaction is preferably carried out by using a metal complex and a ligand as a catalyst. Usually, as the metal complex, a palladium complex, a nickel complex or the like is used. As the catalyst, although various builders can be used, it is preferred to use a so-called low valence palladium complex or a nickel complex, in particular, a zero valence using a tertiary phosphine or a tertiary phosphite as a ligand. The complex is better. Further, an appropriate precursor which can be easily converted into a zero-valent complex can be used in the reaction system. More 'in the reaction system' can also be mixed as a ligand which does not contain a tertiary phosphine or tertiary phosphorous acid' with a tertiary phosphine or tertiary phosphite, and will produce a tertiary phosphine or three a phosphinic acid as a ligand of a lower valence complex 〇 as a ligand for a tertiary phosphine or a tertiary phosphite, for example, for example, tri-39-201219450 phenylphosphine, tolylphosphonium phosphine, diphenyl Methyl phosphine, phenyl dimethyl phosphine, I, 2-bis(diphenylphosphino)ethane, 1,3-bis(diphenylphosphino)propane, 1,4-bis(diphenyl) Styrene), butane, 1,1'-bis(diphenylphosphino)ferrocene, trimethylphosphite, triethylphosphite, triphenylphosphoric acid, etc., can also be suitably used to contain such a mixture Two or more complexes of a ligand. As a catalyst, it is preferable to combine a palladium complex which does not contain a tertiary phosphine or a tertiary phosphite and/or a complex containing a tertiary phosphine or a tertiary phosphite with the above ligand. To use. As a complex which does not contain a tertiary phosphine or a tertiary phosphite used in combination with the above ligand, for example, bis(benzylideneacetone)palladium, ginseng (benzylideneacetone)dipalladium, bis(acetonitrile) Dichloropalladium, bis(benzonitrile)dichloropalladium, palladium acetate, palladium chloride, palladium-activated carbon, and the like. Further, as a complex containing a tertiary phosphine or a tertiary phosphite as a ligand, for example, dimethylbis(triphenylphosphine)palladium or dimethylbis(diphenylmethylphosphine)palladium, (ethylene) bis(triphenylphosphine)palladium, iridium (triphenylphosphine)palladium, bis(triphenylphosphine)dichloropalladium or the like, but is not limited thereto. The amount of the palladium complex to be used may be a so-called amount of the catalyst, and is usually sufficient to make the reaction compound 20 mol% or less, usually 10 mol% or less. As a test 'except inorganic test or methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, dipropylamine, tripropylamine, different Propylamine, diisopropylamine, triisopropylamine, butylamine, dibutylamine, tributylamine, diisopropylethylamine, pyridine, imidazole, quinoline, colin base, etc. Other than the amine, sodium acetate, potassium acetate, lithium acetate or the like can also be used. -40-
S 201219450 作爲溶媒,只要是在該當反應條件下爲 不會妨礙反應者即可,可適宜地予以選擇。 水、醇類、胺類、非質子性極性有機溶媒( 、二甲基亞碾、二甲基乙醯胺、N-甲基吡略 類(二乙基醚、二異丙基醚、tert-丁基甲基 基醚、四氫呋喃、二噁烷等)、脂肪族烴類 、庚烷、石油醚等)、芳香族烴類(苯、甲 均三甲苯、氯苯、二氯苯、硝基苯、四氫萘 烴類(氯仿、二氯甲烷、四氯化碳、二氯乙 脂肪酸酯類(醋酸甲酯、醋酸乙酯、醋酸丁 等)、腈類(乙腈、丙腈、丁腈等)。此等 量反應條件或反應之容易產生性等而予以選 ,能以單獨1種或混合2種以上使用。又,視 用脫水劑或乾燥劑來作爲非水溶媒使用。 反應溫度爲- l〇〇°C〜所使用溶媒之沸點 1 5 (TC之範圍。 反應時間較佳爲0.1〜1,〇〇〇小時。 如上述般所得到的化合物4,亦能以再 矽凝膠管柱層析法、活性碳等予以純化。 化合物5之製法 以上述所得到的二硝基體4,予以選擇 雙鍵般之還原反應條件,來進行硝基之還原 目的物之二胺化合物5。 安定,惰性而 例如,可使用 二甲基甲醯胺 啶酮等)、醚 醚、環戊基甲 (戊烷、己烷 苯、二甲苯、 等)、鹵素系 院等)、低級 酯、丙酸甲酯 溶媒,可於考 擇,此情形時 情況,亦可使 ,較佳爲-5 0〜 結晶、蒸餾、 不損及側鏈之 ’可變換成爲 -41 - 201219450 對於使側鏈之雙鍵以原樣之硝基之還原,較佳爲將Fe 、Sn、Zn等之金屬、或此等之金屬鹽與質子源一起使用。 金屬與金屬鹽亦能以單體或共同來予以使用。 作爲質子源,可使用鹽酸等之酸、氯化銨等之銨鹽、 甲醇、乙醇等之質子性溶媒。 溶媒,只要是能承受還原性氣氛下之環境者即可,可 使用非質子性極性有機溶媒(二甲基甲醯胺、二甲基亞碾 、二甲基乙醯胺、N-甲基吡咯啶酮等)、醚類.(二乙基醚 、二異丙基醚、tert-丁基甲基醚、環戊基甲基醚、四氫呋 喃、二噁烷等)、脂肪族烴類(戊烷、己烷、庚烷、石油 醚等)、芳香族烴類(苯、甲苯、二甲苯、均三甲苯、氯 苯、二氯苯、硝基苯、四氫萘等)、低級脂肪酸酯類(醋 酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯等)、腈類(乙 腈、丙腈、丁腈等)。此等溶媒,可於考量反應條件或反 應之容易產生性等而予以選擇,能以單獨1種或混合2種以 上使用。又,視情況,亦可使用適當的脫水劑或乾燥劑來 作爲非水溶媒使用。 反應溫度爲-100°C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 反應時間較佳爲0.1〜1,000小時。 如上述般所得到的化合物5,亦能以再結晶、蒸餾、 矽凝膠管柱層析法、活性碳等予以純化。 製法2 -42-S 201219450 is a solvent, and may be appropriately selected as long as it does not interfere with the reaction under the reaction conditions. Water, alcohols, amines, aprotic polar organic solvents ( dimethyl azorun, dimethyl acetamide, N-methylpyrrol (diethyl ether, diisopropyl ether, tert-) Butylmethyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons, heptane, petroleum ether, etc., aromatic hydrocarbons (benzene, methylated xylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetra Hydronaphthalenes (chloroform, dichloromethane, carbon tetrachloride, dichloroethylene fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). The reaction conditions may be selected as the same, or may be used alone or in combination of two or more. The dehydrating agent or the desiccant may be used as the non-aqueous solvent. The reaction temperature is - l〇〇. °C~ the boiling point of the solvent used is 1 5 (the range of TC. The reaction time is preferably 0.1 to 1, 〇〇〇 hours. The compound 4 obtained as described above can also be re-ruthenium gel column chromatography. Purification of activated carbon, etc. The preparation method of the compound 5 is carried out by selecting the double bond as the dinitrogen 4 obtained above. The reaction conditions are reduced to carry out the reduction of the nitro group to the desired diamine compound 5. Stable, inert, for example, dimethylformamide or the like can be used, ether ether, cyclopentylmethyl (pentane, hexane) Benzene, xylene, etc., halogen system, etc., lower ester, methyl propionate solvent, can be selected, in this case, it can also be, preferably -5 0~ crystal, distillation, no damage And the side chain 'can be converted to -41 - 201219450 For the reduction of the double bond of the side chain as the original nitro group, it is preferred to use a metal such as Fe, Sn, Zn or the like, together with the proton source The metal and the metal salt can also be used as a monomer or a combination. As the proton source, an acid such as hydrochloric acid, an ammonium salt such as ammonium chloride, or a protic solvent such as methanol or ethanol can be used. It can be used in an environment under a reducing atmosphere, and an aprotic polar organic solvent (dimethylformamide, dimethyl amide, dimethylacetamide, N-methylpyrrolidone, etc.) can be used. Ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, Amyl hydrocarbons (tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane, heptane, petroleum ether, etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorine) Benzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile) The solvent may be selected in consideration of the reaction conditions, the ease of production, and the like, and may be used alone or in combination of two or more. Further, an appropriate dehydrating agent or desiccant may be used as the case may be. The reaction temperature is -100 ° C to the boiling point of the solvent to be used, preferably in the range of -50 to 150 ° C. The reaction time is preferably from 0.1 to 1,000 hours. The compound 5 obtained as described above can also be purified by recrystallization, distillation, hydrazine gel column chromatography, activated carbon or the like. Method 2 - 42-
S 201219450 藉由二硝基體1,與丙嫌酸衍生物19、或酸性鹵化物 之化合物20之反應,可製造側鏈爲具有桂皮酸部位之二硝 基體4。所得到的二硝基體4’藉由選擇對於側鏈之雙鍵部 分不會有影響之還原方法’並予以實施’可變換成爲目的 物之二胺化合物5。 【化33】S 201219450 By reacting the dinitrogen 1, with the acrylic acid derivative 19 or the acid halide compound 20, a dinitrogen matrix 4 having a side chain having a cinnamic acid moiety can be produced. The dinitrogen compound 4' thus obtained can be converted into the target diamine compound 5 by selecting a reduction method which does not affect the double bond portion of the side chain and is carried out. 【化33】
化合物20之製法 【化34】Method for preparing compound 20
在化合物1 9與化合物20中,X示爲鹵素的F、Cl、Br、 或I,X4示爲單鍵、-0-、-S-、或-NH-。 X5、X6、X7、及η爲與前述爲同義。 化合物20之製法,爲將化合物19與酸鹵素化劑反應之 -43- 201219450 方法。χ ’就試劑之取得性、反應性之觀點而言,較佳爲 C1、或Β Γ。作爲所使用的酸鹵素化劑,例如,舉例如亞硫 醯氯、草醯氯、光氣、氯、氧氯化磷、三氯化磷、五氯化 磷、N-氯琥珀酸醯亞胺、三氯化硼、亞硫醯溴、草醯溴、 溴、氧溴化磷、三溴化磷、·五溴化磷、N-溴基琥珀酸醯亞 胺等。較佳爲使用亞硫醯氯、或亞硫醯溴。作爲酸鹵素化 劑’相對於化合物1 9,通常以2〜1 0 0倍莫耳、較佳以2〜 3 0倍莫耳、更佳以2〜3倍莫耳予以使用。 上述反應,在亞硫醯氯等之酸齒素化劑中亦可進行, 視所需要可使用溶媒。 溶媒,只要是對於反應爲惰性者即可,無特別限定, 例如’可使用非質子性極性有機溶媒(二甲基甲醯胺、二 甲基亞颯、二甲基乙醢胺、N-甲基吡咯啶酮等)、醚類( 二乙基醚、二異丙基醚、四丁基甲基醚、環戊基甲基醚、 四氫呋喃、二噁烷等)、脂肪族烴類(戊烷、己烷、庚烷 、石油醚等)、芳香族烴類(苯、甲苯、二甲苯、均三甲 苯、氯苯 '二氯苯、硝基苯、四氫萘等)、鹵素系烴類( 氯仿、二氯甲烷、四氯化碳、二氯乙烷等)、低級脂肪酸 酯類(醋酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯等)、 腈類(乙腈、丙腈、丁腈等)。此等溶媒,可於考量反應 之容易產生性等而予以選擇,能以單獨1種或混合2種以上 使用。又,視情況,亦可使用適當的脫水劑或乾燥劑來作 爲非水溶媒使用。 又,上述之反應,無觸媒下亦可進行,但藉由添加觸 -44-In the compound 19 and the compound 20, X is represented by halogen, F, Cl, Br, or I, and X4 is shown as a single bond, -0-, -S-, or -NH-. X5, X6, X7, and η are synonymous with the foregoing. The compound 20 is prepared by reacting the compound 19 with an acid halogenating agent - 43 - 201219450. χ ′ is preferably C1 or Β 观点 from the viewpoint of availability of the reagent and reactivity. As the acid halogenating agent to be used, for example, sulfoxide, chloroform, phosgene, chlorine, phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride, bismuth imidate , boron trichloride, sulfinium bromide, oxalic acid bromine, bromine, phosphorus oxybromide, phosphorus tribromide, phosphorus pentabromide, bismuth imidate and N-bromosuccinate. Preferably, sulfinium chloride or sulfoxide is used. The acid halogenating agent is usually used in an amount of 2 to 1,000 moles, preferably 2 to 30 moles, more preferably 2 to 3 moles per mole of the compound 19. The above reaction can be carried out in an acid dentate agent such as sulfinium chloride, and a solvent can be used as needed. The solvent is not particularly limited as long as it is inert to the reaction, and for example, an aprotic polar organic solvent (dimethylformamide, dimethylammonium, dimethylacetamide, N-methyl) can be used. Alkyl pyrrolidone, etc., ethers (diethyl ether, diisopropyl ether, tetrabutyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane Alkane, heptane, petroleum ether, etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene 'dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), halogenated hydrocarbons (chloroform, Dichloromethane, carbon tetrachloride, dichloroethane, etc.), lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile) Wait). These solvents can be selected in consideration of the ease of production of the reaction, etc., and can be used alone or in combination of two or more. Further, an appropriate dehydrating agent or desiccant may be used as the non-aqueous solvent, as the case may be. Moreover, the above reaction can be carried out without a catalyst, but by adding a touch-44-
S 201219450 媒可減少氯化劑之使用量,且可加快反應之進行。作爲觸 媒,無特別限定者’例如,舉例如三乙基胺、吡啶、嗤啉 、N、N-二甲基苯胺、二甲基甲醯胺等之有機鹼類、甲氧 基鈉、甲氧基鉀或t-丁氧基鉀等之金屬烷氧化物類。較佳 舉例如三乙基胺吡啶、二甲基甲醯胺。又,更佳舉例如吡 啶。此等觸媒,相對於酸性鹵化物,通常以0〜1 00倍莫耳 、較佳爲以〇.〇1〜10倍莫耳予以使用。 反應溫度爲-100°C〜所使用溶媒之沸點,較佳爲-5 0〜 1 5 0 °c之範圍。 反應時間通常爲〇 . 1〜1,0 0 0小時。 又’如上述般所得到的化合物20,亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。 化合物1 9之製法-1 【化35】S 201219450 The medium can reduce the amount of chlorinating agent used and accelerate the reaction. The catalyst is not particularly limited. For example, an organic base such as triethylamine, pyridine, porphyrin, N, N-dimethylaniline or dimethylformamide, sodium methoxide or the like is used. a metal alkoxide such as potassium oxy or potassium t-butoxide. Preferred examples are triethylamine pyridine and dimethylformamide. Further, more preferably, for example, pyridine. These catalysts are usually used in an amount of from 0 to 100 moles, preferably from 1 to 10 moles, per mole of the acid halide. The reaction temperature is -100 ° C to the boiling point of the solvent to be used, preferably in the range of -5 0 to 150 ° C. The reaction time is usually 〇. 1~1,0 0 0 hours. Further, the compound 20 obtained as described above can also be purified by an operation such as recrystallization, distillation, hydrazine gel column chromatography or the like. Method 1 of Compound 1 9 [Chem. 35]
3 213 21
在化合物21中’ A示爲烷基、矽基或氫,例如甲基、 乙基、丙基、η-丁基、異丙基、Urt-丁基、sec-丁基、苯 基、苄基、矽基、四氫哌喃基、四氫呋喃基、甲氧基甲基 、甲氧基乙氧基、乙烯基等。 上述反應’爲將化合物3與21在金屬錯合物觸媒、配 -45- 201219450 位基及鹼之共存下,藉由Heck反應等之偶合反應,而可合 成化合物19。反應條件,與在製法1之化合物4之合成法中 所示方法爲相同。 A爲烷基、或矽基時,反應後,在酸、或鹼存在下, 藉由將酯基-COOA以水進行水解,可衍生成爲對應的化合 物19。作爲所使用的酸,舉例如稀硫酸等之礦酸、或p-甲 苯磺酸、蟻酸、醋酸等之有機酸。又,作爲鹼,舉例如碳 酸氫鉀、碳酸氫鈉、碳酸鉀、碳酸鈉等之碳酸鹽類、氫氧 化鈉、氫氧化鉀等之鹼金屬之氫氧化物、氫氧化鈣、氫氧 化鎂等之鹼土類金屬之氫氧化物、磷酸二氫鈉或磷酸二氫 鉀等之磷酸鹽類、醋酸鈉或醋酸鉀等之羧酸鹽類、三乙基 胺、吡啶等之有機鹼類、甲氧基鈉、乙氧基鈉等之金屬烷 氧化物類、氫化鈉等之金屬氫化物類等。 水解係爲了使反應圓滑地進行,亦可在與水混合之溶 媒中進行,作爲所使用的溶媒,舉例如二甲基甲醯胺、二 甲基亞颯、二甲基乙醯胺等之非質子性極性有機溶媒、乙 腈、丙腈、丁.腈等之腈類、吡啶等之有機弱鹼性溶媒、甲 醇、乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁醇、tert-丁醇 等之醇類。又,藉由進行加熱,可使反應更迅速地進行。 反應溫度爲- l〇〇°C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 反應時間通常爲0.1〜1,000小時。 又,如上述般所得到的化合物1 9,亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。In compound 21 'A is shown as alkyl, mercapto or hydrogen, such as methyl, ethyl, propyl, η-butyl, isopropyl, Urt-butyl, sec-butyl, phenyl, benzyl , mercapto, tetrahydropyranyl, tetrahydrofuranyl, methoxymethyl, methoxyethoxy, vinyl, and the like. The above reaction ' is a compound 19 obtained by coupling a compound 3 and 21 in the presence of a metal complex catalyst, a -45-201219450 group and a base, by a Heck reaction or the like. The reaction conditions are the same as those shown in the synthesis method of the compound 4 of Process 1. When A is an alkyl group or a mercapto group, after the reaction, the ester group -COOA can be derivatized into the corresponding compound 19 by hydrolysis of water in the presence of an acid or a base. The acid to be used may, for example, be a mineral acid such as dilute sulfuric acid or an organic acid such as p-toluenesulfonic acid, formic acid or acetic acid. Further, examples of the base include carbonates such as potassium hydrogencarbonate, sodium hydrogencarbonate, potassium carbonate, and sodium carbonate; hydroxides of alkali metals such as sodium hydroxide and potassium hydroxide; calcium hydroxide and magnesium hydroxide; a hydroxide of an alkaline earth metal, a phosphate such as sodium dihydrogen phosphate or potassium dihydrogen phosphate, a carboxylate such as sodium acetate or potassium acetate, an organic base such as triethylamine or pyridine, or a methoxy group. Metal alkoxides such as sodium hydride and sodium ethoxide, metal hydrides such as sodium hydride, and the like. The hydrolysis may be carried out in a solvent mixed with water in order to smoothly carry out the reaction, and as the solvent to be used, for example, dimethylformamide, dimethylhydrazine or dimethylacetamide may be used. A protic polar organic solvent, a nitrile such as acetonitrile, propionitrile or butyl nitrile, an organic weakly alkaline solvent such as pyridine, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butyl An alcohol such as an alcohol or tert-butanol. Further, by heating, the reaction can be carried out more rapidly. The reaction temperature is -1 ° ° C to the boiling point of the solvent used, preferably in the range of -50 to 150 ° C. The reaction time is usually from 0.1 to 1,000 hours. Further, the compound 1.9 obtained as described above can also be purified by an operation such as recrystallization, distillation, hydrazine gel column chromatography or the like.
S 201219450 化合物19之製法-2S 201219450 Formulation of Compound 19-2
【化36】 OHC【化36】 OHC
X4-Xs-X6 22 +X4-Xs-X6 22 +
在化合物22與化合物23中,X4、X5、X6、Χ7、η、及 Α與前述同義。又,有關Α所示例之基,亦與前述相同。 化合物19之製法,例如,A爲烷基、或矽基時,有將 化合物22與化合物23在鹼之存在下,使脫水縮合後,將二 酯部分予以水解,使脫碳酸之方法。又,A爲氫時,有將 化合物22與化合物23在鹼之存在下,使脫水縮合後,使脫 碳酸之方法。 A爲氫時,雖無特別限定,但例如在吡u定溶媒中、哌 啶存在下,藉由以60〜100 °C使產生反應,使醛基與丙二 酸脫水縮合,之後,藉由加熱至100〜150 °C,使脫碳酸反 應進行,可得到化合物1 9。 使用於脫水縮合反應的鹼,只要是使用具有使反應圓 滑進行之鹼之強度(鹼度)之鹼即可,無特別限定。例如 ,鋰、鈉、鉀般之鹼金屬之氫氧化物或碳酸鹽、鋰醯胺、 胺化鈉、胺化鉀般之鹼金屬醯胺、氫化鋰、氫化鈉、氫化 鉀般之鹼金屬氫化物、鹼土類金屬、鈉或鉀之甲醇化物、 乙醇化物、η-丙醇化物、異丙醇化物、η-丁醇化物、sec- -47- 201219450 丁醇化物、tert-丁醇化物、2-甲基-2-丁醇化物、2-甲基-2-戊醇化物、3-甲基-3-戊醇化物、3-乙基-3-戊醇化物般由 —級、二級或三級之碳數1〜10之脂肪族醇所衍生的鹼金 屬醇化物、二吖雙環辛烷、二吖雙環十一烯、4-二甲基胺 基吡啶、吡咯啶、哌啶等之有機脂肪族、芳香族、雜環之 氮鹼。此等之鹼,亦可作爲混合物予以使用。作爲鹼,較 佳爲乙氧基鈉、氫化鈉。鹼之使用量,通常相對於化合物 22爲0.1〜10倍莫耳、較佳爲〇.1〜5倍莫耳。 溶媒,只要是不會與化合物22及化合物23反應之溶媒 即可予以使用。例如,可使用二甲基甲醯胺、二甲基亞楓 、二甲基乙醯胺、N-甲基吡咯啶酮等之非質子性極性有機 溶媒、二乙基醚、二異丙基醚、四丁基甲基醚、環戊基甲 基醚、四氫呋.喃、二噁烷等之醚類、戊烷、己烷、庚烷、 石油醚等之脂肪族烴類、苯、甲苯、二甲苯、均三甲苯、 氯苯、二氯苯、硝基苯、四氫萘等之芳香族烴類、乙腈、 丙腈、丁腈等之腈類、吡啶、喹啉等之有機弱鹼性溶媒等 。又,亦可使用甲醇、乙醇、1-丙醇、2 -丙醇、1-丁醇、 2-丁醇、tert-丁醇等之醇類。此等溶媒,可於考量反應之 容易產生性等而予以選擇,能以單獨1種或混合2種以上使 用。又,視情況,亦可使用適當的脫水劑或乾燥劑來作爲 非水溶媒使用。 以水之水解條件,與在化合物1 9之製法-1所示方法爲 相同。 反應溫度爲-100°C〜所使用溶媒之沸點,較佳爲-50〜 -48-In the compound 22 and the compound 23, X4, X5, X6, Χ7, η, and Α are synonymous with the above. Moreover, the basis of the example shown in Α is also the same as described above. The method for producing the compound 19, for example, when A is an alkyl group or a fluorenyl group, a method in which the compound 22 and the compound 23 are dehydrated and condensed in the presence of a base, and the diester portion is hydrolyzed to decarbonate. Further, when A is hydrogen, there is a method in which the compound 22 and the compound 23 are dehydrated and condensed in the presence of a base to decarbonate. When A is hydrogen, it is not particularly limited. For example, in the presence of piperidine in a pyridinated solvent, the reaction is carried out at 60 to 100 ° C to dehydrate and condense the aldehyde group and malonic acid, and then, by using The reaction is carried out by heating to 100 to 150 ° C to carry out the decarbonation reaction to obtain a compound 19. The base to be used in the dehydration condensation reaction is not particularly limited as long as it is a base having a strength (basicity) of a base which allows the reaction to proceed smoothly. For example, lithium, sodium, potassium base metal hydroxide or carbonate, lithium decylamine, sodium amination, potassium alkoxide alkali metal amide, lithium hydride, sodium hydride, potassium hydride alkali metal hydrogenation , alkaline earth metal, sodium or potassium methanolate, ethanolate, η-propanolate, isopropanolate, η-butanolate, sec- -47- 201219450 butanolate, tert-butanolate, 2 -methyl-2-butanolate, 2-methyl-2-pentanolate, 3-methyl-3-pentanolate, 3-ethyl-3-pentanolate, by-grade, secondary or Organics of alkali metal alkoxides derived from aliphatic alcohols having a carbon number of 1 to 10, dicyclobicyclooctane, dioxodicycloundecene, 4-dimethylaminopyridine, pyrrolidine, piperidine, etc. Aliphatic, aromatic, heterocyclic nitrogen base. These bases can also be used as a mixture. As the base, sodium ethoxide or sodium hydride is preferred. The amount of the base to be used is usually 0.1 to 10 moles, preferably 1 to 5 moles per mole of the compound 22. The solvent can be used as long as it does not react with the compound 22 and the compound 23. For example, an aprotic polar organic solvent such as dimethylformamide, dimethyl sulfoxide, dimethylacetamide or N-methylpyrrolidone, diethyl ether or diisopropyl ether can be used. , ethers such as tetrabutyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc., aliphatic hydrocarbons such as pentane, hexane, heptane, petroleum ether, benzene, toluene, and An aromatic hydrocarbon such as toluene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene or tetrahydronaphthalene; a nitrile such as acetonitrile, propionitrile or butyronitrile; or an organic weakly alkaline solvent such as pyridine or quinoline. Wait. Further, an alcohol such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol or tert-butanol can also be used. These solvents can be selected in consideration of the ease of production of the reaction, etc., and can be used alone or in combination of two or more. Further, as the case may be, a suitable dehydrating agent or drying agent may be used as the nonaqueous solvent. The hydrolysis conditions of water are the same as those shown in Process 1 of Compound 19. The reaction temperature is -100 ° C ~ the boiling point of the solvent used, preferably -50 to -48-
S 201219450 1 5 0 °C之範圍。 反應時間通常爲0.1〜1,〇〇〇小時。 又’如上述般所得到的化合物丨9,亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。 化合物22之製法 【化37】 L-Xs-X6S 201219450 1 5 0 °C range. The reaction time is usually 0.1 to 1, 〇〇〇 hours. Further, the compound 丨9 obtained as described above can also be purified by an operation such as recrystallization, distillation, hydrazine gel column chromatography or the like. Method for preparing compound 22 [Chem. 37] L-Xs-X6
在化合物24中,U、及η爲與前述同義。 化合物22之製法,例如,將化合物24與化合物18進行 反應之方法。又,幾個化合物24與化合物18,可作爲市售 品容易地予以取得。 化合物24之取代基U爲-OH、-SH、或-ΝΗ2,化合物18 之X5爲單鍵、或由前述[Χ5-1]〜[X5-4]之群所選出之碳環 時,在鹼之存在下’藉由使化合物24與化合物18反應’可 得到化合物22。反應條件,可將在製法1之化合物3之合成 法中,X5爲由前述[X5-l]〜[Χ5-4]之群所選出之構造時之 方法予以適用。 化合物24之取代基ϋ爲-OH、-SH、或-ΝΗ2,化合物18 之X5爲單鍵、或前述[χ5_5]之碳環時’在鹼之存在下’可 藉由將金屬錯合物與配位基作爲觸媒之偶合反應而予以合 -49- 201219450 成。反應條件,可將製法1之化合物3之合成法中’ X5爲前 述[Χ5-5]時之方法予以適用。 化合物24之取代基U爲鹵素F、Cl、Br、或I,化合物 22之X4爲單鍵時,在鹼之存在下,可藉由將金屬錯合物與 配位基作爲觸媒之偶合反應而予以合成。反應條件’可將 製法1之化合物3之合成法中,X4爲單鍵時之方法予以適用 化合物19之製法-3In the compound 24, U and η are synonymous with the above. The method of producing the compound 22 is, for example, a method of reacting the compound 24 with the compound 18. Further, several of the compound 24 and the compound 18 can be easily obtained as a commercial product. The substituent U of the compound 24 is -OH, -SH, or -ΝΗ2, and the X5 of the compound 18 is a single bond or a carbocyclic ring selected from the group of the above [Χ5-1] to [X5-4], in the base In the presence of 'reaction of compound 24 with compound 18', compound 22 can be obtained. The reaction conditions can be applied to the method of the synthesis of the compound 3 of Process 1, wherein X5 is a structure selected from the group of the above [X5-1] to [Χ5-4]. The substituent ϋ of the compound 24 is -OH, -SH, or -ΝΗ2, and the X5 of the compound 18 is a single bond, or the carbon ring of the above [χ5_5] 'in the presence of a base' can be obtained by The ligand is combined as a coupling reaction of the catalyst -49-201219450. The reaction conditions can be applied to the method in the synthesis of the compound 3 of the process 1 in which the 'X5 is the above-mentioned [Χ5-5]. The substituent U of the compound 24 is halogen F, Cl, Br, or I. When X4 of the compound 22 is a single bond, in the presence of a base, a coupling reaction of the metal complex with a ligand as a catalyst can be carried out. And to synthesize. The reaction condition ' can be applied to the method for synthesizing the compound 3 of the method 1, and the method for the case where X4 is a single bond.
在化合物25中,A與前述爲同義,關於示例之基,亦 與前述相同。 化合物19之製法,例如,將化合物22與化合物25在鹼 之存在下,使脫水縮合反應後,將酯基-COO A以水進行水 解之方法。 使用於上述反應的鹼,只要是使用具有使反應圓滑進 行之鹼之強度(鹼度)之鹼即可,無特別限定。例如,鋰 、鈉、鉀般之鹼金屬之氫氧化物、鋰醯胺、胺化鈉、胺化 鉀般之鹼金屬醯胺、氫化鋰、氫化鈉、氫化鉀般之鹼金屬 氫化物、鹼土類金屬、鈉或鉀之甲醇化物、乙醇化物、n-In the compound 25, A is synonymous with the above, and the examples are also the same as described above. The method for producing the compound 19 is, for example, a method in which the ester group -COO A is hydrolyzed with water after the dehydration condensation reaction of the compound 22 and the compound 25 in the presence of a base. The base to be used in the above reaction is not particularly limited as long as it is a base having a strength (basicity) of a base which makes the reaction smooth. For example, lithium, sodium, potassium alkali metal hydroxide, lithium decylamine, sodium amination, potassium alkoxide alkali metal amide, lithium hydride, sodium hydride, potassium hydride alkali metal hydride, alkaline earth a metalloid, sodium or potassium methoxide, ethanolate, n-
-50- S 201219450 丙醇化物、異丙醇化物、n-丁醇化物、sec-丁醇化物、 tert-丁醇化物、2-甲基-2-丁醇化物、2-甲基-2-戊醇化物、 3-甲基-3-戊醇化物、3-乙基-3-戊醇化物般之由一級、二 級或三級之碳數1〜10之脂肪族醇所衍生之鹼金屬醇化物 等。此等之鹼,亦可使用作爲混合物》作爲鹼,較佳爲乙 氧基鈉、氫化鈉。此等之鹼,通常相對於化合物22以0.1 〜10倍莫耳、較佳爲以0.1〜5倍莫耳而予以使用。 溶媒,只要是不會與化合物22及化合物25反應之溶媒 即可使用。例如,可使用二甲基甲醯胺、二甲基亞楓、二 甲基乙醯胺、N-甲基吡咯啶酮等之非質子性極性有機溶媒 、二乙基醚 '二異丙基醚、四丁基甲基醚、環戊基甲基醚 、四氫呋喃、二噁烷等之醚類、戊烷、己烷、庚烷、石油 醚等之脂肪族烴類、苯、甲苯、二甲苯、均三甲苯、氯苯 、二氯苯、硝基苯、四氫萘等之芳香族烴類、乙腈、丙腈 、丁腈等之腈類、吡啶、喹啉等之有機弱鹼性溶媒等。又 ,亦可使用甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁 醇、tert-丁醇等之醇類。此等溶媒,可於考量反應之容易 產生性等而予以選擇,能以單獨1種或混合2種以上使用。 又,視情形,亦可使用適當的脫水劑或乾燥劑來作爲非水 溶媒使用》 以水之水解條件,與在化合物1 9之製法-1所示方法相 同》 反應溫度爲-l〇〇°C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 -51 - 201219450 反應時間通常爲0.1〜1,000小時® 又,如上述般所得到的化合物1 9,亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。 化合物19之製法-4 【化39】-50- S 201219450 propanolate, isopropoxide, n-butanolate, sec-butanolate, tert-butanolate, 2-methyl-2-butanolate, 2-methyl-2- Alkali metal derived from a primary alcohol of a primary, secondary or tertiary carbon number of 1 to 10, such as a pentoxide, a 3-methyl-3-pentanolate or a 3-ethyl-3-pentanolate Alcohol compounds and the like. These bases may also be used as a mixture as a base, preferably sodium ethoxide or sodium hydride. These bases are usually used in an amount of 0.1 to 10 moles, preferably 0.1 to 5 moles, per mole of the compound 22. The solvent can be used as long as it does not react with the compound 22 and the compound 25. For example, an aprotic polar organic solvent such as dimethylformamide, dimethyl sulfoxide, dimethylacetamide or N-methylpyrrolidone, diethyl ether 'diisopropyl ether can be used. An ether such as tetrabutyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran or dioxane, an aliphatic hydrocarbon such as pentane, hexane, heptane or petroleum ether, benzene, toluene, xylene, and the like. An aromatic hydrocarbon such as toluene, chlorobenzene, dichlorobenzene, nitrobenzene or tetrahydronaphthalene; a nitrile such as acetonitrile, propionitrile or butyronitrile; or an organic weakly alkaline solvent such as pyridine or quinoline. Further, an alcohol such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol or tert-butanol can also be used. These solvents can be selected in consideration of the ease of production and the like, and can be used alone or in combination of two or more. Further, depending on the case, an appropriate dehydrating agent or desiccant may be used as the non-aqueous solvent. The hydrolysis conditions of water are the same as those shown in Process 1 of the compound 19. The reaction temperature is -l〇〇. The boiling point of the solvent to be used is preferably in the range of -50 to 150 °C. -51 - 201219450 The reaction time is usually 0.1 to 1,000 hours. Further, the compound 169 obtained as described above can also be purified by recrystallization, distillation, hydrazine gel column chromatography or the like. Process for the preparation of compound 19 - [Chem. 39]
X7 η 在化合物26中,A與前述爲同義,關於示例之基,亦 與前述相同。W爲三苯基膦、或膦酸酯。 化合物19之製法,例如,使化合物22與化合物26於 Wittig反應、或 Horner-Wadsworth-Emmons反應後,將醋 基-C 0 0 A水解之方法。反應,較佳爲在溶媒中,使用鹼來 予以進行。 使用於反應的驗,較佳爲使用使phosphonium ylide圓 滑地產生之強度之鹼。作爲鹼,例如,可使用鋰、鈉、鉀 般之鹼金屬之氫氧化物或碳酸鹽、丁基鋰、sec-丁基鋰、 tert-丁基鋰般之烷基鋰、鋰醯胺、胺化鈉、胺化鉀般之鹼 金屬醯胺、氫化鋰、氫化鈉、氫化鉀般之鹼金屬氫化物、 六甲基二矽氮烷鋰、六甲基二矽氮烷鈉、六甲基二矽氮烷 鉀般之鹼金屬二矽氮烷(disilazide)類、鹼土類金屬、鈉 或鉀之甲醇化物、乙醇化物、η-丙醇化物、異丙醇化物、 η-丁醇化物、sec-丁醇化物、tert-丁醇化物、2-甲基-2-丁 醇化物、2-甲基-2-戊醇化物、3-甲基-3-戊醇化物、3-乙 -52-X7 η In the compound 26, A is synonymous with the foregoing, and the examples are also the same as described above. W is triphenylphosphine or a phosphonate. The method of producing the compound 19, for example, a method of hydrolyzing hydroxy-C 0 0 A after reacting the compound 22 with the compound 26 in a Wittig reaction or a Horner-Wadsworth-Emmons reaction. The reaction is preferably carried out using a base in a solvent. For the test of the reaction, it is preferred to use a base which gives the phosphonium ylide a smooth strength. As the base, for example, a hydroxide or carbonate of a lithium, sodium or potassium base metal, a butyllithium, a sec-butyllithium, a tert-butyllithium-like alkyllithium, a lithium decylamine or an amine can be used. Sodium, potassium alkoxide, metal amide, lithium hydride, sodium hydride, potassium hydride, alkali metal hydride, lithium hexamethyldiazepine, sodium hexamethyldisodium azide, hexamethyl Alkaloids such as disilazide, alkaline earth metals, sodium or potassium methanolates, ethanolates, η-propanolates, isopropoxides, η-butanolates, sec- Butanolate, tert-butanolate, 2-methyl-2-butanolate, 2-methyl-2-pentanolate, 3-methyl-3-pentanolate, 3-B-52-
S 201219450 基-3-戊醇化物般之由一級、二級或三級之碳數1〜10之脂 肪族醇所衍生的鹼金屬醇化物、二吖雙環辛烷、二吖雙環 十一烯、4-二甲基胺基吡啶、吡咯啶、哌啶等之有機脂肪 族、芳香族、雜環之氮鹼等。特別以丁基鋰、tert-丁基鋰 爲宜。 作爲溶媒’只要是不會與化合物22及化合物26反應之 溶媒即可使用。例如’可使用醚類(二乙基醚、二異丙基 醚、四丁基甲基醚、環戊基甲基醚、四氫呋喃、二噁烷等 )、非質子性極性有機溶媒(二甲基甲醯胺 '二甲基亞颯 、二甲基乙醯胺、N-甲基吡咯啶酮等)、脂肪族烴類(戊 烷、己烷 '庚烷、石油醚等)、芳香族烴類(苯、甲苯、 二甲苯、均三甲苯、氯苯、二氯苯、硝基苯、四氫萘等) 、腈類(乙腈、丙腈、丁腈等)。此等溶媒,可於考量反 應之容易產生性等而予以選擇,能以單獨1種或混合2種以 上使用。又,視情況,亦可使用脫水劑或乾燥劑來作爲非 水溶媒使用。 以水之水解條件,與在化合物1 9之製法-1所示方法相 同。 反應溫度爲-l〇〇°C〜所使用溶媒之沸點,較佳爲_50〜 150°C之範圍》 反應時間爲0.1〜1,〇〇〇小時。 又,如上述般所得到的化合物1 9 ’亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。 -53- 201219450 化合物19之製法-5 【化40】S 201219450 Alkyl-3-pentoxide, an alkali metal alkoxide derived from a primary, secondary or tertiary aliphatic alcohol having 1 to 10 carbon atoms, dinonicyclooctane, dinonicycloundecene, An organic aliphatic, aromatic or heterocyclic nitrogen base such as 4-dimethylaminopyridine, pyrrolidine or piperidine. In particular, butyl lithium or tert-butyl lithium is preferred. The solvent ' can be used as long as it does not react with the compound 22 and the compound 26. For example, 'ethers (diethyl ether, diisopropyl ether, tetrabutyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aprotic polar organic solvents (dimethylformamide) can be used. Amines 'dimethyl hydrazine, dimethyl acetamide, N-methyl pyrrolidone, etc.), aliphatic hydrocarbons (pentane, hexane 'heptane, petroleum ether, etc.), aromatic hydrocarbons (benzene , toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). These solvents can be selected in consideration of the ease of production and the like, and can be used alone or in combination of two or more. Further, a dehydrating agent or a desiccant may be used as a nonaqueous solvent, as the case may be. The hydrolysis conditions of water are the same as those shown in Process 1 of Compound 19. The reaction temperature is -10 ° C to the boiling point of the solvent used, preferably in the range of _50 to 150 ° C. The reaction time is 0.1 to 1, 〇〇〇 hr. Further, the compound 1 9 ' obtained as described above can also be purified by an operation such as recrystallization, distillation, hydrazine gel column chromatography or the like. -53- 201219450 Formulation of Compound 19-5 [Chemical 40]
x4-x5-x6 "χ5"χ6+X4-x5-x6 "χ5"χ6+
χ4-χ5-χ6 在化合物27與化合物28中,X4、X5、X6、X7、及η爲 與前述爲同義。 Μ爲Li、MgCl、MgBr'或Mgl之有機金屬反應劑。 A爲與前述同義,關於示例之基,亦與前述相同。 化合物19之製法,例如,在溶媒中,使化合物27與銅 鹽、鋅鹽、或二烷基鋅混合,調製銅酸鹽、或二芳基鋅化 合物,再與化合物28所示化合物進行l,4-付加反應後,將 酯基-C 00 A以水進行水解之方法。 使用於此反應的銅鹽、鋅鹽、或二烷基鋅,可單獨使 用,又,亦可將此等銅鹽、鋅鹽、二烷基鋅組合而予以使 用。 作爲使用於反應的銅鹽之例,有CuCl、CuBr、Cul、 CuCN、或CuCl^LiCl之混合鹽等,特別以Cul爲宜。 又,作爲使用於反應的鋅鹽之例,有ZnCl2、ZnBr2、 或Znl2,特別以ZnCl2爲宜。 作爲使用於反應的二烷基鋅之例,有二丁基鋅、二乙 基鋅、或二丁烯基鋅,特別以二乙基鋅爲宜。 關於溶媒,只要是不會與有機金屬反應劑反應之溶媒 即可使用。 例如,可使用醚類(二乙基醚、二異丙基醚、四丁基Χ4-χ5-χ6 In the compound 27 and the compound 28, X4, X5, X6, X7, and η are synonymous with the above. Antimony is an organometallic reactant of Li, MgCl, MgBr' or Mgl. A is synonymous with the foregoing, and the base of the example is also the same as described above. The method for producing the compound 19, for example, by mixing the compound 27 with a copper salt, a zinc salt or a dialkyl zinc in a solvent to prepare a cuprate or a diaryl zinc compound, and then performing a compound represented by the compound 28, 4-After adding the reaction, the ester group-C 00 A is hydrolyzed by water. The copper salt, zinc salt or dialkylzinc used in the reaction may be used singly or in combination with such a copper salt, a zinc salt or a dialkyl zinc. Examples of the copper salt used in the reaction include a mixed salt of CuCl, CuBr, Cul, CuCN, or CuCl^LiCl, and particularly preferably Cul. Further, as an example of the zinc salt used for the reaction, there are ZnCl2, ZnBr2, or Znl2, and particularly ZnCl2. As an example of the dialkylzinc used in the reaction, there may be dibutylzinc, diethylzinc or dibutenylzinc, and particularly preferably diethylzinc. The solvent can be used as long as it does not react with the organometallic reactant. For example, ethers (diethyl ether, diisopropyl ether, tetrabutyl) can be used.
S -54- 201219450 甲基醚、環戊基甲基醚、四氫呋喃、二噁烷等)、非質子 性極性有機溶媒(二甲基甲醯胺、二甲基亞楓、二甲基乙 醯胺、N -甲基吡咯啶酮等)、脂肪族烴類(戊烷、己烷、 庚烷、石油醚等)、芳香族烴類(苯、甲苯、二甲苯、均 三甲苯、氯苯、二氯苯、硝基苯、四氫萘等)。此等溶媒 ,可於考量反應之容易產生性等而予以選擇,能以單獨1 種或混合2種以上使用。又,視情況,亦可使用適當的脫 水劑或乾燥劑來作爲非水溶媒使用。 以水之水解條件,與在化合物19之製法-1所示方法相 同。 反應溫度爲-100°C〜所使用溶媒之沸點,較佳爲-50〜 1 5 0 °C之範圍。 反應時間爲0 · 1〜1,0 0 0小時。 又,如上述般所得到的化合物1 0,亦能以再結晶、蒸 餾、矽凝膠管柱層析法等之操作予以純化。 化合物27之製法 【化41】S-54- 201219450 methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aprotic polar organic solvent (dimethylformamide, dimethyl sulfoxide, dimethyl acetamide) , N-methylpyrrolidone, etc.), aliphatic hydrocarbons (pentane, hexane, heptane, petroleum ether, etc.), aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, two Chlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.). These solvents can be selected in consideration of the ease of production of the reaction, and the like, and can be used alone or in combination of two or more. Further, as the case may be, a suitable dehydrating agent or desiccant may be used as the nonaqueous solvent. The hydrolysis conditions of water are the same as those shown in Process 19 of Compound 19. The reaction temperature is -100 ° C to the boiling point of the solvent to be used, preferably in the range of -50 to 150 ° C. The reaction time is 0 · 1 to 1, 0 0 0 hours. Further, the compound 10 obtained as described above can also be purified by an operation such as recrystallization, distillation, hydrazine gel column chromatography or the like. Method for preparing compound 27
在化合物29與化合物30中,U、X、X4、X5、X6、X7 、及η爲與前述爲同義。 -55- 201219450 化合物27之製法,例如’藉由化合物29與化合物18之 反應合成化合物30,之後,使化合物30與金屬鎂、或鋰化 劑反應之方法。幾個化合物29與化合物1 8,可作爲市售品 容易地取得6 化合物29之取代基U爲-OH、-SH、或·ΝΗ2,化合物18 之X5爲單鍵、或由前述[X5-l]〜[Χ5-4]之群所選出之碳環 時,在鹼之存在下,藉由使化合物29與化合物18反應’可 得到化合物3 0 »反應條件,可將在製法1之化合物3之合成 法中,X5爲由前述[X5-l]〜[Χ5-4]之群所選出之碳環時之 方法予以適用。 化合物29之取代基U爲·OH、-SH、或-ΝΗ2,化合物18 之X5爲單鍵、或前述[Χ5-5]之碳環時,在鹼之存在下,可 藉由將金屬錯合物與配位基作爲觸媒之偶合反應而予以合 成。反應條件,可將在製法1之化合物3之合成法中’ X5爲 前述[Χ5-5]時之方法予以適用。 化合物29之取代基U爲鹵素F、Cl、Br、或I ’化合物 27之X4爲單鍵時,在鹼之存在下,可藉由將金屬錯合物與 配位基作爲觸媒之偶合反應而予以合成。反應條件’可將 在製法1之化合物3之合成法中,X4爲單鍵時之方法予以適 用。 對於所得到的化合物30,在醚溶媒中,加入金屬Mg使 反應,得到可使用於格任亞反應之化合物27 ( M = MgF、 MgCl、MgBr、Mgl)。又,在溶媒中,使金屬鋰反應’可 得到Μ爲Li之化合物27。 -56-In the compound 29 and the compound 30, U, X, X4, X5, X6, X7, and η are synonymous with the above. -55-201219450 A method of producing Compound 27, for example, a method of synthesizing Compound 30 by the reaction of Compound 29 with Compound 18, followed by reacting Compound 30 with metallic magnesium or a lithiating agent. Several of the compound 29 and the compound 18 can be easily obtained as a commercial product. The substituent U of the compound 29 is -OH, -SH, or ΝΗ2, and the X5 of the compound 18 is a single bond, or the above [X5-l When the carbocyclic ring selected by the group [~5-4] is reacted with the compound 18 in the presence of a base to obtain the compound 3 0 reaction condition, the compound 3 in the process 1 can be obtained. In the synthesis method, X5 is a method in which the carbon ring selected from the group of the above [X5-l] to [Χ5-4] is applied. The substituent U of the compound 29 is ·OH, -SH, or -ΝΗ2, and when X5 of the compound 18 is a single bond or the above-mentioned carbocyclic ring of [Χ5-5], in the presence of a base, the metal may be misaligned The compound and the ligand are synthesized as a coupling reaction of a catalyst. The reaction conditions can be applied to the method in the synthesis method of the compound 3 of Process 1 wherein X 5 is the above [Χ 5-5]. When the substituent U of the compound 29 is halogen F, Cl, Br, or I', when X4 of the compound 27 is a single bond, in the presence of a base, a coupling reaction of the metal complex with a ligand as a catalyst can be carried out. And to synthesize. The reaction conditions' can be applied in the method of synthesizing the compound 3 of Process 1, and X4 is a single bond. With respect to the obtained compound 30, a metal Mg was added to an ether solvent to carry out a reaction, and a compound 27 (M = MgF, MgCl, MgBr, Mgl) which can be used for the Grenj reaction was obtained. Further, in the solvent, lithium metal is reacted to obtain a compound 27 in which ruthenium is Li. -56-
S 201219450 化合物19之製法-6 【化42】S 201219450 Preparation of Compound 19-6 [Chem. 42]
l-x5-x6 18 -X4~XS-X6 1 X7 Jn 在化合物31中,U、及n爲與前述爲同義。 化合物1 9之製法,例如,使化合物3丨與化合物1 8反應 ,反應後,將酯基-COOΑ以水進行水解之方法。又,幾個 化合物3 1與化合物1 8,可作爲市售品容易地取得。 化合物31之取代基U爲-OH、-SH、或-NH2,化合物18 之X5爲單鍵、或由前述[X5-l]〜[X5-4]之群所選出之碳環 時,在鹼之存在下,使化合物31與化合物18反應,反應後 ,進行在化合物1 9之製法-1所示的以水之水解,得到化合 物19。反應條件,可將在製法1之化合物3之合成法中,X5 爲由前述[X5-l]〜[X5-4]之群所選出之碳環時之方法予以 適用。 化合物31之取代基U爲-OH、-SH、或·ΝΗ2,化合物18 之X5爲單鍵、或前述[Χ5-5]時,在鹼之存在下’將金屬錯 合物與配位基作爲觸媒使偶合反應’反應後’藉由實施在 化合物1 9之製法-1所示的以水之水解’可得到化合物1 9。 反應條件,可將在製法1之化合物3之合成法中’ χ5爲前述 [Χ、5]時之方法予以適用。 -57- 201219450 化合物31之取代基U爲鹵素F、Cl、Br、或I ’化合物 19之X4爲單鍵時,在鹼之存在下,將金屬錯合物與配位基 作爲觸媒使偶合反應,反應後,藉由實施在化合物19之製 法-1所示的以水之水解,可得到化合物1 9。反應條件’可 將在製法1之化合物3之合成法中’ X4爲單鍵時之方法予以 適用。 化合物4之製法 化合物4,在溶媒中,可藉由化合物1與丙烯酸衍生物 之化合物19、或化合物20之酯化反應而予以製造。 特別在如化合物20般之酸性鹵化物與化合物1之反應 中,酸性鹵化物較佳爲酸性氯化物(acid chloride )、酸 溴化物(acid bromide )等之酸性鹵化物類,更,在鹼之 存在下予以進行反應,係因爲反應會圓滑地進行之故。作 爲鹼,例如,可使用氫氧化鈉、氫氧化鉀、氫氧化鋰、碳 酸氫鈉、碳酸氫鉀、磷酸鉀、碳酸鈉、碳酸鉀、碳酸鋰、 碳酸鉋、氫化鈉、氫化鉀等之無機鹼、三甲基胺、三乙基 胺、三丙基胺、三異丙基胺、三丁基胺、二異丙基乙基胺 、吡啶、喹啉、柯林鹼等之胺類、tert-鈉丁氧化物' tert-鉀丁氧化物等之有機鹼。 作爲溶媒’只要是在該當反應條件下爲安定,惰性而 不會妨礙反應者即可,可適宜地予以選擇。例如,可使用 胺類、非質子性極性有機溶媒(二甲基甲醯胺、二甲基亞 颯、二甲基乙醯胺、N-甲基吡咯啶酮等)、醚類(二乙基 -58-L-x5-x6 18 -X4~XS-X6 1 X7 Jn In the compound 31, U and n are synonymous with the above. The method for producing the compound 19 is, for example, a method in which the compound 3丨 is reacted with the compound 18, and after the reaction, the ester group-COOΑ is hydrolyzed by water. Further, several of the compound 31 and the compound 18 can be easily obtained as a commercial product. The substituent U of the compound 31 is -OH, -SH, or -NH2, and the X5 of the compound 18 is a single bond or a carbocyclic ring selected from the group of the above [X5-1] to [X5-4], in the case of a base In the presence of the compound 31, the compound 31 is reacted with the compound 18, and after the reaction, hydrolysis with water as shown in Process-1 of the compound 19 is carried out to obtain the compound 19. The reaction conditions can be applied to the method of synthesizing the compound 3 of Process 1, wherein X5 is a carbocyclic ring selected from the group of the above [X5-1] to [X5-4]. The substituent U of the compound 31 is -OH, -SH, or ΝΗ2, and when X5 of the compound 18 is a single bond or the above [Χ5-5], the metal complex and the ligand are used as a ligand in the presence of a base. The catalyst is subjected to a coupling reaction 'after the reaction' to obtain a compound 19 by performing hydrolysis in water as shown in Process 1 of Compound 19. The reaction conditions can be applied to the method in the synthesis method of the compound 3 of Process 1 wherein χ5 is the above [Χ, 5]. -57- 201219450 The substituent U of compound 31 is halogen F, Cl, Br, or I. When X4 of compound 19 is a single bond, the metal complex and the ligand are coupled as a catalyst in the presence of a base. After the reaction, the reaction is carried out by hydrolysis of water as shown in Process-1 of Compound 19 to give Compound 19. The reaction condition ' can be applied to the method in which the compound X of the method 1 is a single bond. Process for Producing Compound 4 Compound 4 can be produced by esterification reaction of Compound 1 with Compound 19 of the acrylic acid derivative or Compound 20 in a solvent. Particularly in the reaction of the acid halide such as the compound 20 with the compound 1, the acid halide is preferably an acid halide such as an acid chloride or an acid bromide, and more, in the alkali The reaction is carried out in the presence of a smooth reaction. As the base, for example, inorganic substances such as sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium hydrogencarbonate, potassium hydrogencarbonate, potassium phosphate, sodium carbonate, potassium carbonate, lithium carbonate, carbonic acid planer, sodium hydride, potassium hydride or the like can be used. Alkali, trimethylamine, triethylamine, tripropylamine, triisopropylamine, tributylamine, diisopropylethylamine, pyridine, quinoline, colin base, etc., tert - an organic base such as sodium butoxide-tert-potassium butoxide. The solvent "is stable as long as it is stable under the reaction conditions, and does not interfere with the reaction, and can be suitably selected. For example, an amine, an aprotic polar organic solvent (dimethylformamide, dimethylhydrazine, dimethylacetamide, N-methylpyrrolidone, etc.), an ether (diethyl) can be used. -58-
S 201219450 醚、二異丙基醚、tert-丁基甲基醚、環戊基甲基醚、四氫 呋喃、二噁烷等)、脂肪族烴類(戊烷、己烷、庚烷、石 油酸等)、芳香族烴類(苯、甲苯、二甲苯、均三甲苯、 氯苯、二氯苯、硝基苯、四氫萘等)、鹵素系烴類(氯仿 、二氯甲烷、四氯化碳、二氯乙烷等)、低級脂肪酸酯類 (醋酸甲酯、醋酸乙酯、醋酸丁酯、丙酸甲酯等)、腈類 (乙腈、丙腈、丁腈等)。此等溶媒,可於考量反應條件 或反應之容易產生性等而予以選擇,能以單獨1種或混合2 種以上使用。又,視情況,亦可使用脫水劑或乾燥劑來作 爲非水溶媒使用。 反應溫度爲-100°C〜所使用溶媒之沸點,較佳爲-50〜 1 5 ot之範圍。 反應時間較佳爲0.1〜1,000小時。 如上述般所得到的化合物4,亦能以再結晶、蒸餾、 矽凝膠管柱層析法、活性碳等予以純化。 又,在化合物19與化合物1之反應中,使用二環己基 碳二醯亞胺、1-乙基-3- (3-二甲基胺基丙基)碳二醯亞胺 、羰基二咪唑等之縮合劑爲一般的。此時,觸媒量之酸或 N,N-二甲基胺基吡啶之添加,對於反應之進行爲有效果的 ,故宜。 化合物5之製法 使用化合物4之化合物5之製造’可藉由在製法1所述 之方法來予以進行。 201219450 <聚醯胺酸、聚醯胺酸酯、聚醯亞胺> 本發明之二胺化合物,係藉由使四羧酸、四羧酸二鹵 化物、四羧酸二酐等之四羧酸或該衍生物反應,可得到在 側鏈具有特定構造之聚醯胺酸。又,除了四羧酸或該衍生 物以外,藉由四羧酸二酯二氯化物與二胺化合物之反應、 或將四羧酸二酯與二胺化合物在縮合劑、鹼等之存在下使 反應,可得到聚醯亞胺之前驅物之聚醯胺酸酯。更,使此 聚醯胺酸脫水閉環,或藉由將聚醯胺酸酯以高溫進行加熱 ,並促使脫醇使閉環,可得到在側鏈具有特定構造之聚醯 亞胺。 <聚醯胺酸> 本發明之聚醯胺酸,係藉由含有式〔1〕所示二胺化 合物之二胺成分與四羧酸二酐之反應所得到的聚醯胺酸。 本發明之聚醯胺酸酯,係藉由將含有式〔1〕所示二 胺化合物之二胺成分與四羧酸二酯二氯化物,在鹼之存在 下使反應,或將四羧酸二酯與二胺化合物,在縮合劑、鹼 等之存在下使反應,所得到的聚醯胺酸酯。 本發明之聚醯亞胺,係使此聚醯胺酸脫水閉環,或藉 由使聚醯胺酸酯加熱閉環所得到的聚醯亞胺。 聚醯胺酸、聚醯胺酸酯及聚醯亞胺,在作爲用來得到 液晶配向膜之聚合物皆爲有用的。 用於藉由與四羧酸二酐之反應來得到聚醯胺酸之二胺S 201219450 ether, diisopropyl ether, tert-butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran, dioxane, etc.), aliphatic hydrocarbons (pentane, hexane, heptane, petroleum acid, etc.), Aromatic hydrocarbons (benzene, toluene, xylene, mesitylene, chlorobenzene, dichlorobenzene, nitrobenzene, tetrahydronaphthalene, etc.), halogenated hydrocarbons (chloroform, dichloromethane, carbon tetrachloride, two Ethyl chloride (etc.), lower fatty acid esters (methyl acetate, ethyl acetate, butyl acetate, methyl propionate, etc.), nitriles (acetonitrile, propionitrile, butyronitrile, etc.). These solvents can be selected in consideration of the reaction conditions, the ease of reaction, and the like, and can be used alone or in combination of two or more. Further, depending on the case, a dehydrating agent or a desiccant may be used as the nonaqueous solvent. The reaction temperature is -100 ° C to the boiling point of the solvent used, preferably in the range of -50 to 15 ot. The reaction time is preferably from 0.1 to 1,000 hours. The compound 4 obtained as described above can also be purified by recrystallization, distillation, hydrazine gel column chromatography, activated carbon or the like. Further, in the reaction of the compound 19 with the compound 1, dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, carbonyldiimidazole or the like is used. The condensing agent is general. In this case, it is preferred that the amount of the catalyst or the addition of N,N-dimethylaminopyridine is effective for the progress of the reaction. Process for Producing Compound 5 The production of Compound 5 using Compound 4 can be carried out by the method described in Process 1. 201219450 <polyglycine, polyphthalate, polyimine> The diamine compound of the present invention is obtained by using tetracarboxylic acid, tetracarboxylic acid dihalide, tetracarboxylic dianhydride or the like. The carboxylic acid or the derivative is reacted to obtain a polylysine having a specific structure in a side chain. Further, in addition to the tetracarboxylic acid or the derivative, the reaction of the tetracarboxylic acid diester dichloride with the diamine compound or the presence of the tetracarboxylic acid diester and the diamine compound in the presence of a condensing agent, a base or the like is used. The reaction provides a polyamidomate of the polyimide precursor. Further, by dehydrating the polyglycolic acid, or by heating the polyglycolate at a high temperature and promoting the dealcoholization to form a ring closure, a polyimine having a specific structure in the side chain can be obtained. <Polyuric acid> The polylysine of the present invention is a polyamic acid obtained by a reaction of a diamine component containing a diamine compound represented by the formula [1] with a tetracarboxylic dianhydride. The polyglycolate of the present invention is obtained by reacting a diamine component containing a diamine compound represented by the formula [1] with a tetracarboxylic acid diester dichloride in the presence of a base, or a tetracarboxylic acid. The diester and the diamine compound are reacted in the presence of a condensing agent, a base or the like to obtain a polyglycolate. The polyimine of the present invention is a polyimine obtained by dehydration of the polyamine or by heating the ring closure of the polyphthalate. Polyglycine, polyphthalate and polyimine are useful as polymers for obtaining liquid crystal alignment films. For obtaining a polyamine of polylysine by reaction with tetracarboxylic dianhydride
-60- S 201219450 中’式〔1〕所示二胺化 所不一胺化合物之含有 成分(以下,亦稱爲二胺成分) 合物之含有比例無限制。式〔;!〕 比例,例如,二胺成分之莫耳%以上、較佳爲2〇莫耳% 以上、更佳爲30莫耳%以上。二胺成分之1〇〇莫耳%爲式 〔1〕所示二胺化合物亦可。式〔i〕所示二胺化合物之含 有比例越大時’在做成液晶配向膜時,使液晶垂直站立之 能力會變得越高’且’光配向處理之效率會變高。依式〔 1〕所不—fee化合物之側鍵之構造、或使用液晶之垂直配 向能,因爲光配向處理時之預傾角會變化,故爲了得到所 希望的預傾角,式〔1〕所不二胺化合物之含有比例,可 在較佳之範圍內予以選擇。 在二胺成分中,式〔1〕所示二胺化合物爲以未滿100 莫耳%之情形被使用,雖然式〔1〕所示二胺化合物以外 之二胺化合物(亦稱爲其他二胺化合物)未特別限定,若 舉例該具體例時,如同以下。 作爲脂環式二胺類之例’舉例如1,4-二胺基環己烷、 1,3-二胺基環己烷、4,4’-二胺基二環己基甲烷、4,4’_二胺 基-3,3’-二甲基二環己基胺、異佛酮二胺等。 作爲芳香族二胺類之例,舉例如0 -苯二胺、m_苯二胺 、p-苯二胺、2,4 -二胺基甲苯、2,5 -二胺基甲苯、3,5-二胺 基甲苯、1,4-二胺基-2-甲氧基苯、2,5-二胺基-P-二甲苯、 1,3-二胺基-4-氯苯、3,5-二胺基安息香酸、1,4_二胺基· 2,5-二氯苯、4,4,-二胺基-1,2 -二苯基乙烷、4,4’ -二胺基-2,2,-二甲基聯苄、4,4,-二胺基二苯基甲烷、3,3’-二胺基 -61 - 201219450 二苯基甲烷、3,4’-二胺基二苯基甲烷、4,4’-二胺基-3,3’-二甲基二苯基甲烷、2,2’-二胺基芪、4,4’-二胺基芪、 4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、4,4’-二胺 基二苯基硫化物、4,4’-二胺基二苯基颯、3,3’-二胺基二苯 基楓、4,4’-二胺基二苯基酮、1,3-雙(3-胺基苯氧基)苯 、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯氧基)苯 、:3,5-雙(4-胺基苯氧基)安息香酸、4,4’-雙(4-胺基苯 氧基)聯苄、2,2-雙〔(4-胺基苯氧基)甲基〕丙烷、 2,2-雙〔4-(4-胺基苯氧基)苯基〕六氟丙烷、2,2-雙〔4-(4-胺基苯氧基)苯基〕丙烷、雙〔4- ( 3-胺基苯氧基) 苯基〕颯、雙〔4-(4-胺基苯氧基)苯基〕楓、1,1-雙( 4-胺苯基)環己烷、α、α’-雙(4-胺苯基)-1,4-二異丙 基苯、9,9-雙(4-胺苯基)芴、2,2-雙(3-胺苯基)六氟丙 烷、2,2-雙(4-胺苯基)六氟丙烷、4,4’-二胺基二苯基胺 、2,4-二胺基二苯基胺、1,8-二胺基萘、1,5-二胺基萘、 1,5-二胺基蔥肽、1,3-二胺基芘、1,6-二胺基芘、1,8-二胺 基芘、2,7-二胺基芴、1,3-雙(4-胺苯基)四甲基二矽氧 烷、聯苯胺、2,2’-二甲基聯苯胺、1,2-雙(4-胺苯基)乙 烷、1,3-雙(4-胺苯基)丙烷、1,4-雙(4-胺苯基)丁烷、 1,5-雙(4-胺苯基)戊烷、1,6-雙(4-胺苯基)己烷、1,7-雙(4-胺苯基)庚烷、1,8-雙(4-胺苯基)辛烷、1,9-雙( 4-胺苯基)壬烷、1,1〇-雙(4-胺苯基)癸烷、1,3-雙(4-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷-60- S 201219450 The content of the component (hereinafter, also referred to as diamine component) of the diamined compound represented by the formula [1] is not limited. formula〔;! The ratio is, for example, more than or equal to 2% by mole of the diamine component, more preferably 2% by mole or more, and still more preferably 30% by mole or more. The 1% molar % of the diamine component may be a diamine compound represented by the formula [1]. When the proportion of the diamine compound represented by the formula [i] is larger, the ability to stand the liquid crystal vertically becomes higher when the liquid crystal alignment film is formed, and the efficiency of the optical alignment treatment becomes higher. According to the structure of the side bond of the formula [1], or the vertical alignment energy of the liquid crystal, since the pretilt angle during the photoalignment treatment changes, in order to obtain the desired pretilt angle, the formula [1] does not The content ratio of the diamine compound can be selected within a preferred range. In the diamine component, the diamine compound represented by the formula [1] is used in the case of less than 100% by mole, although a diamine compound other than the diamine compound represented by the formula [1] (also referred to as other diamine) The compound) is not particularly limited, and when the specific example is exemplified, it is as follows. Examples of the alicyclic diamines include, for example, 1,4-diaminocyclohexane, 1,3-diaminocyclohexane, 4,4'-diaminodicyclohexylmethane, 4,4 '_Diamino-3,3'-dimethyldicyclohexylamine, isophorone diamine, and the like. Examples of the aromatic diamines include 0-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,4-diaminotoluene, 2,5-diaminotoluene, and 3,5. -diaminotoluene, 1,4-diamino-2-methoxybenzene, 2,5-diamino-P-xylene, 1,3-diamino-4-chlorobenzene, 3,5 -diaminobenzoic acid, 1,4-diamino 2,5-dichlorobenzene, 4,4,-diamino-1,2-diphenylethane, 4,4'-diamino -2,2,-dimethylbibenzyl, 4,4,-diaminodiphenylmethane, 3,3'-diamino-61 - 201219450 diphenylmethane, 3,4'-diamino Diphenylmethane, 4,4'-diamino-3,3'-dimethyldiphenylmethane, 2,2'-diaminopurine, 4,4'-diaminopurine, 4,4 '-Diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenylanthracene, 3,3'-diaminodiphenyl maple, 4,4'-diaminodiphenyl ketone, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4- Aminophenoxy)benzene, 1,4-bis(4-aminophenoxy)benzene, 3,5-bis(4-aminophenoxy)benzoic acid, 4,4'-bis (4 -aminophenoxy Bibenzyl, 2,2-bis[(4-aminophenoxy)methyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2 - bis[4-(4-aminophenoxy)phenyl]propane, bis[4-(3-aminophenoxy)phenyl]anthracene, bis[4-(4-aminophenoxy) Phenyl] maple, 1,1-bis(4-aminophenyl)cyclohexane, α,α'-bis(4-aminophenyl)-1,4-diisopropylbenzene, 9,9-double (4-Aminophenyl)anthracene, 2,2-bis(3-aminophenyl)hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-diaminodiyl Phenylamine, 2,4-diaminodiphenylamine, 1,8-diaminonaphthalene, 1,5-diaminonaphthalene, 1,5-diamino onion peptide, 1,3-diamine Base, 1,6-diaminoguanidine, 1,8-diaminoguanidine, 2,7-diaminoguanidine, 1,3-bis(4-aminophenyl)tetramethyldioxane, Benzidine, 2,2'-dimethylbenzidine, 1,2-bis(4-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,4-double (4 -amine phenyl)butane, 1,5-bis(4-aminophenyl)pentane, 1,6-bis(4-aminophenyl)hexane, 1,7-bis(4-aminephenyl) Heptane, 1,8-bis (4-aminophenyl) Octane, 1,9-bis(4-aminophenyl)decane, 1,1 fluorene-bis(4-aminophenyl)decane, 1,3-bis(4-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane
-62- S 201219450 、1,7-雙(4-胺基苯氧基)庚烷、1,8-雙(4-胺基苯 辛烷、1,9·雙(4-胺基苯氧基)壬烷、1,10-雙(4-氧基)癸烷、二(4-胺苯基)丙烷-1,3-二酸二甲酯 4-胺苯基)丁烷-1,4-二酸二甲酯、二(4-胺苯基: 1,5-二酸二甲酯、二(4-胺苯基)己烷-1,6-二酸二 二(4-胺苯基)庚烷-1,7-二酸二甲酯、二(4-胺苯 烷-1,8-二酸二甲酯、二(4-胺苯基)壬烷-1,9-二酸 、二(4-胺苯基)癸烷-1,10-二酸二甲酯、1,3-雙〔 胺基苯氧基)苯氧基〕丙烷、1,4-雙〔4- ( 4-胺基 )苯氧基〕丁烷、1,5-雙〔4- (4-胺基苯氧基)苯 戊烷、1,6-雙〔4-(4-胺基苯氧基)苯氧基〕己烷、 〔4-(4-胺基苯氧基)苯氧基〕庚烷、1,8-雙〔4-( 苯氧基)苯氧基〕辛烷、1,9-雙〔4-(4-胺基苯氧 氧基〕壬烷、1,1〇-雙〔4-(4-胺基苯氧基)苯氧基 等。 作爲芳香族-脂肪族二胺之例,舉例如3-胺基苄 4-胺基苄基胺、3-胺基-N-甲基苄基胺、4-胺基-N-基胺、3-胺基苯乙基胺、4-胺基苯乙基胺、3-胺基-苯乙基胺、4-胺基-N-甲基苯乙基胺、3- ( 3-胺基丙 胺、4- ( 3-胺基丙基)苯胺、3- ( 3-甲基胺基丙基 、4- ( 3-甲基胺基丙基)苯胺、3- ( 4-胺基丁基) 4- (4-胺基丁基)苯胺、3-(4-甲基胺基丁基)苯 (4-甲基胺基丁基)苯胺、3- ( 5-胺基戊基)苯胺 5- 胺基戊基)苯胺、3- ( 5-甲基胺基戊基)苯胺、 氧基) 胺基苯 、二( 戊烷-甲酯、 基)辛 二甲酯 4-(4- 苯氧基 氧基〕 1,7-雙 4-胺基 基)苯 〕癸烷 基胺、 甲基苄 N-甲基 基)苯 )苯胺 苯胺、 胺、4-、4 -( 4-(5- -63- 201219450 甲基胺基戊基)苯胺、2- ( 6-胺基萘基)甲基胺、3- ( 6-胺基萘基)甲基胺、2- ( 6-胺基萘基)乙基胺、3- ( 6-胺 基萘基)乙基胺等。 作爲雜環式二胺類之例,舉例如2,6-二胺基吡啶、 2,4-二胺基吡啶、2,4-二胺基-1,3,5-三吖哄、2,7-二胺基二 苯并呋喃、3,6-二胺基咔唑、2,4-二胺基-6-異丙基-1,3,5-三吖哄、2,5·雙(4-胺苯基)-1,3,4-噚二唑等。 作爲脂肪族二胺類之例,舉例如1,2-二胺基乙烷、 1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺 基壬烷、1,10-二胺基癸烷、1,3-二胺基-2,2-二甲基丙烷、 1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷 、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、 1,9-二胺基-5-甲基庚烷、1,12-二胺基十二烷、1,18-二胺 基十八烷、1,2-雙(3-胺基丙氧基)乙烷'等。 亦可倂用在側鏈具有烷基、含氟烷基、芳香環、脂肪 族環、雜環、以及由此等所成的大環狀取代體之二胺化合 物。具體可示例如下述之式〔DA-1〕〜式〔DA-26〕所示 二胺。 【化43】-62- S 201219450 , 1,7-bis(4-aminophenoxy)heptane, 1,8-bis(4-aminophenyloctane, 1,9·bis(4-aminophenoxy) ) decane, 1,10-bis(4-oxy)decane, dimethyl bis(4-aminophenyl)propane-1,3-dicarboxylate 4-aminephenyl)butane-1,4- Dimethyl dicarboxylate, di(4-aminophenyl: dimethyl 1,5-dicarboxylate, bis(4-aminophenyl)hexane-1,6-diacid di-di(4-aminophenyl) Dimethyl heptane-1,7-dicarboxylate, dimethyl 2-(4-aminophenyl benzene-1,8-dicarboxylate, bis(4-aminophenyl)decane-1,9-diacid, two (4-Aminophenyl)nonane-1,10-dicarboxylic acid dimethyl ester, 1,3-bis[aminophenoxy)phenoxy]propane, 1,4-bis[4-(4-amine) Phenoxy]butane, 1,5-bis[4-(4-aminophenoxy)benzenepentane, 1,6-bis[4-(4-aminophenoxy)phenoxy Hexane, [4-(4-aminophenoxy)phenoxy]heptane, 1,8-bis[4-(phenoxy)phenoxy]octane, 1,9-bis[4] -(4-Aminophenoxyoxy) decane, 1,1 fluorene-bis[4-(4-aminophenoxy)phenoxy, etc. As an example of the aromatic-aliphatic diamine, for example, 3-aminobenzyl 4-amine Amine, 3-amino-N-methylbenzylamine, 4-amino-N-ylamine, 3-aminophenethylamine, 4-aminophenethylamine, 3-amino-benzene Ethylamine, 4-amino-N-methylphenethylamine, 3-(3-aminopropylamine, 4-(3-aminopropyl)aniline, 3-(3-methylaminopropyl) 4-(3-Methylaminopropyl)aniline, 3-(4-aminobutyl) 4-(4-aminobutyl)aniline, 3-(4-methylaminobutyl)benzene (4-methylaminobutyl)aniline, 3-(5-aminopentyl)aniline 5-aminopentyl)aniline, 3-(5-methylaminopentyl)aniline, oxy)amine Benzobenzene, bis(pentane-methyl ester, yl)octyl dimethyl ester 4-(4-phenoxyoxy) 1,7-bis 4-amino)phenyl]nonanylamine, methylbenzyl N -methyl)phenyl)aniline aniline, amine, 4-, 4-(4-(5--63-201219450 methylaminopentyl)aniline, 2-(6-aminonaphthyl)methylamine, 3-(6-aminonaphthyl)methylamine, 2-(6-aminonaphthyl)ethylamine, 3-(6-aminonaphthyl)ethylamine, etc. as a heterocyclic diamine For example, 2,6-diaminopyridine, 2,4-diaminopyridine, 2,4-diamino-1,3,5-three Bismuth, 2,7-diaminodibenzofuran, 3,6-diaminocarbazole, 2,4-diamino-6-isopropyl-1,3,5-triazine, 2 , 5·bis(4-aminophenyl)-1,3,4-oxadiazole, etc. As an example of the aliphatic diamine, for example, 1,2-diaminoethane, 1,3-diamine Propane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diamino Octane, 1,9-diaminodecane, 1,10-diaminodecane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2, 5-dimethylhexane, 1,7-diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamine 3-methyl heptane, 1,9-diamino-5-methylheptane, 1,12-diaminododecane, 1,18-diaminooctadecane, 1,2- Bis(3-aminopropoxy)ethane' and the like. A diamine compound having an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring, a heterocyclic ring, and a large cyclic substituent formed therefrom may also be used. Specifically, a diamine represented by the following formula [DA-1] to formula [DA-26] can be exemplified. 【化43】
-64 --64 -
S 201219450 (r6爲碳數1〜22之院基或含氟院基)°S 201219450 (r6 is the base of the carbon number 1~22 or the fluorine-containing yard base)°
(s 5 示爲-(:00-、-0(:0-、-〇0仰-、->^(:0-、-〇112-、-0-、-CO-、或-NH-,R6示爲碳數1〜22之烷基或含氟烷 基)。 【化45】(s 5 is shown as -(:00-,-0(:0-, -〇0-----;^(:0-, -〇112-,-0-, -CO-, or -NH-) R6 is shown as an alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group).
(s6 示爲- 0-、_OCH2-、-CH20-、-COOCH2-、或 -CH2OCO-,R7爲碳數1〜22之烷基、烷氧基、含氟烷基或 含氟烷氧基)。 【化46】(s6 is represented by -0-, _OCH2-, -CH20-, -COOCH2-, or -CH2OCO-, and R7 is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group) . 【化46】
OCO (S7 不爲-COO-、 CONH- 、 -NHCO- -65- 201219450 COOCH2-、-CH2OCO-、-CH20-、-OCH2-、或-CH2-,R8 爲 碳數1〜22之烷基、烷氧基、含氟烷基或含氟烷氧基)。 【化47】OCO (S7 is not -COO-, CONH-, -NHCO--65- 201219450 COOCH2-, -CH2OCO-, -CH20-, -OCH2-, or -CH2-, R8 is an alkyl group having 1 to 22 carbon atoms, Alkoxy, fluoroalkyl or fluoroalkoxy). 【化47】
Η2Ν· NH, 'SeO~0~R9 [DA-16] (s8 示爲- COO-、-OCO-、-CONH-、-NHCO-、 -cooch2-、-CH2OCO-、-CH20-、-OCH2-、-CH2-、-O- ^ 或-NH-,R9爲氟基、氰基、三氟甲烷基、硝基、偶氮基、 甲醯基、乙醯基、乙醯氧基、或羥基)。 【化48】Η2Ν· NH, 'SeO~0~R9 [DA-16] (s8 is shown as - COO-, -OCO-, -CONH-, -NHCO-, -cooch2-, -CH2OCO-, -CH20-, -OCH2- , -CH2-, -O-^ or -NH-, R9 is fluoro, cyano, trifluoromethyl, nitro, azo, methyl, ethyl, ethoxy, or hydroxy) . 【化48】
NH2NH2
η力Λη力Λ
[DA-19][DA-19]
RioRio
R10 (Rio爲碳數3〜12之烷基,1,4-環己烯(1,4-cyclohexylene)之順-反異性,分別爲反體)。R10 (Rio is an alkyl group having 3 to 12 carbon atoms, and cis-trans isomerism of 1,4-cyclohexylene, respectively, is a trans-body).
-66- S 201219450 【化49】 Ο-66- S 201219450 【化49】 Ο
tX〇 h2ntX〇 h2n
[DA-17][DA-17]
【化50】【化50】
【化51】【化51】
與一般式 所示二胺化合物同時地,以補償垂直 -67- 201219450 配向能爲目的,亦可倂用上述〔DA-1〕〜〔DA-26〕之二 胺化合物。作爲能倂用之更佳的二胺,就電壓保持率或殘 留儲存電壓等方面而言,較佳爲式〔DA-10〕〜〔DA-26 〕'更佳爲〔DA-10〕〜〔DA-16〕之二胺化合物。此等 二胺化合物之較佳含有量,雖然無特別限定,但在二胺成 分中較佳爲5〜50莫耳%、更佳爲5〜30莫耳%。 又,亦可倂用以下之二胺化合物。 【化52】Simultaneously with the diamine compound of the general formula, the diamine compound of the above [DA-1] to [DA-26] may be used for the purpose of compensating for the vertical alignment of -67 to 201219450. As a more preferable diamine, in terms of voltage holding ratio or residual storage voltage, it is preferred that the formula [DA-10] to [DA-26] is more preferably [DA-10]~[ DA-16] diamine compound. The content of the diamine compound is preferably 5 to 50 mol%, more preferably 5 to 30 mol%, based on the diamine component, although it is not particularly limited. Further, the following diamine compound can also be used. 【化52】
【DA· 28][DA· 28]
[DA-29] ,nh2 € [DA-30][DA-29] ,nh2 € [DA-30]
NH2NH2
uaCH.XNXr '(CH2)n [DA-34] 藉由使含有[DA-27]或[DA-28]’可提昇電壓保持率( VHR ),因[DA-29]〜〔DA-34〕對於儲存電荷之減低具有 效果,故宜。 此外,如下述式〔DA-27〕所示二胺基砂氧垸等’亦 可舉例作爲其他二胺化合物。uaCH.XNXr '(CH2)n [DA-34] can increase the voltage holding ratio (VHR) by including [DA-27] or [DA-28], because [DA-29]~[DA-34] It is suitable for the reduction of stored charge. Further, a diamine-based oxazide or the like represented by the following formula [DA-27] can also be exemplified as another diamine compound.
-68- S 201219450 【化53】-68- S 201219450 【化53】
(m爲1〜10之整數)。 其他二胺化合物’因應在做成液晶配向膜之際之液晶 配向性、電壓保持特性、儲存電荷等之特性’亦可混合1 種或2種以上予以使用。 爲了得到本發明之聚醯胺酸(聚醯胺酸)而使與二胺 成分反應之四羧酸二酐’無特別限定。以下爲舉例該具體 例。 作爲具有脂環式構造或脂肪族構造之四羧酸二酐’舉 例如1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁 烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4·四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊 烷四羧酸二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,2,4,5-環 己烷四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二酐、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐、1,2,3,4-丁烷四羧 酸二酐、雙環〔3,3,0〕辛烷-2,4,6,8-四羧酸二酐、 3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基醋酸 二酐、順-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酐、 三環〔4.2.1.02’5〕壬烷-3,4,7,8-四羧酸-3,4:7,8-二酐、六 環〔6.6.0.12’7.03’6.19’14.01()’13〕六癸烷-4,5,11,12-四羧酸-4,5: 11,12-二酐、4- (2,5-二氧四氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸酐等。 -69- 201219450 除了具有上述脂環式構造或脂肪族構造之四羧酸二酐 以外’若使用芳香族四羧酸二酐時,由於液晶配向性會提 昇,且可使液晶晶胞之儲存電荷降低,故宜。作爲芳香族 四羧酸二酐,舉例如焦蜜石酸二酐、3,3,,4,4,-聯苯基四羧 酸二酐、2,2’,3,3’·聯苯基四羧酸二酐、2,3,3,,4-聯苯基四 羧酸二酐、3,3’,4,4’-二苯基酮四羧酸二酐、2,3,3,,4-二苯 基酮四羧酸二酐、雙(3,4 -二羧基苯基)醚二酐、雙( 3,4-二羧基苯基)楓二酐、ι,2,5,6-萘四羧酸二酐、 2.3.6.7- 萘四羧酸二酐等。 爲了得到本發明之聚醯胺酸酯而使與二胺成分反應之 四羧酸二烷基酯,無特別限定。以下爲舉例該具體例。 作爲脂肪族四羧酸二酯,舉例如1,2,3,4 -環丁烷四羧 酸二烷基酯、1,2-二甲基-1,2,3,4-環丁烷四羧酸二烷基酯 ' 1,3-二甲基-1,2,3,4-環丁烷四羧酸二烷基酯、ι,2,3,4-四 甲基-1,2,3,4-環丁烷四羧酸二烷基酯、ι,2,3,4-環戊烷四羧 酸二烷基酯、2,3,4,5-四氫呋喃四羧酸二烷基酯、i,2,4,5-環己烷四羧酸二烷基酯、3,4-二羧基-1-環己基琥珀酸二烷 基酯、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二烷基酯、 1,2,3,4-丁烷四羧酸二烷基酯、雙環〔3,3,〇〕辛烷- 2.4.6.8- 四羧酸二烷基酯、3,3’,4,4’-二環己基四羧酸二烷 基酯、2,3,5-三羧基環戊基醋酸二烷基酯、順-3,7-二丁基 環辛-1,5-二烯-1,2,5,6-四羧酸二烷基酯、三環〔4.2.1.〇2,5 〕壬烷-3,4,7,8-四羧酸-3,4 : 7,8-二烷基酯、六環〔 6.6.0.12,7.〇3,6.19,14.〇丨〇’13〕六癸烷-4,5,11,12_四羧酸-4,5 -70-(m is an integer from 1 to 10). The other diamine compound may be used in combination of one or two or more kinds depending on the properties of the liquid crystal alignment, the voltage-holding property, and the storage charge in the case of forming a liquid crystal alignment film. The tetracarboxylic dianhydride which reacts with the diamine component in order to obtain the polyglycolic acid (polyglycolic acid) of the present invention is not particularly limited. The following is an example of this specific example. As a tetracarboxylic dianhydride having an alicyclic structure or an aliphatic structure, for example, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3, 4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4·tetramethyl-1, 2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,2 , 4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1-cyclohexyl succinic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydro-1- Naphthalene succinic dianhydride, 1,2,3,4-butane tetracarboxylic dianhydride, bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride, 3,3 ',4,4'-Dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, cis-3,7-dibutylcyclooctane-1,5-diene- 1,2,5,6-tetracarboxylic dianhydride, tricyclo[4.2.1.02'5]nonane-3,4,7,8-tetracarboxylic acid-3,4:7,8-dianhydride, six Ring [6.6.0.12'7.03'6.19'14.01()'13]hexadecane-4,5,11,12-tetracarboxylic acid-4,5:11,12-dianhydride, 4-(2,5- Dihydrotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic anhydride and the like. -69- 201219450 In addition to the tetracarboxylic dianhydride having the above alicyclic structure or aliphatic structure, when an aromatic tetracarboxylic dianhydride is used, the liquid crystal alignment property is improved and the storage charge of the liquid crystal cell can be obtained. Reduced, it is appropriate. Examples of the aromatic tetracarboxylic dianhydride include pyromellitic dianhydride, 3,3,4,4,-biphenyltetracarboxylic dianhydride, and 2,2',3,3'·biphenyl. Tetracarboxylic dianhydride, 2,3,3,4-diphenyltetracarboxylic dianhydride, 3,3',4,4'-diphenyl ketone tetracarboxylic dianhydride, 2,3,3, , 4-diphenyl ketone tetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether dianhydride, bis(3,4-dicarboxyphenyl) dianhydride, ι, 2, 5, 6 - naphthalenetetracarboxylic dianhydride, 2.3.6.7-naphthalenetetracarboxylic dianhydride, and the like. The dicarboxylic acid dialkyl ester which is reacted with the diamine component in order to obtain the polyphthalate of the present invention is not particularly limited. The following is an example of this specific example. As the aliphatic tetracarboxylic acid diester, for example, dialkyl 1,2,3,4-cyclobutanetetracarboxylate, 1,2-dimethyl-1,2,3,4-cyclobutane IV Dialkyl carboxylic acid '1,3-Dimethyl-1,2,3,4-cyclobutane tetracarboxylic acid dialkyl ester, iota, 2,3,4-tetramethyl-1,2, Dialkyl 3,4-cyclobutanetetracarboxylate, dialkyl 2,3,4-cyclopentanetetracarboxylate, dialkyl 2,3,4,5-tetrahydrofuran tetracarboxylate , i, 2,4,5-cyclohexanetetracarboxylic acid dialkyl ester, 3,4-dicarboxy-1-cyclohexyl succinic acid dialkyl ester, 3,4-dicarboxy-1,2,3 , 4-tetrahydro-1-naphthalene succinate dialkyl ester, 1,2,3,4-butane tetracarboxylic acid dialkyl ester, bicyclo[3,3, fluorene] octane - 2.4.6.8- Dialkyl carboxylate, dialkyl 3,3',4,4'-dicyclohexyltetracarboxylate, dialkyl 2,3,5-tricarboxycyclopentyl acetate, cis-3,7 -Dibutylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic acid dialkyl ester, tricyclo[4.2.1.〇2,5]decane-3,4,7 , 8-tetracarboxylic acid-3,4: 7,8-dialkyl ester,hexacyclo[ 6.6.0.12,7.〇3, 6.19,14.〇丨〇'13]hexadecane-4,5, 11,12_tetracarboxylic acid-4,5-70-
S 201219450 :11,12-二烷基酯、4- (2,5 -二氧四氫呋喃_3_基 1,2,3,4-四氫萘-1,2-二羧酸二烷基酯等。 作爲芳香族四羧酸二烷基酯’舉例如焦蜜石酸二 酯、3,3’,4,4’-聯苯基四羧酸二烷基酯、2,2’,3,3,-聯 四羧酸二烷基酯、2,3,3’,4-聯苯基四羧酸二烷基 3,3’,4,4’-二苯基酮四羧酸二烷基酯、2,3,3,,4-二苯基 羧酸二烷基酯、雙(3,4-二羧基苯基)醚二烷基醋、 3.4- 二羧基苯基)颯二烷基酯、1,2,5,6-萘四羧酸二烷 、2,3,6,7-萘四羧酸二烷基酯等。 用來將本發明之二胺化合物作爲原料來得到聚醯 而使與二胺成分反應之二羧酸,無特別限定。作爲二 或該衍生物之脂肪族二羧酸之具體例,可舉例如丙二 蓚酸、二甲基丙二酸、琥珀酸、福馬酸、戊二酸、已 、黏康酸、2-甲基已二酸、三甲基已二酸、庚二酸、 二甲基戊二酸、3,3-二乙基琥珀酸、壬二酸、癸二酸 二酸等之二羧酸。 作爲脂環式構造之二羧酸,可舉例如1,1·環丙院二 ' 1,2-環丙烷二羧酸、1,1-環丁烷二羧酸、丨,2_環丁院 酸、1,3-環丁烷二羧酸、3,4-二苯基-1,2-環丁烷二錢 2.4- 二苯基-l,3-環丁烷二羧酸、1-環丁烯二殘酸 環丁烯-3,4-二羧酸、1,1-環戊烷二羧酸、丨,]·環戊院 酸、1,3-環戊烷二羧酸、1,1-環己烷二羧酸、L2 —環己 羧酸、1,3-環己烷二羧酸、1,4-環己烷二羧酸、;ι,4_ ( 莰烯)二羧酸、降莰烯-2,3-二羧酸、雙環[2.2.2]辛院 ? ) * 烷基 苯基 酯、 酮四 雙( 基酯 胺, 羧酸 酸、 二酸 2,2- 、辛 羧酸 —羧 酸、 ' 1 - 二羧 烷二 2-降 -1,4- -71 - 201219450 二羧酸、雙環[2.2.2]辛烷-2,3-二羧酸、2,5-二氧-1,4-雙環 [2.2.2]辛烷二羧酸、1,3-金剛烷二羧酸、4,8-二氧-1,3-金 剛烷二羧酸、2,6-螺[3.3]庚烷二羧酸、1,3-金剛烷二醋酸 、camphor acid 等。 作爲芳香族二羧酸,可舉例如〇-鄰苯二甲酸、異鄰苯二 甲酸、對苯二甲酸、5-甲基異鄰苯二甲酸、5-tert-丁基異 鄰苯二甲酸、5-胺基異鄰苯二甲酸、5-羥基異鄰苯二甲酸 、2,5-二甲基對苯二甲酸、四甲基對苯二甲酸、1,4-萘二 羧酸、2,5-萘二羧酸、2,6-萘二羧酸、2,7-萘二羧酸、1,4-蒽二羧酸、1,4-蔥肽二羧酸、2,5-聯苯基二羧酸、4,4’-聯 苯基二羧酸、1,5-伸聯苯二羧酸、4,4”-聯三苯基二羧酸、 4,4’-二苯基甲烷二羧酸、4,4’-二苯基乙烷二羧酸、4,4’-二苯基丙烷二羧酸、4,4’-二苯基六氟丙烷二羧酸、4,4’-二 苯基醚二羧酸、4,4’-聯苄二羧酸、4,4’·芪二羧酸、4,4’-二苯乙決二羧酸、4,4’-羰基二安息香酸、4,4’-磺醯基二安 息香酸、4,4’-二硫代二安息香酸、p-伸苯基二醋酸、3,3’-p-伸苯基二丙酸、4-羧基桂皮酸、p-伸苯基二丙烯酸、 3,3’-〔 4,4’-(亞甲基二-P-伸苯基)〕二丙酸、4,4’-〔 4,4’-(氧二-P-伸苯基)〕二丙酸、4,4’-〔 4,4’-(氧二-P-伸苯基)〕二丁酸、(異亞丙基二-P-伸苯基二氧)二丁酸 、雙(P-羧基苯基)二甲基矽烷等。 作爲含有雜環之二羧酸,可舉例如1,5- ( 9-氧芴)二 羧酸、3,4-呋喃二羧酸、4,5-噻唑二羧酸、2-苯基-4,5-噻 唑二羧酸、1,2,5-噻二唑-3,4-二羧酸、1,2,5-噚二唑-3,4- -72-S 201219450 : 11,12-dialkyl ester, 4-(2,5-dioxotetrahydrofuran_3_yl 1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid dialkyl ester, etc. As a dialkyl aromatic tetracarboxylate, for example, dimethoate diester, 3,3',4,4'-biphenyltetracarboxylic acid dialkyl ester, 2,2',3,3 ,-dialkyldicarboxylate, 2,3,3',4-biphenyltetracarboxylic acid dialkyl 3,3',4,4'-diphenyl ketone tetracarboxylic acid dialkyl ester , 2,3,3,4-diphenyldicarboxylate, bis(3,4-dicarboxyphenyl)ether dialkyl vinegar, 3.4-dicarboxyphenyl)decane dialkyl ester, 1,2,5,6-naphthalenetetracarboxylic acid dialkyl, 2,3,6,7-naphthalenetetracarboxylic acid dialkyl ester, and the like. The dicarboxylic acid used to obtain the polyfluorene of the diamine compound of the present invention as a raw material to react with the diamine component is not particularly limited. Specific examples of the aliphatic dicarboxylic acid of the di or the derivative include, for example, malonic acid, dimethylmalonic acid, succinic acid, fumaric acid, glutaric acid, hexamethylene, bismuthic acid, and 2-methyl group. A dicarboxylic acid such as adipic acid, trimethyl adipic acid, pimelic acid, dimethyl glutaric acid, 3,3-diethyl succinic acid, sebacic acid or sebacic acid. Examples of the dicarboxylic acid having an alicyclic structure include 1,1·cyclopropene bis- 1,2-cyclopropanedicarboxylic acid, 1,1-cyclobutanedicarboxylic acid, hydrazine, and 2 ring-rings. Acid, 1,3-cyclobutanedicarboxylic acid, 3,4-diphenyl-1,2-cyclobutane dimethanol 2.4-diphenyl-l,3-cyclobutanedicarboxylic acid, 1-ring Butene diunsaturated cyclobutene-3,4-dicarboxylic acid, 1,1-cyclopentanedicarboxylic acid, hydrazine, cyclopentaic acid, 1,3-cyclopentanedicarboxylic acid, 1, 1-cyclohexanedicarboxylic acid, L2-cyclohexanecarboxylic acid, 1,3-cyclohexanedicarboxylic acid, 1,4-cyclohexanedicarboxylic acid, iota, 4-(decene) dicarboxylic acid, Decalene-2,3-dicarboxylic acid, bicyclo [2.2.2] xinyuan?) * alkyl phenyl ester, ketone tetra bis (ester amide, carboxylic acid, diacid 2,2-, octyl carboxylate Acid-carboxylic acid, '1-dicarboxyalkane-2-low-1,4-71-201219450 dicarboxylic acid, bicyclo[2.2.2]octane-2,3-dicarboxylic acid, 2,5-di Oxy-1,4-bicyclo[2.2.2]octanedicarboxylic acid, 1,3-adamantane dicarboxylic acid, 4,8-dioxo-1,3-adamantane dicarboxylic acid, 2,6-spiro [3.3] Heptane dicarboxylic acid, 1,3-adamantane diacetic acid, camphor acid, etc. As the aromatic dicarboxylic acid, for example, hydrazine -phthalic acid, isophthalic acid, terephthalic acid, 5-methylisophthalic acid, 5-tert-butylisophthalic acid, 5-aminoisophthalic acid, 5 -hydroxyisophthalic acid, 2,5-dimethylterephthalic acid, tetramethylterephthalic acid, 1,4-naphthalene dicarboxylic acid, 2,5-naphthalene dicarboxylic acid, 2,6- Naphthalene dicarboxylic acid, 2,7-naphthalene dicarboxylic acid, 1,4-anthraquinone dicarboxylic acid, 1,4- onion peptide dicarboxylic acid, 2,5-biphenyldicarboxylic acid, 4,4'-linked Phenyl dicarboxylic acid, 1,5-extended biphenyl dicarboxylic acid, 4,4"-biphenyldicarboxylic acid, 4,4'-diphenylmethane dicarboxylic acid, 4,4'-diphenyl Ethylene dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'-diphenylhexafluoropropane dicarboxylic acid, 4,4'-diphenyl ether dicarboxylic acid, 4, 4'-bibenzyldicarboxylic acid, 4,4'-indole dicarboxylic acid, 4,4'-diphenylethylenedicarboxylic acid, 4,4'-carbonyl dibenzoic acid, 4,4'-sulfonyl Dibenzoic acid, 4,4'-dithiodibenzoic acid, p-phenylene diacetate, 3,3'-p-phenylene dipropionic acid, 4-carboxycinnamic acid, p-phenylene Acrylic acid, 3,3'-[ 4,4'-(methylenebis-P-phenylene)dipropionic acid, 4,4'-[ 4,4'-(oxydi-P-phenylene)]dipropionic acid, 4,4'-[4,4'-(oxydi-P-phenylene)]butyric acid, (isopropylene) a bis-P-phenylene dioxy)dibutyric acid, bis(P-carboxyphenyl)dimethyl decane, etc. As the dicarboxylic acid containing a heterocyclic ring, for example, 1,5-(9-oxonium) Dicarboxylic acid, 3,4-furandicarboxylic acid, 4,5-thiazole dicarboxylic acid, 2-phenyl-4,5-thiazole dicarboxylic acid, 1,2,5-thiadiazole-3,4 -dicarboxylic acid, 1,2,5-oxadiazole-3,4-72-
S 201219450 二羧酸、2,3-吡啶二羧酸、2,4-吡啶二羧酸、2,5-吡啶二羧 酸、2,6-吡啶二羧酸、3,4-吡啶二羧酸、3,5-吡啶二羧酸等 〇 上述的各種二羧酸,亦可爲酸性二鹵化物或酐。此等 二羧酸之中,又特別以能給予直線構造之聚醯胺之二羧酸 ,就保持液晶分子之配向性方面而言爲宜。之中較佳爲使 用對苯二甲酸、異對苯二甲酸、1,4-環己烷二羧酸、4,4,· 聯苯基二羧酸、4,4’·二苯基甲烷二羧酸、4,4’-二苯基乙烷 二羧酸、4,4’-二苯基丙烷二羧酸、4,4’-二苯基六氟丙烷二 羧酸、2,2-雙(苯基)丙烷二羧酸、4、4鑄聯三苯基二羧 酸、2,6-萘二羧酸、2,5-吡啶二羧酸或此等之酸性二鹵化 物等。此等化合物中亦有異性體存在,亦可爲含有此等之 混合物。又,亦可併用2種以上之化合物。 尙,使用於本發明之二羧酸類,並不限定於上述示例 之化合物。 四羧酸二酐,因應在做成液晶配向膜之際之液晶配向 性、電壓保持特性、儲存電荷等之特性,可倂用1種或2種 以上。 藉由四羧酸二酐與二胺成分之反應來得到本發明之聚 醯胺酸之際,可使用習知的合成手段。一般爲使四羧酸二 酐與二胺成分在有機溶媒中反應之方法。四羧酸二酐與二 胺化合物之反應,在有機溶媒中相較地較容易進行,且在 不會產生副產物之方面爲有利的。 作爲使用於四羧酸二酐與二胺化合物之反應之有機溶 -73- 201219450 媒,只要是所生成的聚醯胺酸會溶解者即可,無特別限定 。以下爲舉例該具體例。 N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、N-甲基己內醯胺、二甲 基亞颯、四甲基尿素、妣陡、二甲基颯、六甲基亞颯、 r-丁內酯、異丙基醇、甲氧基甲基戊醇、二戊烯、乙基 戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基 異丙基酮、甲基賽璐蘇、乙基賽璐蘇、甲基賽璐蘇醋酸酯 、乙基賽璐蘇醋酸酯、丁基卡必醇、乙基卡必醇、乙二醇 、乙二醇單醋酸酯、乙二醇單異丙基醚、乙二醇單丁基醚 、丙二醇、丙二醇單醋酸酯、丙二醇單甲基醚、丙二醇-tert-丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二醇單 醋酸酯、二乙二醇二甲基醚、二丙二醇單醋酸酯單甲基醚 、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇單醋 酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單醋酸酯單 丙基醚、3_甲基-3_甲氧基丁基醋酸酯、三丙二醇甲基醚、 3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異 丁烯、醋酸戊酯、丁基丁酯、丁基醚、二異丁基酮、甲基 環己烯、丙基醚、二己基醚、二噁烷、η-己烷、η-戊烷、 η-辛烷、二乙基醚、環已酮、乙烯碳酸酯、丙烯碳酸酯、 乳酸甲酯、乳酸乙酯、醋酸甲酯、醋酸乙酯、醋酸η-丁酯 、醋酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲 氧基丙酸甲酯、3·乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙 酯、3-乙氧基丙酸、3-甲氧基丙酸、3·甲氧基丙酸丙酯、 -74-S 201219450 dicarboxylic acid, 2,3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 2,5-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid, 3,4-pyridinedicarboxylic acid The various dicarboxylic acids described above, such as 3,5-pyridinedicarboxylic acid, may also be acidic dihalides or anhydrides. Among these dicarboxylic acids, in particular, a dicarboxylic acid capable of imparting a polyamine of a linear structure is preferable in terms of maintaining the alignment of the liquid crystal molecules. Among them, terephthalic acid, isoterephthalic acid, 1,4-cyclohexanedicarboxylic acid, 4,4,2-biphenyldicarboxylic acid, 4,4'-diphenylmethane are preferably used. Carboxylic acid, 4,4'-diphenylethane dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'-diphenylhexafluoropropane dicarboxylic acid, 2,2-double (Phenyl) propane dicarboxylic acid, 4, 4 cast triphenyl dicarboxylic acid, 2,6-naphthalene dicarboxylic acid, 2,5-pyridinedicarboxylic acid or the like. Also present in these compounds are heterologous or mixtures containing such. Further, two or more kinds of compounds may be used in combination. The dicarboxylic acid used in the present invention is not limited to the compounds exemplified above. The tetracarboxylic dianhydride may be one or more selected from the group consisting of liquid crystal alignment, voltage retention characteristics, and storage charge when the liquid crystal alignment film is formed. When the polyglycine of the present invention is obtained by the reaction of a tetracarboxylic dianhydride with a diamine component, a conventional synthesis means can be used. It is generally a method of reacting a tetracarboxylic dianhydride with a diamine component in an organic solvent. The reaction of the tetracarboxylic dianhydride with the diamine compound is relatively easy to carry out in an organic solvent, and is advantageous in that no by-products are produced. The organic solvent-73-201219450 which is used for the reaction of the tetracarboxylic dianhydride and the diamine compound is not particularly limited as long as the produced polylysine is dissolved. The following is an example of this specific example. N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-methylene Indamine, dimethyl hydrazine, tetramethyl urea, samarium, dimethyl hydrazine, hexamethylarylene, r-butyrolactone, isopropyl alcohol, methoxymethylpentanol, dipentene , Ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cyproterone, ethyl cyanidin, methyl cyanisol Acetate, ethyl cyproterone acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether , propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether , dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl Ether, 3-methyl-3-methoxyethoxy Acid ester, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyl ester, butyl ether , diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, dioxane, η-hexane, η-pentane, η-octane, diethyl ether, cyclohexanone, ethylene Carbonate, propylene carbonate, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, η-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, 3-methoxy Methyl propyl propionate, methyl ethyl ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3 methoxy propyl Acid propyl ester, -74-
S 201219450 3-甲氧基丙酸丁酯、二甘二甲醚、4-羥基-4-甲基-2-戊酮 、3-甲氧基-Ν,Ν-二甲基丙烷醯胺、3-乙氧基-N,N-二甲基 丙烷醯胺、3-丁氧基-N,N-二甲基丙烷醯胺等。此等可單 獨使用或混合後使用。更,即使是無法使聚醯胺酸溶解之 溶媒,在所生成的聚醯胺酸不會析出之範圍內,亦可混合 於上述溶媒中使用。 又,有機溶媒中之水分會阻礙聚合反應,更因爲會成 爲使生成的聚醯胺酸水解之原因,故有機溶媒較佳爲使用 已盡可能脫水乾燥者。 使四羧酸二酐與二胺成分在有機溶媒中反應之際,可 舉例如使有機溶媒中爲已分散或溶解有二胺成分之溶液攪 拌,將四羧酸二酐成分原樣地添加、或使四羧酸二酐成分 分散或溶解於有機溶媒中再予以添加之方法,相反地,可 舉例如將二胺成分添加於有機溶媒中爲已分散或溶解有四 羧酸二酐成分之溶液之方法、將四羧酸二酐成分與二胺成 分交互地添加之方法等,可使用此等方法之任一。又,若 四羧酸二酐成分或二胺成分爲由複數種之化合物所成時, 能使用已事先混合之狀態使反應,或使個別依序產生反應 ,更,亦可使已個別反應之低分子量體予以混合反應,以 成爲高分子量體》 此時之聚合溫度,可選擇-20〜150t之任意溫度,較 佳爲-5〜100°C之範圍。又,反應雖然可在任意之濃度下 進行,但濃度過低時,會變得難以得到高分子量之聚合物 ,又,濃度過高時,反應液之黏性會變得過高,均一之攪 -75- 201219450 拌變得困難,故在反應溶液中四羧酸二酐與二胺成分之合 計濃度較佳爲1〜50質量%、更佳爲5〜30質量%。反應初 期爲以高濃度進行,之後,可追加有機溶媒。 在上述反應中,四羧酸二酐之合計莫耳數與二胺成分 之合計莫耳數之比,較佳爲0.8〜1.2、更佳爲0.9〜1.1。 與通常的縮聚合反應相同,此莫耳比越接近1.0時,生成 的聚醯胺酸之分子量變得越大。 本發明之聚醯亞胺,係使前述的聚醯胺酸脫水閉環所 得到的聚醯亞胺,在作爲用來得到液晶配向膜之聚合物爲 有用的。 在本發明之聚醯亞胺中,醯胺酸基之脫水閉環率(醯 亞胺化率),並非一定要爲100%,可因應用途或目的而 予以任意調整。 <聚醯亞胺> 作爲使聚醯胺酸醯亞胺化之方法,舉例如將聚醯胺酸 之溶液依原樣地進行加熱之熱醯亞胺化、將觸媒添加於聚 醯胺酸之溶液之觸媒醯亞胺化。 使聚醯胺酸在溶液中進行熱醯亞胺化時之溫度爲100 〜400 °C、較佳爲120〜250 °C,將因醯亞胺化反應所生成 的水一邊排除至系外一邊予以進行之方法爲宜。 聚醯胺酸之觸媒醯亞胺化,可將鹼性觸媒與酸酐添加 於聚醯胺酸之溶液中,並藉由-20〜250 °C、較佳爲〇〜180 。(:之攪拌來予以進行。鹼性觸媒之量’爲醯胺酸基之0·5S 201219450 3-methoxypropionic acid butyl ester, diglyme, 4-hydroxy-4-methyl-2-pentanone, 3-methoxy-indole, hydrazine-dimethylpropane decylamine, 3 - Ethoxy-N,N-dimethylpropane decylamine, 3-butoxy-N,N-dimethylpropane decylamine, and the like. These can be used alone or in combination. Further, even a solvent in which polylysine cannot be dissolved can be used in combination with the above solvent within a range in which the produced polyamine does not precipitate. Further, the water in the organic solvent hinders the polymerization reaction, and further, since it causes hydrolysis of the produced polylysine, it is preferred to use the organic solvent as far as possible. When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, for example, a solution in which the diamine component is dispersed or dissolved in the organic solvent is stirred, and the tetracarboxylic dianhydride component is added as it is, or A method in which a tetracarboxylic dianhydride component is dispersed or dissolved in an organic solvent, and a method of adding a diamine component to an organic solvent as a solution in which a tetracarboxylic dianhydride component has been dispersed or dissolved is exemplified. As a method, a method of adding a tetracarboxylic dianhydride component and a diamine component alternately, etc., any of these methods can be used. Further, when the tetracarboxylic dianhydride component or the diamine component is formed of a plurality of compounds, the reaction can be carried out in a state of being mixed beforehand, or the reaction can be carried out in an individual order, or the individual reaction can be carried out. The low molecular weight body is subjected to a mixing reaction to form a high molecular weight body. The polymerization temperature at this time may be any temperature of from -20 to 150 t, preferably from -5 to 100 °C. Further, although the reaction can be carried out at any concentration, when the concentration is too low, it becomes difficult to obtain a polymer having a high molecular weight, and when the concentration is too high, the viscosity of the reaction liquid becomes too high, and the viscosity is excessively stirred. -75-201219450 The mixing becomes difficult, so the total concentration of the tetracarboxylic dianhydride and the diamine component in the reaction solution is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction is carried out at a high concentration, and thereafter, an organic solvent can be added. In the above reaction, the ratio of the total number of moles of the tetracarboxylic dianhydride to the total number of moles of the diamine component is preferably from 0.8 to 1.2, more preferably from 0.9 to 1.1. As with the usual polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the produced polylysine becomes. The polyimine of the present invention is useful as a polymer for obtaining a liquid crystal alignment film by dehydrating a ring closure of the above polyamic acid. In the polyimine of the present invention, the dehydration ring closure ratio of the proline group (the imidization ratio) is not necessarily 100%, and may be arbitrarily adjusted depending on the purpose or purpose. <Polyimine> As a method for imidating polyphosphonium amide, for example, a solution of polylysine is heated and heated by imidization, and a catalyst is added to polyamine. The catalyst solution of the acid solution is imidized. The temperature at which the polyaminic acid is thermally imidized in the solution is 100 to 400 ° C, preferably 120 to 250 ° C, and the water formed by the imidization reaction is excluded to the outside of the system. The method to be carried out is suitable. The catalyst of the polyaminic acid is imidized, and the basic catalyst and the acid anhydride are added to the solution of the polyamic acid at a temperature of -20 to 250 ° C, preferably 〇 180. (: stirring is carried out. The amount of alkaline catalyst is 0. 5 of the proline group)
-76- S 201219450 〜30莫耳倍、較佳爲2〜20莫耳倍;酸酐之量,爲醯胺酸 基之1〜50莫耳倍、較佳爲3〜30莫耳倍。 作爲鹼性觸媒,可舉例如吡啶、三乙基胺、三甲基胺 、三丁基胺、三辛基胺等,之中又以吡啶,因爲具有使反 應進行之適度鹼性,故宜。 作爲酸酐,可舉例如醋酸酐、偏苯三酸酐、焦蜜石酸 二酐等,之中有以使用醋酸酐時,因爲反應結束後之純化 變得容易,故宜。藉由觸媒醯亞胺化之醯亞胺化率,可藉 由調節觸媒量、反應溫度、反應時間予以控制。 <聚醯胺酸酯> 作爲合成聚醯胺酸酯之方法,藉由將四羧酸二酯二氯 化物與二胺化合物之反應、或四羧酸二酯與二胺化合物, 在縮合劑、鹼等之存在下使反應,而可得到聚醯亞胺之前 驅物之一種的聚醯胺酸酯。或,事先將聚醯胺酸聚合,並 利用高分子反應將醯胺酸中之羧酸予以酯化,亦可得到聚 醯胺酸酯。 具體爲,將四羧酸二酯二氯化物與二胺化合物在鹼與 有機溶劑之存在下,藉由在-20〜150 °C、較佳爲0〜50充 中,使反應3 0分鐘〜2 4小時、較佳爲1〜4小時,可予以合 成。 鹼方面,可使闬吡啶、三乙基胺、4-二甲基胺基吡啶 等’爲了穩定地進行反應,較佳爲吡啶。鹼之添加量,就 容易除去之量,且容易得到高分子量體等觀點而言,相對 -77- 201219450 於四羧酸二酯二氯化物,較佳爲2〜4莫耳倍^ 在縮合劑之存在下進行縮聚合反應時,作爲縮合劑, 可使用三苯基亞磷酸、二環己基碳二醯亞胺、1-乙基 3-二甲基胺基丙基)碳二醯亞胺鹽酸鹽、N,N’-羰基二味 唑、二甲氧基-1,3,5-三哄基甲基嗎福啉、0-(苯并三哩_1-基)->1,^1,]^’,:^’-四甲基脲四氟硼酸鹽、0-(苯幷三哩_1_ 基)-N,N,N’,N,-四甲基脲六氟磷酸鹽、(2,3-二氫_2_硫 基-3-苯并D号唑基)膦酸二苯基、4-(4,6-二甲氧基-n% 三吖哄-2-基)4-甲氧基嗎福啉氯化物-n-水合物等。 又’在使用縮合劑之方法中,若添加路易斯酸作爲添 加劑時’反應會有效率地進行。作爲路易斯酸,較佳爲氯 化鋰、溴化鋰等之鹵素化鋰。路易斯酸之添加量,相對於 四羧酸二酯,較佳爲0.1〜1.0莫耳倍。 作爲溶媒’可使用於上述聚合以得到聚醯胺酸之際所 使用的溶媒’就單體及聚合物之溶解性而言,較佳爲Ν_甲 基-2-吡咯啶酮、丁內酯等。此等溶媒,能以1種或混合 2種以上使用。又,爲了防止四羧酸二酯二氯化物之水解 ’使用於聚醯胺酸酯之合成之溶媒,以盡可能爲已脫水者 爲宜。 在反應溶液中四羧酸二酯二氯化物與二胺成分之合計 濃度,就不易產生聚合物之析出,且容易得到高分子量體 等觀點而言,較佳爲1〜30質量%、更佳爲5〜20質量%。 更,反應以在氮氣氛中進行,以防止外氣之混入爲宜 -78--76- S 201219450 〜30 moles, preferably 2 to 20 moles; the amount of the anhydride is 1 to 50 moles, preferably 3 to 30 moles, of the amidate group. Examples of the basic catalyst include pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, etc., among which pyridine is preferred because it has a moderate alkalinity for the reaction. . The acid anhydride may, for example, be acetic anhydride, trimellitic anhydride or pyromellitic dianhydride. Among them, when acetic anhydride is used, purification after completion of the reaction is easy, and therefore it is preferable. The imidization ratio of the imidization of the oxime by the catalyst can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. <Polyurethane> As a method of synthesizing a polyphthalate, by reacting a tetracarboxylic acid diester dichloride with a diamine compound, or a tetracarboxylic acid diester with a diamine compound, The reaction is carried out in the presence of a solvent, a base or the like to obtain a polyglycolate which is one of the precursors of the polyimine. Alternatively, the polyglycolic acid ester can be obtained by polymerizing polylysine in advance and esterifying the carboxylic acid in the lysine by a polymer reaction. Specifically, the tetracarboxylic acid diester dichloride and the diamine compound are allowed to react in the presence of a base and an organic solvent at -20 to 150 ° C, preferably 0 to 50, for 30 minutes. It can be synthesized in 2 hours, preferably 1 to 4 hours. As the base, ruthenium pyridine, triethylamine, 4-dimethylaminopyridine or the like can be used for the purpose of stable reaction, and pyridine is preferred. The amount of the base to be added is easily removed, and it is easy to obtain a high molecular weight body. From the viewpoint of -77 to 201219450 to tetracarboxylic acid diester dichloride, preferably 2 to 4 moles. When the polycondensation reaction is carried out in the presence of a condensing agent, triphenylphosphite, dicyclohexylcarbodiimide, 1-ethyl-3-dimethylaminopropyl)carbodiimide salt can be used. Acid salt, N,N'-carbonyldioxazol, dimethoxy-1,3,5-trimethylmethylmorphine, 0-(benzotriazol-1-yl)-> ^1,]^',:^'-Tetramethylurea tetrafluoroborate, 0-(benzoquinone-1-yl)-N,N,N',N,-tetramethylurea hexafluorophosphate , (2,3-dihydro-2-bromo-3-benzo D-azolyl) phosphonic acid diphenyl, 4-(4,6-dimethoxy-n% trianthylene-2-yl 4-methoxymorpholine chloride-n-hydrate and the like. Further, in the method of using a condensing agent, when a Lewis acid is added as an additive, the reaction proceeds efficiently. The Lewis acid is preferably lithium halide such as lithium chloride or lithium bromide. The amount of the Lewis acid added is preferably 0.1 to 1.0 moles per mole of the tetracarboxylic acid diester. The solvent used in the above-mentioned polymerization to obtain the poly-proline is used as the solvent. The solubility of the monomer and the polymer is preferably Ν-methyl-2-pyrrolidone or butyrolactone. Wait. These solvents can be used alone or in combination of two or more. Further, in order to prevent the hydrolysis of the tetracarboxylic acid diester dichloride, the solvent used for the synthesis of the polyglycolate is preferably as far as possible. In the reaction solution, the total concentration of the tetracarboxylic acid diester dichloride and the diamine component is less likely to cause precipitation of the polymer, and it is preferably from 1 to 30% by mass, more preferably from the viewpoint of easily obtaining a high molecular weight body. It is 5 to 20% by mass. Furthermore, the reaction is carried out in a nitrogen atmosphere to prevent the incorporation of outside air.
S 201219450 <聚醯胺> 聚醯胺亦可與聚醯胺酸酯同樣地進行合成。 <聚合物之回收> 由聚醯胺酸(聚醯胺酸)、聚醯胺酸酯、聚醯亞胺等 之反應溶液,將生成的聚醯胺酸、聚醯胺酸酯、聚醯亞胺 等回收時,只要將反應溶液投入於弱溶劑中,使聚合物沈 澱即可。作爲使用於沈澱之弱溶劑,可舉例如甲醇、丙酮 、己烷、丁基賽璐蘇、庚烷、甲基乙基酮、甲基異丁基酮 、乙醇、甲苯、苯、水等。投入於弱溶劑中使沈澱的聚合 物,在進行過濾回收後,於常壓或減壓下,能以常溫或加 熱予以乾燥。又,將沈澱回收後的聚合物重覆2〜10次之 使再溶解於有機溶媒中並進行再沈澱回收之操作時,可減 少聚合物中雜質。作爲此時的弱溶劑,例如,舉例如醇類 、酮類、烴等,若使用由此等之中所選出的3種以上之弱 溶劑時,因爲純化之效率會更提高一層,故宜。 本發明之液晶配向處理劑中所含有的聚醯胺酸及聚醯 亞胺之分子量,若考量所得到塗膜之強度、塗膜形成時之 作業性、及塗膜之均一性時,以GPC ( Gel Permeation Chromatography )法所測定的重量平均分子量,較佳爲 2,000 〜1,000,000、更佳爲 5,000 〜100,000 » <液晶配向處理劑> -79- 201219450 本發明之液晶配向處理劑,係用來形成液晶配向膜之 塗佈液,係有機溶媒中溶解有用來形成樹脂被膜之樹脂成 分之溶液。在此,前述樹脂成分,爲含有由上述本發明之 聚合物所選出之至少一種的聚合物之樹脂成分。此時,樹 脂成分之含有量,較佳爲1〜20質量%、更佳爲3〜15質量 %、特佳爲3〜10質量%。 在本發明中,前述樹脂成分,可全數爲本發明之聚合 物,亦可爲在本發明之聚合物中混合有其以外之其他聚合 物。此時,樹脂成分中本發明之聚合物以外之其他聚合物 之含有量爲0.5〜15質量%、較佳爲1〜10質量% » 該其他聚合物,例如,在作爲使與四羧酸二酐成分反 應之二胺成分,舉例如使用特定二胺化合物以外之二胺化 合物所得到的聚醯胺酸或聚醯亞胺等。 使用於本發明之液晶配向處理劑之有機溶媒,只要是 使樹脂成分溶解之有機溶媒即可,無特別限定。以下爲舉 例該具體例。 舉例如N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲 基-2-吡咯啶酮、N-甲基己內醯胺、2-吡咯啶酮、N-乙基吡 咯啶酮、N-乙烯基吡咯啶酮、二甲基亞颯、四甲基尿素、 吡啶、二甲基楓、六甲基亞颯、7-丁內酯、3 -甲氧基_ N,N-二甲基丙烷醯胺、3-乙氧基-Ν,Ν·二甲基丙烷醯胺、3_ 丁氧基-Ν,Ν-二甲基丙烷醯胺、1,3-二甲基-咪唑啶酮、乙 基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲 基異丙基酮、環已酮、乙烯碳酸酯、丙烯碳酸酯、二甘二S 201219450 <Polyuramine> Polyamide can also be synthesized in the same manner as polyglycolate. <Recovery of Polymer> The resulting polyglycine, polyglycolate, and poly are formed from a reaction solution of polyglycine (polyglycolic acid), polyphthalate, or polyamidiamine. When recovering ruthenium or the like, the reaction solution may be placed in a weak solvent to precipitate a polymer. Examples of the weak solvent used for the precipitation include methanol, acetone, hexane, butyl cyanidin, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, and the like. The polymer which has been precipitated in a weak solvent is filtered and recovered, and then dried at normal temperature or under reduced pressure under normal pressure or reduced pressure. Further, when the polymer recovered by precipitation is repeated for 2 to 10 times to be redissolved in an organic solvent and subjected to reprecipitation recovery, impurities in the polymer can be reduced. As the weak solvent at this time, for example, an alcohol, a ketone, a hydrocarbon or the like is used. When three or more kinds of weak solvents selected from the above are used, the efficiency of purification is further improved. When the molecular weight of the polyamic acid and the polyimine contained in the liquid crystal alignment treatment agent of the present invention is considered to be the strength of the coating film obtained, the workability at the time of formation of the coating film, and the uniformity of the coating film, GPC is used. The weight average molecular weight measured by the (Gel Permeation Chromatography) method is preferably 2,000 to 1,000,000, more preferably 5,000 to 100,000 » <Liquid crystal alignment treatment agent> -79 - 201219450 The liquid crystal alignment treatment agent of the present invention is A coating liquid for forming a liquid crystal alignment film in which a solution of a resin component for forming a resin film is dissolved in an organic solvent. Here, the resin component is a resin component containing a polymer selected from at least one of the polymers of the present invention. In this case, the content of the resin component is preferably from 1 to 20% by mass, more preferably from 3 to 15% by mass, even more preferably from 3 to 10% by mass. In the present invention, the resin component may be all the polymer of the present invention, or may be a polymer other than the polymer of the present invention. In this case, the content of the polymer other than the polymer of the present invention in the resin component is 0.5 to 15% by mass, preferably 1 to 10% by mass. The other polymer, for example, as a tetracarboxylic acid The diamine component to be reacted with the anhydride component is, for example, polyamine or polyimine obtained by using a diamine compound other than the specific diamine compound. The organic solvent to be used in the liquid crystal alignment agent of the present invention is not particularly limited as long as it is an organic solvent that dissolves the resin component. The following is an example of this example. For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone, N-ethylpyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethyl urea, pyridine, dimethyl maple, hexamethylarylene, 7-butyrolactone, 3-methoxy —N,N-Dimethylpropane decylamine, 3-ethoxy-indole, hydrazine-dimethylpropane decylamine, 3-butoxy-hydrazine, hydrazine-dimethylpropane decylamine, 1,3- Dimethyl-imidazolidinone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate Ester, digan
-80- S 201219450 甲醚、4-羥基-4-甲基-2-戊酮等。此等能以單獨使用,或 混合後使用。 本發明之液晶配向處理劑,亦可含有上述以外之成分 。作爲該例,有將液晶配向處理劑塗佈之際,使膜厚均一 性或表面平滑性提昇之溶媒或化合物、使液晶配向膜與基 板之密著性提昇之化合物等。 作爲使膜厚之均一性或表面平滑性提昇之溶媒(弱溶 劑)之具體例,舉例如以下。 例如,異丙基醇、甲氧基甲基戊醇、甲基賽璐蘇、乙 基賽璐蘇、丁基賽璐蘇、甲基賽璐蘇醋酸酯、乙基賽璐蘇 醋酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇醋酸酯、 乙二醇、乙二醇單醋酸酯、乙二醇單異丙基醚、乙二醇單 丁基醚、丙二醇、丙二醇單醋酸酯、丙二醇單甲基醚、丙 二醇-tert-丁基醚、二丙二醇單甲基醚、二乙二醇、二乙 二醇單醋酸酯、二乙二醇二甲基醚、二丙二醇單醋酸酯單 甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二 醇單醋酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單醋 酸酯單丙基醚、3-甲基-3-甲氧基丁基醋酸酯、三丙二醇甲 基醚、3·甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚 、二異丁烯、醋酸戊酯、丁基丁酯、丁基醚、二異丁基酮 '甲基環己烯、丙基醚、二己基醚、1-己醇、η-己烷、n-戊烷、η-辛烷、二乙基醚、乳酸甲酯、乳酸乙酯、醋酸甲 酯、醋酸乙酯、醋酸η-丁酯、醋酸丙二醇單乙基醚、丙酮 酸甲酯 '丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸 -81 - 201219450 甲基乙酯、3·甲氧基丙酸乙酯' 3-乙氧基丙酸、3-甲氧基 丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基· 2-丙醇、丙二醇單醋酸酯、丙二醇二醋酸酯、丙二醇-1-單 甲基醚-2-醋酸酯、丙二醇-1-單乙基醚-2-醋酸酯、二丙二 醇、2- ( 2-乙氧基丙氧基)丙醇、乳酸甲基酯、乳酸乙基 酯、乳酸η-丙基酯、乳酸η-丁基酯、乳酸異戊基酯等具有 低表面張力之溶媒等。 此等弱溶劑,能以1種或混合複數種予以使用。使用 如上述之溶媒時,較佳爲液晶配向處理劑中所含有全體溶 媒之5〜80質量%、更佳爲20〜60質量%。 作爲使膜厚之均一性或表面平滑性提昇之化合物,舉 例如氟系界面活性劑、聚矽氧系界面活性劑、非離子系界 面活性劑等。 更具體地,例如,舉例如F-Top EF301、EF3 03、 EF3 5 2 ( Tokem Products 公司製)、MEGAFACE F1 7 1、 F173、R-30 ( DIC公司製)、Fluorad FC43 0、FC43 1 (住 友 3M 公司製)、AashiGuard AG710、Surflon S-3 82、 SC101、SC102、SC103、SC104、SC105、SC106 (旭硝子 公司製)等。此等界面活性劑之使用比例,相對於液晶配 向處理劑中所含有樹脂成分之100質量份,較佳爲0.01〜2 質量份、更佳爲〇.〇1〜1質量份。 作爲使液晶配向膜與基板之密著性提昇之化合物之具 體例,舉例如以下所示之含有官能性矽烷化合物或含有環-80- S 201219450 Methyl ether, 4-hydroxy-4-methyl-2-pentanone, and the like. These can be used alone or in combination. The liquid crystal alignment agent of the present invention may contain components other than the above. In this case, a solvent or a compound which improves film thickness uniformity or surface smoothness, a compound which improves the adhesion between the liquid crystal alignment film and the substrate, and the like are applied when the liquid crystal alignment agent is applied. Specific examples of the solvent (weak solvent) for improving the uniformity of the film thickness or the surface smoothness are as follows. For example, isopropyl alcohol, methoxymethylpentanol, methyl cyproterone, ethyl cyproterone, butyl cyproterone, methyl cyproterone acetate, ethyl cyproterone acetate, butyl Kikabi alcohol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol Monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol single Acetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3- Methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3·methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, acetic acid pentane Ester, butyl butyl ester, butyl ether, diisobutyl ketone 'methyl cyclohexene, propyl ether, dihexyl ether, 1-hexanol, η-hexane, n-pentane, η-octane Second Ether, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, η-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate 'ethyl pyruvate, 3-methoxypropionic acid Ester, 3-ethoxypropionic acid-81 - 201219450 methyl ethyl ester, ethyl 3-methoxypropionate 3- 3-methoxypropionic acid, 3-methoxypropionic acid, 3-methoxypropene Acid propyl ester, butyl 3-methoxypropionate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-benzene Oxyl 2-propanol, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2 - (2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, η-propyl lactate, η-butyl lactate, isoamyl lactate and other solvents with low surface tension Wait. These weak solvents can be used in one type or in a mixture of plural kinds. When the solvent is used, it is preferably 5 to 80% by mass, more preferably 20 to 60% by mass based on the total amount of the solvent contained in the liquid crystal alignment agent. Examples of the compound which improves the uniformity of the film thickness or the surface smoothness include a fluorine-based surfactant, a polyoxyn-based surfactant, and a nonionic surfactant. More specifically, for example, F-Top EF301, EF3 03, EF3 5 2 (manufactured by Tokem Products Co., Ltd.), MEGAFACE F1 7 1 , F173, R-30 (manufactured by DIC Corporation), Fluorad FC43 0, FC43 1 (Sumitomo 3M company), AashiGuard AG710, Surflon S-3 82, SC101, SC102, SC103, SC104, SC105, SC106 (made by Asahi Glass Co., Ltd.). The use ratio of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 1 to 1 part by mass, per 100 parts by mass of the resin component contained in the liquid crystal alignment agent. As a specific example of the compound which improves the adhesion between the liquid crystal alignment film and the substrate, for example, a functional decane compound or a ring-containing compound is shown below.
-82- S 201219450 氧基化合物等。 例如,舉例如3-胺基丙基三甲氧基矽烷、3-胺基丙基 三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三 乙氧基矽烷、N- (2-胺基乙基)-3-胺基丙基三甲氧基矽烷 、N- (2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲 基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧 基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基 丙基三乙氧基矽烷、N-三乙氧基矽基丙基三乙烯三胺、N-三甲氧基矽基丙基三乙烯三胺、10-三甲氧基矽基-1,4,7-三吖癸烷、10-三乙氧基矽基-1,4,7-三吖癸烷、9-三甲氧基 矽基-3,6-二吖壬基醋酸酯、9-三乙氧基矽基-3,6-二吖壬基 醋酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺 基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷 、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧乙烯)-3-胺基丙基三 乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油 醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙 二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6 -己二醇 二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二 縮水甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、 沐>^,>^’,^^,-四縮水甘油基-111-二甲苯二胺、1,3-雙(]^,;^-二 縮水甘油基胺基甲基)環己烷、N,N,N’,N’,-四縮水甘油 基-4、4’-二胺基二苯基甲烷等。 更,除了基板與膜之密著性提昇外,以防止因背光之 -83- 201219450 電氣特性之降低等目的,液晶配向處理劑中亦可含有如以 下之酚醛塑料(phenoplast )系添加劑。具體的酚醛塑料 系添加劑如以下所示,但不限定於此構造。 【化1】-82- S 201219450 Oxygen compounds, etc. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N-(2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-urea Propyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyl Triethoxy decane, N-triethoxymercaptopropyltriethylenetriamine, N-trimethoxydecylpropyltriethylenetriamine, 10-trimethoxyindolyl-1,4,7- Trioxane, 10-triethoxyindolyl-1,4,7-trioxane, 9-trimethoxyindolyl-3,6-dimercaptoacetate, 9-triethoxy Mercapto-3,6-dimercaptoacetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-benzene 3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N-bis(oxyethylene)-3-aminopropyltrimethoxydecane, N - bis(oxyethylene)-3-amine Propyl triethoxy decane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol Diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl -2,4-hexanediol, Mu>^,>^',^^,-tetraglycidyl-111-xylenediamine, 1,3-bis(]^,;--diglycidyl Aminomethyl)cyclohexane, N,N,N',N',-tetraglycidyl-4,4'-diaminodiphenylmethane, and the like. Further, in addition to the adhesion between the substrate and the film, the liquid crystal alignment treatment agent may contain a phenoplast-based additive as described below for the purpose of preventing deterioration of the electrical characteristics of the backlight - 83 - 201219450. The specific phenolic plastic additive is as follows, but is not limited to this configuration. 【化1】
使用提昇與基板之密著性之化合物時,該使用量,相 對於液晶配向處理劑中所含有樹脂成分之100質量份,較 佳爲0.1〜30質量份、更佳爲1〜20質量份。使用量若未滿 0.1質量份時,無法期待密著性提昇之效果;若變得較30 質量份爲多時,液晶之配向性會有變差之情形。 本發明之液晶配向處理劑中,除了上述以外,只要是 在不會損及本發明效果之範圍,就使液晶配向膜之介電常 數或導電性等之電氣特性變化之目的,可添加介電質或導 電物質,更,就提高製做成液晶配向膜之際之膜之硬度或 緻密度爲目的,可添加交聯性化合物》 <液晶配向膜及液晶顯示元件> 本發明之液晶配向處理劑,在基板上予以塗佈並锻燒 後,以磨擦處理或光照射等進行配向處理,或在垂直配向 -84 -In the case of using a compound which improves the adhesion to the substrate, the amount of use is preferably from 0.1 to 30 parts by mass, more preferably from 1 to 20 parts by mass, per 100 parts by mass of the resin component contained in the liquid crystal alignment agent. When the amount of use is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected; if it is more than 30 parts by mass, the alignment of the liquid crystal may be deteriorated. In the liquid crystal alignment treatment agent of the present invention, in addition to the above, the dielectric properties of the liquid crystal alignment film may be changed so as not to impair the effects of the present invention, and dielectric properties may be added. For the purpose of improving the hardness or density of the film formed into a liquid crystal alignment film, a crosslinkable compound may be added. <Liquid crystal alignment film and liquid crystal display element> Liquid crystal alignment of the present invention The treatment agent is applied to the substrate and calcined, and then subjected to alignment treatment by rubbing treatment or light irradiation, or in vertical alignment -84 -
S 201219450 用途等時,可作爲無配向處理之液晶配向膜來使用。此時 ’作爲使用的基板,只要是透明性高之基板即可,無特別 限定’可使用玻璃基板、或丙烯酸基板或聚碳酸酯基板等 之塑膠基板等。又,使用已形成有用來驅動液晶之ITO電 極等之基板,就程序之簡便化之觀點而言爲宜。又,就反 射型液晶顯示元件而言,若僅爲單側之基板時,亦可使用 矽晶圓等之不透明物,此情形之電極亦可使用鋁等將光反 射之材料。 雖然液晶配向處理劑之塗佈方法無特別限定,但工業 性而言一般有網板印刷、平板印刷、快乾印刷、注入等。 作爲其他的塗佈方法,亦有浸漬、輥塗佈機、隙縫(slit )塗佈機、旋塗機等,因應目的亦可使用此等。 將液晶配向處理劑塗佈於基板後之鍛燒,藉由加熱板 等之加熱手段以50〜300°C、較佳爲80〜250°C予以進行, 使溶媒蒸發,可形成塗膜。於锻燒後所形成塗膜之厚度, 若過厚時,在液晶顯示元件之消費電力方面爲不利,又, 若過薄時,因爲會有液晶顯示元件之信賴性降低之情形, 較佳爲5〜3 00nm、更佳爲10〜100nm。使液晶水平配向或 傾斜配向時,將锻燒後之塗膜以磨擦或偏光紫外線照射等 進行處理。 本發明之液晶顯示元件,爲在以上述之手段由本發明 之液晶配向處理劑得到附著有液晶配向膜之基板後,使用 習知的方法製作液晶晶胞’而做成液晶顯示元件者。 若舉例液晶晶胞製作之一例時’可示例如準備1對已 -85- 201219450 形成有液晶配向膜之基板,將間隔物(spacer )散布於單 方基板之液晶配向膜上,並使液晶配向膜面以成爲內側地 將另一方之基板貼合,將液晶減壓注入後予以封止之方法 、或、於已散佈有間隔物之液晶配向膜面上將液晶滴下後 ,將基板貼合、予以封止之方法等。此時間隔物之厚度, 較佳爲1〜30μιη、更佳爲2〜ΙΟμιη。 如以上般,使用本發明之液晶配向處理劑所製作的液 晶顯示元件,爲成爲信賴性優異者,可適當地使用於大畫 面、高精細之液晶電視等。 【實施方式】 〔實施例〕 以下舉例實施例,更詳細將本發明予以說明,惟,本 發明並不限定於此等。 【化55】 ΟΗS 201219450 It can be used as a liquid crystal alignment film without alignment treatment when it is used. In this case, the substrate to be used is not particularly limited as long as it is a substrate having high transparency. A glass substrate or a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used. Further, it is preferable to use a substrate on which an ITO electrode or the like for driving a liquid crystal is formed, from the viewpoint of simplification of the procedure. Further, in the case of the reflective liquid crystal display device, if it is only a single-sided substrate, an opaque material such as a germanium wafer or the like may be used. In this case, a material such as aluminum or the like may be used. Although the coating method of the liquid crystal alignment treatment agent is not particularly limited, industrially, there are generally screen printing, lithography, quick-drying printing, injection, and the like. As another coating method, there are also a dipping, a roll coater, a slit coater, a spin coater, etc., and these may be used depending on the purpose. The liquid crystal alignment treatment agent is applied to the substrate and calcined, and is heated at 50 to 300 ° C, preferably 80 to 250 ° C by a heating means such as a hot plate to evaporate the solvent to form a coating film. When the thickness of the coating film formed after calcination is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and if it is too thin, since the reliability of the liquid crystal display element is lowered, it is preferably 5 to 300 nm, more preferably 10 to 100 nm. When the liquid crystal is aligned horizontally or obliquely, the film after calcination is treated by rubbing or polarized ultraviolet rays. In the liquid crystal display device of the present invention, a liquid crystal display cell is produced by a known method using a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention. For example, when one example of liquid crystal cell fabrication is made, it is exemplified that a pair of substrates having a liquid crystal alignment film formed by -85-201219450 is prepared, and a spacer is spread on a liquid crystal alignment film of a single substrate, and a liquid crystal alignment film is formed. The surface is bonded to the other substrate, the liquid crystal is injected under reduced pressure, and the liquid crystal is dropped on the liquid crystal alignment film surface on which the spacer has been dispersed, and then the substrate is bonded and attached. The method of sealing, etc. The thickness of the spacer at this time is preferably from 1 to 30 μm, more preferably from 2 to ΙΟμηη. As described above, the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention can be suitably used for a large-screen, high-definition liquid crystal television or the like in order to be excellent in reliability. [Embodiment] [Embodiment] Hereinafter, the present invention will be described in more detail by way of examples, but the invention is not limited thereto. 【化55】 ΟΗ
2 <實施例1 > 將 4 -碘酚 1 (22.0g、〇.l〇〇mol)、碳酸鉀(20.7g、 0.150mol)及二甲基甲醯胺!30ml (毫升)加入於四頸燒 瓶中,在氮氣氛下予以攪拌後,昇溫至80°C。到達80°C後 ,將1_溴癸院(17.9g、〇.〇8〇9mol)以花費30分鐘進行滴 下,滴下結束後’更攪拌1小時。藉由GC (氣相色譜法) -86- 201219450 確認到1 -溴癸烷之消失後,將溶媒餾去,並加入甲苯 120ml與純水150g進行萃取,將水層除去。之後,將1N NaOH 100ml置入於有機層中進行萃取,將水層除去。將所 得到的有機層以無水硫酸鎂予以乾燥,之後,過濾取得硫 酸鎂,將所得到的有機層在減壓下將溶媒餾去,而得到化 合物2 (得到量26.9g、0.0747mol、得到率92.3% )。化合 物2之構造,以1H-NMR (核磁共振)分析進行確認。 ^-NMR ( CDC13 ) : δ 7.5 5 -7.52 ( m, 2H,Ar-H ), 6.69-6.65 ( m, 2H, Ar-H ) , 3.90 ( t, 2H, J= 6.8Hz, Ar-O-CH2),1.79-1.72 (m, 2H, Ar-0-CH2-CH2-) , 1.47- 1.27 ( m,14H,Ar-0-CH2-CH2-C7H14-),0.87 ( t,3H,J= 6.8Hz,-CH2-CH3 )。 【化56】2 <Example 1 > 4-Iodophenol 1 (22.0 g, 〇.l〇〇mol), potassium carbonate (20.7 g, 0.150 mol), and dimethylformamide! 30 ml (ml) was placed in a four-necked flask, stirred under a nitrogen atmosphere, and then warmed to 80 °C. After reaching 80 ° C, 1 bromo broth (17.9 g, 〇. 〇 8 〇 9 mol) was dripped for 30 minutes, and after the completion of the dropping, the mixture was further stirred for 1 hour. After the disappearance of 1-bromodecane was confirmed by GC (gas chromatography) -86 - 201219450, the solvent was distilled off, and 120 ml of toluene and 150 g of pure water were added for extraction, and the aqueous layer was removed. Thereafter, 100 ml of 1N NaOH was placed in the organic layer for extraction, and the aqueous layer was removed. The obtained organic layer was dried over anhydrous magnesium sulfate, and then magnesium sulfate was obtained by filtration, and the obtained organic layer was distilled off under reduced pressure to give Compound 2 (26.9 g, 0.0747 mol, yield). 92.3%). The structure of Compound 2 was confirmed by 1H-NMR (nuclear magnetic resonance) analysis. ^-NMR (CDC13): δ 7.5 5 -7.52 (m, 2H, Ar-H), 6.69-6.65 (m, 2H, Ar-H), 3.90 ( t, 2H, J = 6.8 Hz, Ar-O- CH2), 1.79-1.72 (m, 2H, Ar-0-CH2-CH2-), 1.47- 1.27 (m, 14H, Ar-0-CH2-CH2-C7H14-), 0.87 (t,3H,J= 6.8 Hz, -CH2-CH3). 【化56】
3 4 <實施例2 > 將混合有3,5·二硝基苄基醇3 (39.6g、0.200mol )、 三乙基胺(26.3g、0.260mol)、四氫呋喃200ml之溶液, 在氮氣氛下,以〇°C予以攬拌’對於該溶液花費30分鐘將 混合有丙烯酸氯化物(21.7g、0.2 40mol)與四氫呋喃40ml 之溶液進行滴下。更,滴下後,進行4小時攪拌,反應結 束後,將溶媒餾去,將水3 0 0 g置入於所得到的粗生成物中 -87- 201219450 ’以漿料狀態’在25 °C攪拌30分鐘。之後,過濾反應液, 將固形分在減壓下、以7 0 °C使乾燥3小時,而得到化合物4 (得到量48.7g0.193mol,得到率96.5%)。化合物4之構 造,以1H-NMR分析進行確認。 !H-NMR ( CDC13 ) :δ 9.02 ( t, 1H, J = 2.4Hz, Ar-H ), 8.58 ( ms 2Ή, Ar-H ) , 6.54 ( dd, 1H, J=17.6, 1.2Hz,-CH = CH2 ) , 6.27-6.20 ( m, 1H, -CH = CH2 ) , 5.99 ( dd, 1H, J=10.8Hz,1.2Hz, -CH = CH2 ) , 5.40 ( s, 2H, Ar-CH2-〇 ) 【化57】 [PdCI2(CH3CN)2]3 4 <Example 2 > A solution of 3,5·dinitrobenzyl alcohol 3 (39.6 g, 0.200 mol), triethylamine (26.3 g, 0.260 mol), and tetrahydrofuran in 200 ml was mixed in nitrogen. Under an atmosphere, the mixture was stirred at 〇 ° C. A solution of acryl chloride (21.7 g, 0.240 mol) and 40 ml of tetrahydrofuran was added dropwise for 30 minutes. Further, after the dropwise addition, the mixture was stirred for 4 hours. After the completion of the reaction, the solvent was distilled off, and 300 g of water was placed in the obtained crude product -87-201219450 'in a slurry state' at 25 ° C. 30 minutes. Thereafter, the reaction solution was filtered, and the solid was dried under reduced pressure at 70 ° C for 3 hours to obtain Compound 4 (yield: 48.7 g, 0.193 mol, yield: 96.5%). The structure of Compound 4 was confirmed by 1H-NMR analysis. !H-NMR ( CDC13 ) : δ 9.02 ( t, 1H, J = 2.4Hz, Ar-H ), 8.58 ( ms 2Ή, Ar-H ) , 6.54 ( dd, 1H, J=17.6, 1.2Hz, -CH = CH2 ) , 6.27-6.20 ( m, 1H, -CH = CH2 ) , 5.99 ( dd, 1H, J = 10.8Hz, 1.2Hz, -CH = CH2 ) , 5.40 ( s, 2H, Ar-CH2-〇) [化57] [PdCI2(CH3CN)2]
P(0-tolyl)3 K3PO4 <實施例3 > 將化合物 2 ( 25_3g、0.0702mol)、化合物 4 ( 21.1g、 0.08 3 7mol )、氯化鈀乙腈錯合物( 0.572g、2.21mmol) 、參(〇-甲苯基)膦(1.28g、4.2 1mmol )、磷酸三鉀( 22.7g、0.107mol )、及二甲基乙醯胺1 70g之懸濁液,在室 溫條件下,以隔膜栗使減壓至50T〇rr後,重覆10次以氮之 使復壓之動作,將反應器內與二甲基乙醯胺中所含有的氧 除去。之後進行昇溫,在氮氣氛下,以110°C攪拌3小時。 反應結束後,將溶媒餾去,以水200g及氯仿25 0g進行萃取 -88- s 201219450 。將已分液之水層’進而以氯仿250g進行2次萃取,將所 得到的有機層以無水硫酸鎂予以乾燥。過濾取得硫酸鎂, 所得到的有機層在減壓下、將溶媒餾去,以乙腈1 70g將所 得到的粗生成物予以洗淨。之後,將結晶過濾,並藉由使 所得到的固形分在減壓下、乾燥,而得到化合物5 (得到 量32.5g、〇.〇671mol、得到率95.6%)。化合物5之構造, 以1H-NMR分析進行確認。 ^-NMR ( CDC13) :δ 9.01 ( t, 1H,Ar-H ) ,8.61 ( d, 2H, J=1.6Hz, Ar-H) , 7.74 ( d, 1H, J=16.0Hz, -CH = CH-Ar ),7.49 ( d, 2H, J = 7.6Hz, Ar-H) , 6.91 ( d, 2H, J = 7.6Hz, Ar-H) , 6.39 ( d, 1H, J=16.0Hz, -CH = CH-Ar) , 5.42 (s, 2H, Ar-CHz-O ) , 3.99 ( t, 2H, J = 6.4Hz, Ar-0-CH2 ), 1.83 - 1.76 (m, 2H, Ar-0-CH2-CH2-) , 1.4 9 - 1.2 8 ( m, 14H, Ar-〇 - C H2 - C H2 - C 7 H 1 4 - ) , 0.89 ( t, 3H, J = 6.4Hz, -CH2-CH3 【化58】P(0-tolyl)3 K3PO4 <Example 3 > Compound 2 (25_3 g, 0.0702 mol), Compound 4 (21.1 g, 0.08 37 mol), palladium chloride acetonitrile complex (0.572 g, 2.21 mmol) a suspension of ginseng (p-tolyl)phosphine (1.28 g, 4.2 1 mmol), tripotassium phosphate (22.7 g, 0.107 mol), and dimethylacetamide 1 70 g at room temperature with a septum After the pressure was reduced to 50 T rr, the pressure was reversed 10 times with nitrogen to remove the oxygen contained in the reactor and dimethyl acetamide. Thereafter, the temperature was raised, and the mixture was stirred at 110 ° C for 3 hours in a nitrogen atmosphere. After completion of the reaction, the solvent was distilled off, and the mixture was extracted with 200 g of water and 25 g of chloroform -88-s 201219450. The aqueous layer which had been separated was further extracted twice with 250 g of chloroform, and the obtained organic layer was dried over anhydrous magnesium sulfate. Magnesium sulfate was obtained by filtration, and the obtained organic layer was evaporated under reduced pressure, and the obtained crude product was washed with acetonitrile (1 70 g). Thereafter, the crystals were filtered, and the obtained solid fraction was dried under reduced pressure to give Compound 5 (yield: 32.5 g, 〇 〇671 mol, yield: 95.6%). The structure of Compound 5 was confirmed by 1H-NMR analysis. ^-NMR (CDC13): δ 9.01 (t, 1H, Ar-H), 8.61 (d, 2H, J = 1.6 Hz, Ar-H), 7.74 (d, 1H, J = 16.0 Hz, -CH = CH -Ar ), 7.49 ( d, 2H, J = 7.6Hz, Ar-H) , 6.91 ( d, 2H, J = 7.6Hz, Ar-H) , 6.39 ( d, 1H, J=16.0Hz, -CH = CH-Ar) , 5.42 (s, 2H, Ar-CHz-O ) , 3.99 ( t, 2H, J = 6.4Hz, Ar-0-CH2 ), 1.83 - 1.76 (m, 2H, Ar-0-CH2- CH2-) , 1.4 9 - 1.2 8 ( m, 14H, Ar-〇- C H2 - C H2 - C 7 H 1 4 - ) , 0.89 ( t, 3H, J = 6.4Hz, -CH2-CH3 】
<實施例4 > 將以純水90.0g溶解氯化銨(9.9g、0.185mol)之溶液 加溫攪拌至5 5 °C 。到達5 5 °C後,置入鐵粉(5 1. 1 g、 -89- 201219450 0.915mol ),更使昇溫至80°C。到達80°C後,將已溶解於 加溫至80°C之145g之甲苯之化合物5 ( 29.0g、0_0599mol) 予以滴下。滴下結束後,更攪拌2小時’反應結束後’在 8(TC之加溫條件下進行熱過濾,將所得到的反應液予以分 液,將水層除去。將活性碳1.2g置入於所得到的有機層中 ,在80 °C加溫條件下攪拌30分鐘。之後,在80 °C之加溫條 件下進行熱過濾,將所得到的有機層使用已事先加溫至8〇 °C之純水予以洗淨2次。將所得到的有機層以無水硫酸鎂 予以乾燥後,過濾除去硫酸鎂,將所得到的有機層在減壓 下、將溶媒餾去,而得到化合物6 (得到量18.7g、 0.0440mol )得到率73.5%)。化合物6之構造,以1Η ·Ν MR 分析進行確認。 *H-NMR ( CDC13 ) : δ 7.67 ( d, 1H, J=16.0 Ηζ,- CH = CH-Ar) , 7.45 ( d, 2Η, J = 8.4Hz, Ar-H ) , 6.88 ( d, 2H, J = 8.4Hz, Ar-H) , 6.34 (d, 1H, J=16.0Hz, -CH = CH-Ar), 6.15 ( d, 2H, J=1.6Hz} Ar-H) , 5.98 ( t, 1H, J=1.6Hz, Ar-H) , 5.05 ( s, 2H, Ar-CH2-〇) , 3.97 ( t, 2H, J = 6.4Hz, Ar-0-CH2 ) , 3.62 ( b, 4H, NH2 ) , 1.82- 1.76 ( m, 2H, Ar-O-CH2-CH2- ) , 1.46- 1.27 ( m, 14H, Ar- 0- CH2- CH2-C7H , 4-), 0.88 ( t, 3H, J = 7.2Hz, -CH2-CH3 )。 【化59】<Example 4> A solution of ammonium chloride (9.9 g, 0.185 mol) dissolved in 90.0 g of pure water was stirred and stirred to 5 5 °C. After reaching 5 5 °C, iron powder (5 1. 1 g, -89-201219450 0.915 mol) was placed, and the temperature was raised to 80 °C. After reaching 80 ° C, Compound 5 (29.0 g, 0_0599 mol) which had been dissolved in 145 g of toluene heated to 80 ° C was dropped. After the completion of the dropwise addition, the mixture was further stirred for 2 hours. After the completion of the reaction, hot filtration was carried out under the conditions of 8 (TC), and the obtained reaction liquid was separated to remove the aqueous layer. 1.2 g of activated carbon was placed therein. The obtained organic layer was stirred at 80 ° C for 30 minutes under heating, and then subjected to hot filtration under heating at 80 ° C, and the obtained organic layer was heated to 8 ° C in advance. The obtained organic layer was washed twice with anhydrous magnesium sulfate, and then magnesium sulfate was removed by filtration, and the obtained organic layer was evaporated under reduced pressure to give compound 6 (yield 18.7 g, 0.0440 mol) yield was 73.5%). The structure of Compound 6 was confirmed by 1 Η·Ν MR analysis. *H-NMR (CDC13): δ 7.67 (d, 1H, J = 16.0 Ηζ, - CH = CH-Ar), 7.45 (d, 2 Η, J = 8.4 Hz, Ar-H), 6.88 (d, 2H, J = 8.4Hz, Ar-H), 6.34 (d, 1H, J=16.0Hz, -CH = CH-Ar), 6.15 ( d, 2H, J=1.6Hz} Ar-H) , 5.98 ( t, 1H , J=1.6Hz, Ar-H) , 5.05 ( s, 2H, Ar-CH2-〇) , 3.97 ( t, 2H, J = 6.4Hz, Ar-0-CH2 ) , 3.62 ( b, 4H, NH2 ) , 1.82- 1.76 ( m, 2H, Ar-O-CH2-CH2- ) , 1.46- 1.27 ( m, 14H, Ar- 0- CH2-CH2-C7H , 4-), 0.88 ( t, 3H, J = 7.2 Hz, -CH2-CH3). 【化59】
-90- s 201219450 花費1小時將硼烷二甲基硫化物錯合物(57.0g、 750mmol)之四氫呋喃(281g)滴下至2、4-二硝基苯基醋 酸(56.6g、250mmol)之四氫呋喃( 452g)溶液中,以22 小時室溫進行攪拌。之後,將水(1 1 2 g )以0 °C花費2小時 予以滴下,於室溫攪拌2小時後,以醋酸乙酯與水進行萃 取,將水層分離,並以硫酸鎂將有機層乾燥。將硫酸鎂藉 由過濾除去,濃縮所得到的有機層,將所得到的粗生成物 由醋酸乙酯與己烷進行再結晶,而得到2,4 -二硝基苯基乙 基醇 1 ( 42.1g、79%收率)。 »H-NMR ( CDC13 ) : δ 8.79 ( d, 1H, J = 2.4 Hz, Ar-H ),8.40 ( dd, 1H,J = 8.4, 2.4Hz, Ar-H ) , 7.70 (d, 1H, J = 8.4Hz, Ar-H) , 4.01 ( dt, 2H, J = 5.2, 6.0 Hz, CH2-OH), 3.29 ( t, 2H, J = 6.0 Hz, Ar-CH2) , 1.63 ( t, 1H, J = 5.2Hz,-OH )。 【化60】-90- s 201219450 Tetrahydrofuran (281 g) of borane dimethyl sulfide complex (57.0 g, 750 mmol) was added dropwise to 2, 4-dinitrophenylacetic acid (56.6 g, 250 mmol) in tetrahydrofuran over 1 hour. (452 g) The solution was stirred at room temperature for 22 hours. Thereafter, water (1 1 2 g ) was added dropwise at 0 ° C for 2 hours, and stirred at room temperature for 2 hours, and then extracted with ethyl acetate and water, the aqueous layer was separated, and the organic layer was dried over magnesium sulfate. . The magnesium sulfate was removed by filtration, and the obtained organic layer was concentrated, and the obtained crude product was recrystallized from ethyl acetate and hexane to obtain 2,4-dinitrophenylethyl alcohol 1 (42.1 g, 79% yield). »H-NMR ( CDC13 ) : δ 8.79 ( d, 1H, J = 2.4 Hz, Ar-H ), 8.40 ( dd, 1H, J = 8.4, 2.4 Hz, Ar-H ) , 7.70 (d, 1H, J = 8.4Hz, Ar-H) , 4.01 ( dt, 2H, J = 5.2, 6.0 Hz, CH2-OH), 3.29 ( t, 2H, J = 6.0 Hz, Ar-CH2) , 1.63 ( t, 1H, J = 5.2 Hz, -OH). 【化60】
OH (W, K2C03> jj^^〇、C4H9 1 2 將二甲基甲醯胺(90.1g )加入於碘丁烷(30.0g、 1 63mmol ) 、4 -碘;酸(3 9.4 g ' 1 7 9mmol )、及碳酸紳( 27.0g、196mmol)中,以85°C攪拌2小時,之後,藉由過 濾將碳酸鉀除去。接著,藉由甲苯與1當量之氫氧化鈉水 溶液進行萃取。將水層分離,並藉由硫酸鎂將所得到的有 機層乾燥,藉由過濾將硫酸鎂除去後,濃縮有機層,得到 -91 - 201219450 醚化合物2(36_2g、81%收率)。 'H-NMR ( CDC13 ) : <5 7.5 3 (OH (W, K2C03> jj^^, C4H9 1 2 dimethylformamide (90.1 g) was added to iodine butane (30.0 g, 1 63 mmol), 4-iodide; acid (3 9.4 g '1 7 9 mmol) and cesium carbonate (27.0 g, 196 mmol) were stirred at 85 ° C for 2 hours, after which potassium carbonate was removed by filtration, followed by extraction with toluene and 1 equivalent of aqueous sodium hydroxide. The layers were separated, and the obtained organic layer was dried over magnesium sulfate, and then filtered, and then evaporated to ethyl sulfate, and the organic layer was concentrated to afford -91 - 201219450 ether compound 2 (36-2 g, 81% yield). ( CDC13 ) : <5 7.5 3 (
2h, J = 8.8 Hz, Ar-H ),6.66 ( d,2H,J = 8.8 Hz,Ar-jj) 5 3.90 ( t, 2H, J = 6.62h, J = 8.8 Hz, Ar-H ), 6.66 ( d, 2H, J = 8.8 Hz, Ar-jj) 5 3.90 ( t, 2H, J = 6.6
Hz, 0-CH2),1.76 ( m,2H, O-CH 2、CH2,),1.47 ( m,2H, CH2-CH3 ) , 0.96 ( t, 3H, J =7.6 Uy, …CH3)。 【化61】Hz, 0-CH2), 1.76 (m, 2H, O-CH 2, CH2,), 1.47 (m, 2H, CH2-CH3), 0.96 (t, 3H, J = 7.6 Uy, ... CH3). 【化61】
CH2=CHC02H, Bu3N, jjj^j^〇、C4H9 Pd(〇Ac)2, (o-tol)3P ^ 2 將二甲基乙醯胺(362g)加入於 w八於醚化合物2 ( 36.2g、 1 3 1 mmol )、丙嫌酸(1 3.0g、! δ Λ 6 l8〇mm〇l )、醋酸鈀( 0.269g、l_20mmol )、參(〇-甲苯基)膦(〇 73〇g、 2.40mmol)、及三 丁基胺(67.9g、3 66_〇丨)中,以 14〇 °C攪拌2小時。之後,以醋酸乙酯與水進行萃取,將水層 分離’將有機層以硫酸鎂乾燥。藉由過濾將硫酸鎂除去, 濃縮所得到的有機層’以醋酸乙酯與己烷將所得到的粗生 成物進行再結晶’得到桂皮酸衍生物3 (21.1g、73%收率 )° •H-NMR ( DMSO ) : δ 12.2 ( s,1Η,C02H),7.62 ( d,2H,J = 8.8 Hz,Ar-H),7.54( d,1H,J=16.0 Hz,CO-CH = CH),6.95 ( d,2H,J = 8.8 Hz,Ar-H ),6.36 ( d,1H, J=16.0 Hz,CO-CH = CH),4.01 ( t’ 2H,j = 6.6 Hz, 0-CH2), 1_69 ( m,2H, 0-CH2-CH2 ),1.44 ( m,2H,CH2-CH3 ), 0.93( t,3H,J = 7.4 Hz,-CH3 )。 s -92- 201219450 【化62】CH2=CHC02H, Bu3N, jjj^j^〇, C4H9 Pd(〇Ac)2, (o-tol)3P^2 Dimethylglyoxime (362g) was added to w8 in ether compound 2 (36.2g, 1 3 1 mmol ), acrylic acid (1 3.0 g, ! δ Λ 6 l8〇mm〇l ), palladium acetate (0.269 g, l_20 mmol), ginseng (p-tolyl) phosphine (〇73〇g, 2.40mmol) And tributylamine (67.9 g, 3 66_〇丨), and stirred at 14 ° C for 2 hours. Thereafter, extraction was carried out with ethyl acetate and water to separate the aqueous layer. The organic layer was dried over magnesium sulfate. The magnesium sulfate was removed by filtration, and the obtained organic layer was concentrated to recrystallize the obtained crude product with ethyl acetate and hexane to obtain cinnamic acid derivative 3 (21.1 g, 73% yield). H-NMR ( DMSO ) : δ 12.2 ( s, 1 Η, C02H), 7.62 (d, 2H, J = 8.8 Hz, Ar-H), 7.54 (d, 1H, J = 16.0 Hz, CO-CH = CH) , 6.95 ( d, 2H, J = 8.8 Hz, Ar-H ), 6.36 ( d, 1H, J = 16.0 Hz, CO-CH = CH), 4.01 ( t' 2H, j = 6.6 Hz, 0-CH2) , 1_69 (m, 2H, 0-CH2-CH2), 1.44 (m, 2H, CH2-CH3), 0.93 (t, 3H, J = 7.4 Hz, -CH3). s -92- 201219450 【化62】
jOC"。' OaN^^N02 HOjCjOC". ' OaN^^N02 HOjC
My、·My,·
EDC, C4H9 £MAP 、c4h9 將桂皮氧化食· 苯基乙基醇1 ( 15.6 0.895 g ' 7.32mm〇l \ g 3 ( 1 6.2 g ' 7 3.5 mm ο 1 )、之 、73.5mmol)、及二甲基月安 培解於四氫呋喃(23 2g )中, 基丙基)碳二醯亞胺鹽酸 硝基 啦啶( 逝將1 - 乙基-3- ( 3-二甲基月安 、84.5_〇。以〇。。加入以 之後,藉 由醋酸乙酯與水進行萃取,將水層分離,將有機層藉由硫 酸鎂乾燥。藉由過濾將硫酸鎂除去,濃縮所得到的有機層 ,將所得到的粗生成物藉由管柱色譜法進行純化,而得到 二硝基化合物4 ( 19.9g、65%收率)。JH-NMR ( CDClj ) : δ 8.83 ( d, 1H, J = 2.4 Hz, Ar-H ),8.40 ( dd, 1H, J = 8.8, 2.4 Hz, Ar-H ) , 7.66 ( d, 1H, J = 8.8 Hz,Ar-H),7-60 ( d,1H,J=16.0 Hz,CO-CH = CH) ’7.46 ( d,2H,J = 8.4 Hz,Ar-H),6.89 ( d,2H,J = 8.4 Hz,Ar- H ),6.21 ( d, 1H,J=16.0 Hz, CO-CH = CH ) 4.53 ( “ 2H, J = 6.4 Hz,CH2-〇C〇),4.00 ( t,2H,J = 6.6 Hz,C6H4-〇-CH2),3 · 4 5 ( m,2 H,J = 6.4 H z,A r - C H 2 ),1 · 7 8 ( m,2 H,〇 _ 鞠 6.2g CH2-CH2 ) , 1.52 ( m, 2H, CH2-CH3 ) , 0.98 3H, 7.4 Hz, -CH3 ) -93- 201219450EDC, C4H9 £MAP, c4h9 Oxidizing food of cassia, phenylethyl alcohol 1 ( 15.6 0.895 g ' 7.32mm〇l \ g 3 (1 6.2 g ' 7 3.5 mm ο 1 ), 73.5 mmol), and Methyl valerin was hydrolyzed in tetrahydrofuran (23 2g), propyl carbodiimide nitropyridine hydrochloride (1 - ethyl-3-(3-dimethylhydanol, 84.5 〇). After the addition, the aqueous layer was separated by ethyl acetate and water, and the organic layer was dried over magnesium sulfate. The magnesium sulfate was removed by filtration, and the obtained organic layer was concentrated. The crude product was purified by column chromatography to give dinitro compound 4 (19.9 g, 65% yield). JH-NMR (CDClj): δ 8.83 (d, 1H, J = 2.4 Hz, Ar -H ), 8.40 ( dd, 1H, J = 8.8, 2.4 Hz, Ar-H ) , 7.66 ( d, 1H, J = 8.8 Hz, Ar-H), 7-60 ( d,1H, J=16.0 Hz ,CO-CH = CH) '7.46 ( d,2H,J = 8.4 Hz, Ar-H), 6.89 ( d,2H, J = 8.4 Hz, Ar- H ), 6.21 ( d, 1H, J=16.0 Hz , CO-CH = CH ) 4.53 (“ 2H, J = 6.4 Hz, CH2-〇C〇), 4.00 ( t, 2H, J = 6.6 Hz, C6H4-〇-CH2), 3 · 4 5 ( m,2 H,J = 6.4 H z,A r - CH 2 ),1 · 7 8 ( m,2 H,〇_ 鞠6.2g CH2-CH2 ) , 1.52 ( m, 2H, CH2- CH3) , 0.98 3H, 7.4 Hz, -CH3 ) -93- 201219450
將二硝基化合物4 ( 19.9g、48.0mmol )、還原鐵( 32.2g、583mmol)、及氯化銨(15.4g、288mmol)溶解於 醋酸乙酯(200g)與水(77.1g)中,以70°C攪拌14小時 。之後,以70。(:原樣使用矽鈣石進行過濾,藉由硫酸鎂將 所得到的濾液乾燥。藉由過濾將硫酸鎂除去,濃縮所得到 的有機層,得到粗生成物。將所得到的粗生成物溶解於四 氫呋喃(200g )中,加入活性碳(2.00g ),以室溫攪拌 1 8小時。藉由過濾將活性碳除去,濃縮有機層而得到目的 物之二胺化合物5(15.5g、91%收率)。 JH-NMR ( CDC13 ) : δ 7.65 ( d, 1H, J=16.0 Hz, CO-CH = CH ),7.4 1 ( d,2H,J = 8.4 Hz, Ar-H,),6.89 ( d, 2H,J = 8.4 Hz,Ar-H ),6.85 ( d,1H,J = 8 · 0 Hz,Ar-H ), 6.30 ( d, 1H, J=16.0 Hz, CO-CH = CH) , 6.10 ( dd, 1H, J = 8.0, 2.4 Hz, Ar-H) , 6.07 ( d, 1H, J = 2.4 Hz Ar-H), 4.30 ( t,2H,J = 7.6 Hz,CH2-OCO),4.00 ( t,2H,J = 6.4 Hz,C6H4-0-CH2),3.88 ( br-s,2H,NH2),3.56 ( br-s, 2H,NH2) , 2.81 ( m,2H,J = 7.6 Hz,Ar-CH2),1.78 ( m, 2H,0-CH2-CH2 ),1.49 ( m,2H,CH2-CH3 ),0.98 ( t, 3H, J = 7.2 Hz, -CH3 )。 〔聚醯胺酸之合成〕 -94- s 201219450 以下爲表示在聚醯胺酸之合成時所使用的四羧酸二酐 及二胺化合物等之簡寫。 (四羧酸二酐) PMDA :焦蜜石酸二酐 CBDA: 1,2,3,4-環丁烷四羧酸二酐 (二胺化合物) p-PDA : P-苯二胺 DA1:3,5-二胺基苄基 3-(4-(4-癸氧基)苯基)丙 烯酸酯 【化64】Dinitro compound 4 (19.9 g, 48.0 mmol), reduced iron (32.2 g, 583 mmol), and ammonium chloride (15.4 g, 288 mmol) were dissolved in ethyl acetate (200 g) and water (77.1 g) to Stir at 70 ° C for 14 hours. After that, take 70. (: As it is, it is filtered using the sulphite, and the obtained filtrate is dried by magnesium sulfate. The magnesium sulfate is removed by filtration, and the obtained organic layer is concentrated to obtain a crude product. The obtained crude product is dissolved. To the tetrahydrofuran (200 g), activated carbon (2.00 g) was added, and the mixture was stirred at room temperature for 18 hours. The activated carbon was removed by filtration, and the organic layer was concentrated to give the desired compound diamine compound 5 (15.5 g, 91% yield). JH-NMR (CDC13): δ 7.65 (d, 1H, J = 16.0 Hz, CO-CH = CH), 7.4 1 (d, 2H, J = 8.4 Hz, Ar-H,), 6.89 (d, 2H, J = 8.4 Hz, Ar-H), 6.85 (d, 1H, J = 8 · 0 Hz, Ar-H), 6.30 (d, 1H, J = 16.0 Hz, CO-CH = CH), 6.10 ( Dd, 1H, J = 8.0, 2.4 Hz, Ar-H), 6.07 (d, 1H, J = 2.4 Hz Ar-H), 4.30 ( t, 2H, J = 7.6 Hz, CH2-OCO), 4.00 (t , 2H, J = 6.4 Hz, C6H4-0-CH2), 3.88 (br-s, 2H, NH2), 3.56 (br-s, 2H, NH2), 2.81 ( m, 2H, J = 7.6 Hz, Ar- CH2), 1.78 (m, 2H, 0-CH2-CH2), 1.49 (m, 2H, CH2-CH3), 0.98 (t, 3H, J = 7.2 Hz, -CH3). [Synthesis of polyglycine] -9 4- s 201219450 The following is a shorthand for the tetracarboxylic dianhydride and the diamine compound used in the synthesis of polylysine. (tetracarboxylic dianhydride) PMDA: pyromellitic dianhydride CBDA: 1, 2,3,4-cyclobutanetetracarboxylic dianhydride (diamine compound) p-PDA : P-phenylenediamine DA1: 3,5-diaminobenzyl 3-(4-(4-decyloxy) )phenyl)acrylate [64]
(有機溶媒) NMP: N -甲基-2-吡咯啶酮 BC : 丁基賽璐蘇 <聚醯亞胺之分子量測定> 聚醯亞胺之分子量,爲使用SSC公司製常溫凝膠浸透 色譜法(GPC)裝置(SSC-7200)、及Shodex公司製管柱 -95- 201219450 (KD-803、KD-805 ),如以下般地進行測定。(Organic solvent) NMP: N-methyl-2-pyrrolidone BC : butyl cyanidin < molecular weight determination of polyimine] The molecular weight of polyimine is saturated with a room temperature gel made by SSC A chromatography (GPC) apparatus (SSC-7200) and a column made by Shodex Co., Ltd.-95-201219450 (KD-803, KD-805) were measured as follows.
管柱溫度:5 0 °C 溶離液:N,N’-二甲基甲醯胺(作爲添加劑,溴化鋰· 水合物(LiBr · H20 )爲30mmol/L、磷酸·無水結晶(〇-磷酸)爲30mmol/L、四氫呋喃(THF )爲10ml/L )。 流速:1 .Oml/分 檢量線製作用標準樣品:tosoh公司製TSK標準聚氧化 乙烯(分子量約 900,000、 150,000、 100,000、 30,000)、 及Polymer Laboratories公司製 聚乙二醇(分子量 約 1 2,000、4,000 ' 1,000 ) 〇 <實施例5 > 將 DAI ( 0.637g、1 .50mmol )、及 p-PDA ( 0.162g、 1.50mmol)在NMP(8.13g)中予以混合,並於室溫攪拌1 小時使溶解後,加入PMDA ( 0.63 5g、2.91mmol ),於室 溫下使反應1 2小時,得到聚醯胺酸溶液。將NMP ( 9.5 6 g ) 、及BC(4.78g)加入於此聚醯胺酸溶液(9.56g)中,藉 由5小時攪拌得到6質量%之液晶配向處理劑(A )。 此聚醯胺酸之數平均分子量爲7,000,重量平均分子 量爲 1 7,000。 <實施例6 > 將 DAI ( 〇.743g、l.75mmol)、及 p-PDA ( 0.081g、 0.75mmol)在NMP(7.67g)中予以混合,並於室溫攪拌1 -96-Column temperature: 50 °C Dissolution: N,N'-dimethylformamide (as an additive, lithium bromide hydrate (LiBr · H20) is 30 mmol / L, phosphoric acid · anhydrous crystals (〇-phosphoric acid) 30 mmol/L and tetrahydrofuran (THF) were 10 ml/L. Flow rate: 1.0 ml of the standard sample for the production of the calibrated wire: TSK standard polyethylene oxide (molecular weight of about 900,000, 150,000, 100,000, 30,000) manufactured by Tosoh Corporation, and polyethylene glycol manufactured by Polymer Laboratories (molecular weight of about 12,000, 4,000 '1,000 ) 〇 <Example 5 > DAI (0.637 g, 1.50 mmol), and p-PDA (0.162 g, 1.50 mmol) were mixed in NMP (8.13 g) and stirred at room temperature 1 After dissolving in an hour, PMDA (0.63 5 g, 2.91 mmol) was added, and the reaction was allowed to proceed at room temperature for 12 hours to obtain a polyaminic acid solution. NMP (9.56 g) and BC (4.78 g) were added to the polyamic acid solution (9.56 g), and 6 mass% of the liquid crystal alignment treatment agent (A) was obtained by stirring for 5 hours. The polyamine has a number average molecular weight of 7,000 and a weight average molecular weight of 17,000. <Example 6 > DAI (〇.743g, 1.75mmol), and p-PDA (0.081g, 0.75mmol) were mixed in NMP (7.67g), and stirred at room temperature 1-96-
S 201219450 小時使溶解後,加入PMDA( 0.529g、2.43mmol),於室 溫下使反應12小時,得到聚醯胺酸溶液。將NMP ( 9.02g ) 、及BC(4_51g)加入於此聚醯胺酸溶液(9_02g)中,藉 由5小時攪拌得到6質量%之液晶配向處理劑(B )。 此聚醯胺酸之數平均分子量爲6,5 00,重量平均分子 量爲 1 6,000。 <實施例7 > 將 DAI ( 〇.849g' 2.0mmol)在 NMP ( 7.21g)中予以 混合’並於室溫攪拌1小時使溶解後,加入PMDA ( 0.424g ' 1.94mmol),於室溫下使反應1 2小時,得到聚醯胺酸溶 液。將NMP ( 8.48g )、及BC ( 4.24g )加入於此聚醯胺酸 溶液(8.48g )中,藉由5小時攪拌得到6質量%之液晶配 向處理劑(C )。 此聚醯胺酸之數平均分子量爲6,000,重量平均分子 量爲16,000 。 <實施例8 > 將 DA1 ( 0.5 0 9 g ' 1.2 0 mm ο 1 )、及 p-PDA ( 0.194g、 1.80mmol )在NMP ( 7.22g )中予以混合,並於室溫攪拌1 小時使溶解後加入CBDA(0.571g、2.91mmol),於室溫 下使反應1 2小時,得到聚醯胺酸溶液。將n Μ P ( 9.0 2 g )、 及BC(4.51g)加入於此聚醯胺酸溶液(9.02g)中,藉由 5小時攪拌得到6質量%之液晶配向處理劑(D )。 -97- 201219450 此聚醯胺酸之數平均分子量爲8000,重量平均分子量 爲 2 1 000。 <實施例9 > 將 DA1 ( 0.6 3 7 g ' 1. 5 Ommo 1 )、及 p-PD A ( 0.1 63g、 1.5 0mmol )在NMP (7.76g)中予以混合,並於室溫攪拌1 小時使溶解後,加入CBDA ( 0.571g、2.91mmol ),於室 溫下使反應12小時,得到聚醯胺酸溶液。將NMP ( 9.1 3g ) 、及BC(4.57g)加入於此聚醯胺酸溶液(9.13g)中,藉 由5小時攪拌得到6質量%之液晶配向處理劑(E ) ^ 此聚醯胺酸之數平均分子量爲7000,重量平均分子量 爲 19000 。 <實施例1 〇 > 使用以實施例5所得到的液晶配向處理劑(A ),以如 下述所示般之程序來進行液晶晶胞之製作。 〔液晶晶胞之製作〕 將實施例5所得到的液晶配向處理劑(A)旋轉塗佈於 由ITO膜所成附著有透明電極之玻璃基板的ITO面上,以80 °C的加熱板乾燥90秒鐘後,以200 °C之熱風循環式烘烤箱 進行30分鐘锻燒,形成膜厚lOOnm之液晶配向膜。 對於此基板,以照射強度8.〇mW/cm2之313nm直線偏 光UV,照射lOOmJ。入射光線之方向,相對於基板法線方 -98-After S 201219450 was dissolved, PMDA (0.529 g, 2.43 mmol) was added, and the reaction was allowed to stand at room temperature for 12 hours to obtain a polyaminic acid solution. NMP (9.22 g) and BC (4_51 g) were added to the polyamic acid solution (9_02 g), and 6 mass% of the liquid crystal alignment treatment agent (B) was obtained by stirring for 5 hours. The polyamine has a number average molecular weight of 6,500 and a weight average molecular weight of 16,000. <Example 7 > DAI (〇.849g' 2.0 mmol) was mixed in NMP (7.11 g) and stirred at room temperature for 1 hour to dissolve, then PMDA (0.424 g ' 1.94 mmol) was added to the chamber. The reaction was allowed to proceed for 12 hours at room temperature to obtain a polyaminic acid solution. NMP (8.58 g) and BC (4.24 g) were added to the polyamic acid solution (8.48 g), and 6 mass% of the liquid crystal alignment treatment agent (C) was obtained by stirring for 5 hours. The polyamine has a number average molecular weight of 6,000 and a weight average molecular weight of 16,000. <Example 8 > DA1 (0.509 g '1.20 mm ο 1 ), and p-PDA (0.194 g, 1.80 mmol) were mixed in NMP (7.22 g), and stirred at room temperature for 1 hour. After dissolving, CBDA (0.571 g, 2.91 mmol) was added, and the reaction was allowed to proceed for 12 hours at room temperature to obtain a polyaminic acid solution. N Μ P (9.0 2 g ) and BC (4.51 g) were added to the polyamic acid solution (9.02 g), and a 6 mass% liquid crystal alignment treatment agent (D) was obtained by stirring for 5 hours. -97- 201219450 The polyamino acid has a number average molecular weight of 8,000 and a weight average molecular weight of 21,000. <Example 9 > DA1 (0.6 3 7 g ' 1. 5 Ommo 1 ), and p-PD A (0.163 g, 1.5 0 mmol) were mixed in NMP (7.76 g), and stirred at room temperature 1 After dissolving for an hour, CBDA (0.571 g, 2.91 mmol) was added, and the reaction was allowed to proceed at room temperature for 12 hours to obtain a polyaminic acid solution. NMP (9.1 3g) and BC (4.57g) were added to the polyamic acid solution (9.13g), and 6 mass% of the liquid crystal alignment treatment agent (E) was obtained by stirring for 5 hours. The average molecular weight was 7,000 and the weight average molecular weight was 19,000. <Example 1> Using the liquid crystal alignment treatment agent (A) obtained in Example 5, a liquid crystal cell was produced by a procedure as shown below. [Production of liquid crystal cell] The liquid crystal alignment agent (A) obtained in Example 5 was spin-coated on the ITO surface of a glass substrate to which a transparent electrode was adhered by an ITO film, and dried by a hot plate at 80 °C. After 90 seconds, the film was calcined in a hot air circulating oven at 200 ° C for 30 minutes to form a liquid crystal alignment film having a film thickness of 100 nm. For this substrate, a linear polarized UV of 313 nm having an irradiation intensity of 8. 〇mW/cm 2 was irradiated with 100 mJ. The direction of the incident light, relative to the substrate normal -98-
S 201219450 向爲傾斜40β。直線偏光UV爲將高壓水銀燈之紫外光通過 313nm之帶通瀘波器後,藉由通過313nm之偏光板所調製 〇 準備上述基板2片,並於另一方基板之液晶配向膜上 散布6 // m之玻珠間隔物後,由其上方印刷封口劑。接著, 使2片基板之液晶配向面相對,使對於各基板之直線偏光 UV之光軸投影方向以成爲逆平行般地進行壓著,以150 °C 、花費105分鐘使封口劑熱硬化。藉由減壓注入法將負型 液晶(Merck公司製、MLC-6608 )注入於此空晶胞中,製 作液晶晶胞。 使用上述方法,將所照射的偏光UV之曝光量,由OmJ 〜1 000mJ予以變化,製造同樣的液晶晶胞。 〔液晶晶胞之評價〕 對於液晶晶胞,藉由偏光顯微鏡觀察在25t外加·解 除8 V電壓時之異常區域之有無,將無異常區域之情況評價 爲「液晶配向性良好」。以上述所製造的液晶晶胞,在無 外加電壓之狀態展現出良好的垂直配向性,在外加電壓時 液晶配向性亦爲良好。 〔預傾角之評價〕 液晶晶胞之預傾角之測定,爲使用Axo Metrix公司 製「AxoScan」,藉由穆勒矩陣(Mueller matrix)法進行 測定。 -99- 201219450 <實施例1 1〉 除了將液晶配向處理劑(A)變更爲液晶配向處理劑 (B)以外,與實施例1 0同樣地製作液晶晶胞,並進行液 晶之配向性、及預傾角之測定。 〈實施例1 2 > 除了將液晶配向處理劑(A )變更爲液晶配向處理劑 (C )以外,與實施例1 0同樣地製作液晶晶胞,並進行液 晶之配向性、及預傾角之測定。 <實施例1 3 > 除了將液晶配向處理劑(A )變更爲液晶配向處理劑 (D )以外,與實施例1 0同樣地製作液晶晶胞,並進行液 晶之配向性、及預傾角之測定。 〈實施例1 4 > 除了將液晶配向處理劑(A )變更爲液晶配向處理劑 (E )以外’與實施例1 0同樣地製作液晶晶胞,並進行液 晶之配向性、及預傾角之測定。 在上述液晶配向處理劑(A)〜(E)之製造所使用的 酸二酐及二胺化合物之各組成比率,如表1所示。表1中, ()內之% ’示爲全酸二酐成分中或全二胺成分中該酸 二酐或二胺化合物之含有比例(莫耳。 -100- 201219450 又,以各實施例所製造的液晶晶胞之預傾角,如表2 所示。 [表1] 實施例 液晶配向處理劑 酸二酐 (莫耳%) 二胺化合物 (莫耳%) PMDA CBDA DA1 p-PDA 10 A 97 一 50 50 11 B 97 — 70 30 12 C 97 一 100 — 13 D 一 97 40 60 14 E — 97 50 50 -101 - 201219450 [表2] 實施例 液晶配向處理劑 uv照射量 ’液晶配向性 預傾角 電壓無外 加(印加) 電壓外加 (印加)時 10 A Om J 良好 不良 9 0° 1 0 Om J 良好 良好 8 8. 8° 3 0 Om J 良好 良好 8 8. 7° 5 0 0 m J 良好 良好 8 8. 8° 1 0 0 OmJ 良好 8 8. 8° 11 B Om J 良好 不良 9 0° 1 0 Om J 良好 良好 8 9. 0° 3 0 0 m J 良好 良好 8 9. 0° 5 0 0 m J m- 良好 8 9. 0° 1 0 0 OmJ 良好 良好 8 9. 1° 12 C Om J m 不良 9 0° 1 0 Om J 良好 良好 8 9. 2° 3 0 0 m J 良好 8 9. 1° 5 0 0 m J 良好 良好 8 9. 2° 1 0 0 OmJ 良好 良好 8 9. 2° 13 D Om J m- 不良 9 0° 1 0 Om J m- 良好 8 8. 6° 3 0 Om J 胁 良好 8 8. 7° 5 0 Om J 餅 良好 8 8. 5° 10 0 OmJ m- 良好 8 8. 9° 14 E 0 m J 良好 不良 9 0° 1 0 Om J 良好 良好 8 8. 9° 3 0 Om J 良好 良好 8 8. 8° 5 0 Om J 良好 良好 8 8. 6° 10 0 OmJ 良好 良好 88. 8° 由表2之結果,確認到使用本發明之新穎二胺化合物 所得到的液晶顯示元件,展現出良好的垂直配向性,又, 藉由照射偏光之紫外線,即使是1 00m J之所謂的少量照射 量,可確認到使液晶配向展現出大的預傾角。更,使用本 發明之新穎二胺化合物之液晶配向膜,確認到不論任何紫 外線之照射量,預傾角亦能保持一定。因此表示,即使是 長時間被曝露於背光等之光後’亦能將預傾角保持於安定 201219450 因此等之內容,本發明之新穎二胺化合物,可使用於 垂直配向方式之液晶顯示元件用液晶配向膜,在藉由紫外 線照射而賦予液晶配向能之光配向法中,亦能宜以使用。 <比較例1 > C 化 65]S 201219450 is inclined 40β. The linear polarized UV is obtained by passing the ultraviolet light of the high pressure mercury lamp through a 313 nm band pass chopper, and preparing the above substrate by modulating the 313 nm polarizing plate, and spreading the film on the liquid crystal alignment film of the other substrate. After the glass bead spacer of m, the sealing agent is printed from above. Then, the liquid crystal alignment surfaces of the two substrates were opposed to each other, and the optical axis projection directions of the linearly polarized UVs for the respective substrates were pressed in antiparallel, and the sealing agent was thermally cured at 150 ° C for 105 minutes. A negative liquid crystal (manufactured by Merck, MLC-6608) was injected into the empty cell by a vacuum injection method to prepare a liquid crystal cell. Using the above method, the exposure amount of the irradiated polarized light UV was changed from OmJ to 1 000 mJ to produce the same liquid crystal cell. [Evaluation of liquid crystal cell] In the liquid crystal cell, the presence or absence of an abnormal region when a voltage of 8 V was applied and removed at 25 t was observed by a polarizing microscope, and the case of no abnormal region was evaluated as "good liquid crystal alignment". The liquid crystal cell produced as described above exhibited good vertical alignment in the absence of an applied voltage, and the liquid crystal alignment was also good when a voltage was applied. [Evaluation of Pretilt Angle] The pretilt angle of the liquid crystal cell was measured by the "AxoScan" manufactured by Axo Metrix Co., Ltd., by a Mueller matrix method. -99-201219450 <Example 1 1> A liquid crystal cell was produced in the same manner as in Example 10 except that the liquid crystal alignment agent (A) was changed to the liquid crystal alignment agent (B), and the alignment of the liquid crystal was performed. And determination of the pretilt angle. <Example 1 2> A liquid crystal cell was produced in the same manner as in Example 10 except that the liquid crystal alignment agent (A) was changed to the liquid crystal alignment agent (C), and the alignment property of the liquid crystal and the pretilt angle were performed. Determination. <Example 1 3> A liquid crystal cell was produced in the same manner as in Example 10 except that the liquid crystal alignment agent (A) was changed to the liquid crystal alignment agent (D), and the alignment property and pretilt angle of the liquid crystal were performed. Determination. <Example 1 4> A liquid crystal cell was produced in the same manner as in Example 10 except that the liquid crystal alignment agent (A) was changed to the liquid crystal alignment agent (E), and the alignment property of the liquid crystal and the pretilt angle were performed. Determination. The composition ratios of the acid dianhydride and the diamine compound used in the production of the liquid crystal alignment agents (A) to (E) are shown in Table 1. In Table 1, the % in () is shown as the content ratio of the acid dianhydride or the diamine compound in the peracid dianhydride component or the total diamine component (mole. -100-201219450, further, in each example The pretilt angle of the manufactured liquid crystal cell was as shown in Table 2. [Table 1] Example Liquid crystal alignment treatment agent Acid dianhydride (mol%) Diamine compound (mol%) PMDA CBDA DA1 p-PDA 10 A 97 A 50 50 11 B 97 — 70 30 12 C 97 a 100 — 13 D a 97 40 60 14 E — 97 50 50 -101 - 201219450 [Table 2] Example liquid crystal alignment treatment agent uv irradiation amount 'liquid crystal alignment pretilt angle Voltage is not applied (Inca) When voltage is applied (Inca) 10 A Om J Good bad 9 0° 1 0 Om J Good 8 8. 8° 3 0 Om J Good 8 8. 7° 5 0 0 m J Good and good 8 8. 8° 1 0 0 OmJ Good 8 8. 8° 11 B Om J Good bad 9 0° 1 0 Om J Good good 8 9. 0° 3 0 0 m J Good good 8 9. 0° 5 0 0 m J m- good 8 9. 0° 1 0 0 OmJ good and good 8 9. 1° 12 C Om J m bad 9 0° 1 0 Om J good good 8 9. 2° 3 0 0 m J good 8 9. 1° 5 0 0 m J Good good 8 9. 2° 1 0 0 OmJ Good good 8 9. 2° 13 D Om J m- Poor 9 0° 1 0 Om J m- Good 8 8. 6° 3 0 Om J Goodness 8 8. 7° 5 0 Om J Cake good 8 8. 5° 10 0 OmJ m- Good 8 8. 9° 14 E 0 m J Good bad 9 0° 1 0 Om J Good good 8 8. 9° 3 0 Om J Good Good 8 8. 8° 5 0 Om J Good and good 8 8. 6° 10 0 OmJ Good and good 88. 8° From the results of Table 2, it was confirmed that the liquid crystal display element obtained by using the novel diamine compound of the present invention exhibited A good vertical alignment property is obtained, and by irradiating the polarized ultraviolet rays, even a so-called small amount of irradiation of 100 m J can confirm that the liquid crystal alignment exhibits a large pretilt angle. Further, by using the liquid crystal alignment film of the novel diamine compound of the present invention, it was confirmed that the pretilt angle can be kept constant irrespective of the irradiation amount of any ultraviolet rays. Therefore, it is indicated that the pre-tilt angle can be maintained in the stability of 201219450 even after being exposed to light such as a backlight for a long period of time. Therefore, the novel diamine compound of the present invention can be used for liquid crystal display elements for vertical alignment. The alignment film can also be used in a photo-alignment method in which liquid crystal alignment energy is imparted by ultraviolet irradiation. <Comparative Example 1 >C; 65]
將 l.llg ( 2.70mmol)之 DA2、及 o.llg ( 〇.3〇mmol) 之DA3,在NMP(10.22g)中予以混合,並於室溫攪拌!小 時使溶解後’加入匚8〇八0.58§(2.94111111〇1),於室溫下使 反應12小時,得到聚醯胺酸溶液。將NMP ( 9.0g)及BC ( 9.0g )加入於此聚醯胺酸溶液(12.0g )中,藉由5小時攪 拌得到6質量%之液晶配向處理劑(F )。此聚醯胺酸之數 平均分子量爲12000,重量平均分子量爲29000。 在上述實施例10中,除了將液晶配向處理劑(A)變 更爲液晶配向處理劑(F )以外,與實施例1 0同樣地製作 液晶晶胞,並進行液晶之配向性、及預傾角之測定。 在上述液晶配向處理劑(F)之合成所使用的酸二酐 -103- 201219450 及二胺化合物之各組成比率,如表3所示。又,以比較例1 所製造的液晶晶胞之預傾角如表4所示。 [表3] 實施例 液晶配向 劑 酸二酐(莫耳%) 二胺(莫耳%) PMDA CBDA DA1 DA2 DA3 p-PDA 比較例1 F 99 90 10 [表4] 實施例 液晶配向劑 UV照射量 液晶酉 B向劑 預傾角 電壓無外加 (印加)時 電壓外加(印 加)時 比較娜 F OmJ 良好 不良 90° lOOmJ 良好 不良 90° 300mJ 良好 良好 89.7° 500mJ 良好 良好 89.3。 lOOOmJ 良好 良好 89.1。 【產業利用性】 具有由本發明之新穎二胺化合物所得到的液晶配向膜 之液晶顯示元件,即使是長時間被曝露於背光等之光中, 預傾角亦能保持安定,爲成爲信賴性優異者,可適當地使 用於大畫面'高精細之液晶電視等。 尙’本發明說明書所揭示內容方面,係引用20 10年7 月5日所提出專利申請之日本國特願2010-153075號之說明 書、專利申請範圍、及摘要之全部內容,並採用其者。 -104-Mix l.llg ( 2.70 mmol) of DA2 and o.llg (〇.3〇mmol) of DA3 in NMP (10.22g) and stir at room temperature! In the case of dissolution, the mixture was dissolved and added to 匚8〇8 0.58 § (2.94111111〇1), and the reaction was allowed to proceed for 12 hours at room temperature to obtain a polyaminic acid solution. NMP (9.0 g) and BC (9.0 g) were added to the polyamic acid solution (12.0 g), and a 6 mass% liquid crystal alignment treatment agent (F) was obtained by stirring for 5 hours. The polyamino acid had an average molecular weight of 12,000 and a weight average molecular weight of 29,000. In the above-described Example 10, a liquid crystal cell was produced in the same manner as in Example 10 except that the liquid crystal alignment agent (A) was changed to the liquid crystal alignment agent (F), and the alignment of the liquid crystal and the pretilt angle were performed. Determination. The composition ratios of the acid dianhydride -103 - 201219450 and the diamine compound used in the synthesis of the liquid crystal alignment agent (F) are shown in Table 3. Further, the pretilt angle of the liquid crystal cell produced in Comparative Example 1 is shown in Table 4. [Table 3] Example Liquid crystal alignment agent acid dianhydride (mol%) Diamine (mol%) PMDA CBDA DA1 DA2 DA3 p-PDA Comparative Example 1 F 99 90 10 [Table 4] Example Liquid crystal alignment agent UV irradiation The amount of liquid crystal 酉B to the pre-tilt voltage of the agent is not applied (increase) when the voltage is applied (imprinted), the comparison is F FJJ good bad 90° lOOmJ good bad 90° 300mJ good good 89.7° 500mJ good good 89.3. lOOOmJ Good Good 89.1. [Industrial Applicability] The liquid crystal display element having the liquid crystal alignment film obtained by the novel diamine compound of the present invention can maintain stability even when exposed to light such as a backlight for a long period of time, and is excellent in reliability. It can be suitably used for large-screen 'high-definition LCD TVs, etc. The entire disclosure of the specification, the scope of the patent application, and the abstract of Japanese Patent Application No. 2010-153075, filed on Jul. 5, 2011, the entire disclosure of which is incorporated herein by reference. -104-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010153075 | 2010-07-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201219450A true TW201219450A (en) | 2012-05-16 |
TWI576369B TWI576369B (en) | 2017-04-01 |
Family
ID=45441244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100123676A TWI576369B (en) | 2010-07-05 | 2011-07-05 | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5939157B2 (en) |
KR (1) | KR101831008B1 (en) |
CN (2) | CN104774157A (en) |
TW (1) | TWI576369B (en) |
WO (1) | WO2012005266A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104220488B (en) * | 2012-02-01 | 2017-05-31 | 日产化学工业株式会社 | New diamine, polymer, aligning agent for liquid crystal, liquid crystal orientation film and use its liquid crystal display cells |
KR102367765B1 (en) * | 2014-09-18 | 2022-02-24 | 닛산 가가쿠 가부시키가이샤 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4094764B2 (en) | 1999-03-30 | 2008-06-04 | Jsr株式会社 | Liquid crystal alignment agent |
JP2000281783A (en) | 1999-03-31 | 2000-10-10 | Kanegafuchi Chem Ind Co Ltd | Novel diamine and novel polyimide composition prepared by using same |
DE60106213T2 (en) * | 2000-01-24 | 2006-03-02 | Rolic Ag | PHOTOACTIVE POLYIMIDES, POLYAMIDIC ACIDS OR ESTERS WITH SIDE-STANDING, PHOTOVER-TERM GROUPS |
JP5019038B2 (en) * | 2007-04-18 | 2012-09-05 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal display element, and polymer and raw material diamine for the same |
KR100837788B1 (en) | 2007-06-13 | 2008-06-13 | 한국화학연구원 | Method for preparing a polyamic acid photoalignment film having a photoreactive aromatic ring side chain group and a liquid crystal cell using the same |
JP5057056B2 (en) | 2007-08-03 | 2012-10-24 | Jsr株式会社 | Liquid crystal aligning agent, method for producing liquid crystal aligning film, polyamic acid, polyimide and diamine compound |
KR101169862B1 (en) * | 2007-10-26 | 2012-07-31 | 제이에스알 가부시끼가이샤 | Liquid crystal aligning agent, method for forming liquid crystal alignment film and liquid crystal display device |
WO2009104468A1 (en) * | 2008-02-22 | 2009-08-27 | 株式会社Adeka | Liquid crystal composition containing polymerizable compound, and liquid crystal display element comprising the liquid crystal composition |
JP5527538B2 (en) * | 2009-10-06 | 2014-06-18 | Jsr株式会社 | Liquid crystal aligning agent, method for producing liquid crystal aligning film, and liquid crystal display element |
-
2011
- 2011-07-05 WO PCT/JP2011/065400 patent/WO2012005266A1/en active Application Filing
- 2011-07-05 CN CN201510203659.1A patent/CN104774157A/en active Pending
- 2011-07-05 JP JP2012523888A patent/JP5939157B2/en active Active
- 2011-07-05 TW TW100123676A patent/TWI576369B/en active
- 2011-07-05 CN CN201180042059.1A patent/CN103097946B/en active Active
- 2011-07-05 KR KR1020137002550A patent/KR101831008B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104774157A (en) | 2015-07-15 |
JP5939157B2 (en) | 2016-06-22 |
CN103097946B (en) | 2015-09-30 |
KR20130041150A (en) | 2013-04-24 |
CN103097946A (en) | 2013-05-08 |
KR101831008B1 (en) | 2018-02-21 |
JPWO2012005266A1 (en) | 2013-09-05 |
TWI576369B (en) | 2017-04-01 |
WO2012005266A1 (en) | 2012-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101170417B1 (en) | Photocrosslinkable materials | |
TWI510519B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same | |
TWI520948B (en) | A liquid crystal alignment device, a liquid crystal alignment device, a liquid crystal display device, and a liquid crystal display device, and a polymerizable compound | |
TWI429617B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
TWI669344B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW201219379A (en) | Liquid crystal-aligning agent, liquid crystal-aligning film, liquid crystal display element and method for producing liquid crystal display elements | |
TWI441801B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
TWI620769B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW201125925A (en) | Liquid crystal alignment agent, liquid crystal display element, polyamic acid, polyimide and compound | |
TW200911884A (en) | Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, and liquid crystal display device | |
KR101890015B1 (en) | Composition for photo-alignment layer and photo-alignment layer | |
TW200837462A (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device and optical member | |
TW201527846A (en) | Liquid crystal aligning agent and liquid crystal display element using same | |
TW201514248A (en) | Liquid-crystal orientation treatment agent, liquid-crystal orientation film, and liquid-crystal display element | |
TWI478959B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device and a compound using the same | |
TWI617595B (en) | Liquid crystal alignment agent, liquid crystal display element obtained, and method of manufacturing the same | |
TWI576369B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same | |
JP6424609B2 (en) | Liquid crystal alignment agent, method of manufacturing liquid crystal display element, liquid crystal alignment film and liquid crystal display element | |
TW201609968A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
KR102073437B1 (en) | Polymer, liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, and diamine | |
JP6753392B2 (en) | Polyimide precursor, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the precursor. | |
JP6662307B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | |
CN114830024A (en) | Liquid crystal alignment film, radical generating film, and method for manufacturing horizontal electric field liquid crystal cell |